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1 General introduction 
1.1 Traditional medicine in Tanzania 
Tanzania is a relative large country with a total area of 945,087 square kilometres, which is 
located in the eastern part of the African continent. Tanzania’s population is estimated to be 
about 45 million people as per national census of 20121, whereby about 35 million (69.1%) of 
the people live in rural areas. Approximately 68% of the population live below the poverty line 
of $1.25 a day and 90% of the poor population live in the rural areas2,3. Despite the existing 
poverty in the country, Tanzania is endowed with a great abundance of floral diversity which is 
estimated to constitute about 12,667 plant species of which 1122 are endemic. About 10% of 
the plant species are reported to be used for traditional medicinal purpose4,5.  
Traditional medicinal practices are a vital component of healthcare in Tanzania. Although the 
modern health care is increasing, more than 60% of Tanzania’s population and actually 80% of 
the rural people rely on traditional medicine as their primary health care6,7. In the year 2000, 
there were about 80,000 traditional medicinal practitioners (TMPs) and 1,500 doctors in the 
country, giving a ratio of TMP to patients of 1:400 while the ratio for medical doctors to 
patients was 1:30,0004,8,9 . This clearly describes the better access to traditional medicine as 
compared to the modern healthcare. Additional reasons for the high dependency on traditional 
medicine are the existing poverty, cultural conservatism, lack of reliable and affordable 
conventional health care services4,6,10. 
The traditional medicinal system in Tanzania is characterized by two categories of disease 
aetiology namely natural and supernatural causes11. Natural causes of sickness include such as 
cold, heat, infections and imbalance in the basic body elements. Supernatural causes of 
illnesses are mainly witchcraft and spiritual causes resulting from penalties incurred for sins and 
breaking taboos. The most prevalent natural diseases which often cause the reason for seeking 
medical attention are parasitic diseases such as malaria and intestinal worms; diseases caused 
by bacterial infections due to inadequate potable water and poor hygienic conditions such as 
cholera, typhoid, acute respiratory infections, pneumonia, skin and eye infections, diarrhoeal 
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diseases and others such as anaemia, perinatal conditions and tuberculosis to mention a 
few12,13. 
TMPs cures the natural caused diseases mostly by using medicinal plants. Medicinal plants are 
available throughout the year. Furthermore, they are easily accessed by people who have 
limited contact to modern health services and by low income earners who are equipped with 
the curative knowledge of the particular plants14. In Tanzania, traditional medicinal knowledge 
and practices have been passed on mainly orally among people as well as TMPs from one 
generation to another. In some cases the medicinal knowledge remains the secret to the 
particular TMP until the old age, not till then he/she passes on the knowledge to a selected 
member of the family. If the TMP encounters sudden death, the knowledge gets lost. 
Despite the great abundance of medicinal plants in Tanzania, their curative effectiveness and 
applicability by a large population, traditional medicine practices are threatened by a lack of 
reliable documentation which has made its promotion difficult within the country. 
Furthermore, medicines derived from plants are currently only limited regulated. There is no 
national pharmacopoeia, no monographs and no safety assessments to demonstrate harmful 
effects of these medicines7. There is also no restriction for selling traditional medicine in the 
market which as well threatens the biodiversity7.  
Regulatory effort to promote and standardize traditional medicine in Tanzania is underway. In 
1974, the government established the Traditional Medicine Research Unit as part of the 
University of Dar es Salaam and the Muhimbili Medical Centre15,16. In 1991, the name of the 
unit was changed to Institute of Traditional Medicine which is now located in Muhimbili 
University of Health and Allied Sciences. The Institute is responsible for research on traditional 
healing systems in Tanzania, to identify useful practices which can be adopted, modernized and 
developed into drugs for use to improve human health. Furthermore, the Institute is carrying 
out clinical observations and toxicological studies as a means to promote safe products and 
identifying and discouraging harmful products. Additionally, it is intending to promote trade in 
herbal medicines, as a way to contribute to national growth and poverty reduction. The 
Institute is also planning to promote community based cultivation of medicinal plants and the 
sale of their extracts and possibly isolated pure compounds within the country and abroad 
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which in the future will promote commerce in medicinal plants and, therefore, become a 
source of income for the people. 
1.2 Aim of the research work 
Tanzania has more than 120 ethnic groups which hold immense knowledge on traditional 
medicinal practices serving on healing several human ailments. Among Tanzania’s ethnic groups 
the Maasai are renowned for their traditional medicinal practices and they greatly rely on 
medicinal plants17,18. Maasai consume medicinal plants as part of their diet in form of herbal 
soup, tea, tonic, decoction and infusion19. Among the common and frequently utilized 
medicinal plants in their area are e.g. Myrica salicifolia, Pappea capensis, Flacourtia indica and 
Vangueria apiculata. Despite the frequent utilization of these plants and its alleged medicinal 
potent, reliable documentation on their traditional medicinal use, drug preparation, 
ethnopharmaceutical information, phytochemical composition and pharmacological 
characterization to prove their medicinal efficacy are scarce. 
Therefore the aim of this research work was, to conduct a detailed survey and document 
information on Maasai traditional medicinal use of these four medicinal plants in Arusha and 
Manyara regions, north-eastern Tanzania.  
In addition to the ethnopharmacological study, plant material should be collected to allow 
subsequent phytochemical characterization of the plants. Following, phytochemical 
characterization of M. salicifolia bark should be done to identify potential active compounds 
that could be responsible for documented activity and usage of the drug. 
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2 Ethnopharmacological survey of four Maasai traditional medicinal 
plants 
Ethnopharmacological survey is a common and crucial method which involves inquiring and 
gathering information on healing abilities of traditional medicines within one or different ethnic 
groups. It is a tool for preserving indigenous traditional medicinal knowledge for future 
generation. Furthermore, ethnopharmacological survey paves a way to scientific investigation, 
proof and validation of the gathered information through phytochemical and pharmacological 
characterization, hence complementing to drugs discovery by pharmaceutical industry20. In this 
study ethnopharmacological survey of four Maasai medicinal plants was conducted in Manyara 
and Arusha regions of the north-eastern Tanzania. 
2.1 The Maasai  
2.1.1 Culture 
Maasai is an ethnic group residing in the north-eastern area of Tanzania extending up to the 
south area of Kenya. They originate from the Nilotic people indigenous to the Nile valley in the 
north of Africa who came to southeast Africa through the way of South Sudan. Maasai is a 
linguistic term, referring to speakers of the Eastern Sudanic language (Maa) of the Nilo-Saharan 
family19. Maasai are a pastoral people, herding cattle, sheep and goats, and sometimes donkeys 
as their source of income and wealthy symbol21,22. Unlike many other ethnic groups in Tanzania, 
Maasai have managed to maintain most of their traditional life style and by doing so they have 
become famous touristic attraction. Maasai are semi nomadic people who have no fixed homes 
and move from one place to another with cattle in searching for pasture. Maasai nomadic life 
has permitted them to have access to various biological resources, which has contributed to an 
enormous traditional knowledge on their landscape21,23. 
Generally, Maasai are divided into sixteen tribe sections with differences in customs, 
appearance, leadership and dialects. These sections are known as the Keekonyokie, 
Loodokolani, Purko, Wuasinkishu, Matapato, Laitayiok, Loitai, Damat, Dalalekutuk, Kisonko, 
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Kaputiei, Kankere, Lmoitanik, Loitokitoki, Larusa, and Sikirari. The sections residing in the north-
eastern area of Tanzania are the Loitai, Kisonko and Larusa section19,21,23. 
In addition to tribe sections, Maasai are characterized by age groups which is the basic political 
and social structure is their rigid system. The age set is primarily applied to the men, women 
become members of the age set through their husbands. Every five to seven years, a new age 
group of the young generation of about 14 years old is initiated into adult life through 
circumcision. The group formed is given a name and lasts throughout the life for its members. 
The oldest groups which were existing in north-eastern Tanzania by the time the survey was 
conducted were Makaa and Landisi while the youngest groups were Korianga and Nyangulo 
(Morans - the junior warriors). 
The Maasai live in small circular houses which are loosely constructed (Kraals) and fenced with 
acacia thorns or long strong poles to prevent lions from attacking their cattle21,22 (Figure 2.1). 
The houses do not have windows and contain only one small door. Inside the house a skin of an 
animal (normally a cow skin) is placed on the ground for warmth. Their houses are always 
smoky and dark due to their habit of cooking inside the house using firewood. In the Maasai 
community, women are responsible for constructing houses using mud, grass, wood and cow 
dung, while men are responsible for making the fence. Habitually, Maasai live with extended 
families in the kraals21. 
Other peculiar characteristics of the Maasai include the application of red ochre to their bodies 
(Figure 2.2), the long hair worn by the Morans (junior warriors), ear piercing and the stretching 
of earlobes, the coils of wire worn on the limbs of the women, the loads of beaded jewellery 
placed around the neck and arms and their colourful tradition sheets (shuka) wrapped around 
the body. The shuka is worn by both men and women and varies in colour depending on the 
occasion. 
Traditionally, Maasai depends on their animals for food such as milk, meat, animal blood, 
honey, plants barks and leaves. In recent days they have begun to consume other foods like 
maize meal beans, rice, potatoes and others19. 
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Figure 2.1: Maasai houses. Left: Fence of long poles. Right: Small round houses fenced with acacia thorns. 
 
 
 
Figure 2.2: Maasai clothing and decorations. Left: Moran worn long hair, stretched earlobes and smeared with red 
ochre (www. sneezr.ca. 05.10.2015). Right - up: Maasai women with shuka and beads decoration 
(www.gettyimages.com. 06.10.2015). Right - low: Morans with shuka and beads decorations (www.reuters.com. 
06.10.2015). 
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2.1.2 Maasai and medicinal plants utilization 
Maasai have been utilizing medicinal plants for years and they are deep-rooted in their life. The 
dependency on medicinal plants is contributed by the immense knowledge they have on nature 
and also by their life in the isolated remote areas where by modern health care is inaccessible 
and unavailable, just like other pastoral areas of East Africa. However, this knowledge is 
declining due to changes towards a more western lifestyle, overgrazing and over exploitation of 
plant resources have already led to a decline of the plant material available18. 
At their early stage of life children are taught about the medicinal value of herbs21,24. 
Traditionally, it is the duty of Maasai young boys to look after small goats and sheep around 
their homes. During this process, they also learn about medicinal plants which are used at 
home. Maasai young boys and the Morans are further trained on medicinal knowledge during 
their tradition meat eating festival and healing retreat (Orpul). In the Orpul festival, apart from 
meat eating, meditation, remembrance of ancestor spirits and celebration, young boys and 
Morans are detailed trained on which medicinal plants are used for the treatments of common 
ailments so that primary health care is provided at the household level25. In another side, young 
Maasai girls obtained their knowledge of medicinal plants from their mothers and 
grandmothers, with whom they spend a lot of time18,23. 
Maasai utilize herbs when they are healthy as well as in sickness situation. In a healthy 
condition, Maasai consume boiled herbal mixtures of bark and roots in soup for improving 
conditions of the stomach and the blood. Additionally, herbal mixtures are used by Morans 
preparing for attacks. For example, the Pappea capensis Eckl. & Zeyh (Sapindaceae) and Acacia 
nilotica (L.) Willd. ex Del. (Fabaceae) are taken as a digestive, excitant, for prevention of hunger 
and thirst. They are also known for preventing fatigue and fear in the wilderness18,26. 
During sickness, Maasai use herbal remedies derived from trees and shrubs for curing minor 
ailments in their home. Some of the diseases treated at home are such as: malaria 18,23,  
gonorrhea and other sexual transmitted diseases, stomach infections18,23,27, painful joints, 
pregnancy disorders, tooth problems, eye infections19, colds and throat infections18,28,29 to 
mention a few. However, for persistent and chronic sicknesses, they seek for professional TMPS 
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consultations23. From the medicinal knowledge they possess, one medicinal plant can be used 
for the treatment of more than one diseases. 
2.2 Surveyed medicinal plants 
The survey should include plants which are prevalent in the area and are commonly used for 
the treatment of diseases by the Maasai. On this basis, four plants were selected, including 
Myrica salicifolia, Pappea capensis, Flacourtia indica and Vangueria apiculata. 
Although preparations of the selected medicinal plants are frequently applied, documentation 
about ethnomedicinal uses, traditional preparation methods, dose administration, 
contraindications and overdose control methods within the area is scarce. Additionally, there is 
only little or no scientific data about phytochemistry of these plants nor any reliable scientific 
investigation about active compounds, bioactivity and healing potential. 
 
2.2.1 Myrica salicifolia A. Rich. 
2.2.1.1 Botany 
Myrica salicifolia A. Rich. is also known as Olkitalaswa (Maasai). It belongs to the family 
Myricaceae of the order Fagales and the former genus Myrica. The genus was divided into two 
genera: Myrica and Morella where by M. salicifolia is now belonging to the genus Morella as 
detailed described in chapter 3 section 3.1.1. The former species name of Myrica salicifolia will 
be used in this study. 
M. salicifolia may grow like a shrub or a tree of up to a height of 12 m30,31 (Figure 2.3 Left). The 
leaves of M. salicifolia are shiny, pale green when young and turn to tinged maroon when 
mature (Figure 2.3 Right - up). They are simple, irregularly serrated and arranged in alternate 
manner31. The bark of M. salicifolia is brown-maroon in colour. The flowers are small and very 
densely, yellow, fragrant and dotted with oil glands, male and female are separate32. The fruits 
of M. salicifolia are crowded small (2 - 4 mm) drupes in nature turning to dark blue purple when 
ripe (Figure 2.3 Right - down). M. salicifolia is reported to be spread in many mountainous 
ranges in Tanzania above 1,200 m high and prefers shallow soil, heath and rocky areas32. The 
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species is distributed mainly in Tanzania, Kenya, Uganda, Rwanda, Burundi, Ethiopia, DR Congo, 
Yemen and Saudi Arabia30,32. 
 
 
Figure 2.3: Left: A small tree of M. salicifolia at Ngorongoro conservation area. Right - up: M. salicifolia leaves. 
Right - down: Fruits of M. salicifolia at Miriakamba area, Arusha National Park. 
 
2.2.1.2 Ethnomedicinal uses  
Traditional medicinal use of M. salicifolia has been previously reported in Tanga – Tanzania. The 
decoction of the M. salicifolia leaves mixed with other plants leaves are used for treatment of 
swellings on the cheek and face. The powdered, dry stem bark of M. salicifolia is mixed with 
honey and eaten against cough. The bark of M. salicifolia is chewed to cure toothache. 
Decoction of the bark is mixed with milk and given to children as a tonic. Roots are used as a 
slow acting medicine in stomach troubles and for headaches. Pounded young leaves are mixed 
with ghee and rubbed on skin diseases33. Additionally, in Bukoba, Tanzania, infusion and 
decoction of M. salicifolia bark and/or root are used for the treatment of HIV/AIDS 
opportunistic diseases such as tuberculosis, chronic diarrhoea, cryptococcal meningitis, and 
herpes simplex34. 
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In Ethiopia, pulverized young leaves of M. salicifolia are mixed with butter and used externally 
to treat skin diseases35. In Western Uganda, oral consumption of boiled pounded roots and 
barks of M. salicifolia has been used for the treatment of men sexual impotence and erectile 
dysfunction36. 
2.2.1.3 Phytochemistry and biological activity 
Geyid et al.37 conducted a phytochemical screening on methanolic extracts of stem bark and 
leaves of M. salicifolia and discovered the presence of polyphenols, unsaturated 
sterols/triterpenes, saponins, glycosides and carbohydrates. Furthermore, these authors found 
that a methanolic extract of M. salicifolia stem bark at high doses of 2 mg/mL was effective 
against Bacillus cereus, Neisseria gonorrhoeae, Shigella dysenteriae and Staphylococcus aureus. 
Njung’e et al.38 carried out an in-vivo testing of a methanolic extract of M. salicifolia on 
laboratory mice regarding its analgesic, antipyretic and anti-inflammatory activity. They 
discovered that M. salicifolia methanolic extract exhibited potent analgesic and antipyretic 
activity at a concentration of 100 mg/kg.  
 
2.2.2 Pappea capensis Eckl. & Zeyh. 
2.2.2.1 Botany 
Pappea capensis Eckl. & Zeyh., also known as Oltimigomi (Maasai), mbamba ngoma (Swahili), 
jacket plum (English), belongs to the family Sapindaceae in the order Sapindales. It is a long-
lived, hardy, evergreen, small to medium tree with a height of 2 - 8 m but occasionally exceeds 
12 m, with a dense, rounded crown32 (Figure 2.4 Up). P. capensis grows in open and grassy 
woodland, rocky outcrops and brackish flat areas, sometimes in the bush close to rivers or dry 
river vicinities39. The leaves of P. capensis are alternate, simple, oblong, hard-textured and 
wavy. They are crowded at the ends of the branches as shown in Figure 2.4 Left - down. The 
leaf margin changes from sharply toothed in young leaves to almost smooth in mature leaves. 
The leaves are paler green below, wavy, rough and leathery. P. capensis has small greenish or 
pale yellow flowers in spikes to 12 cm, male are located at the end and female at the base of 
the spike32 (Figure 2.4 Middle – down). The bark is grey-brown in colour. The fruits of P. 
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capensis are furry green capsules, round and velvety. They have a diameter of over 1 cm. When 
the fruits ripe they split open to expose a bright red flesh containing a brown seed32 (Figure 2.4 
Right - down). P. capensis is drought resistant and adapts to wide temperature variations32,39. 
The species is mainly found in Tanzania Namibia, Botswana, Swaziland Mozambique, 
Zimbabwe, Zambia, Malawi, Kenya, DR Congo, Ethiopia, Eritrea and South Africa32. 
 
 
Figure 2.4: Up: P. capensis tree at Ngorongoro conservation area. Left - down: P. capensis leaves. Middle - down: 
Flowers of P. capensis (www.kumbulanursery.za). Right - down: P. capensis fruits (http://www.wildcard.co.za). 
 
2.2.2.2 Ethnomedicinal uses 
Ethnomedicinal use of P. capensis has been previously reported from other areas of Tanzania 
and Africa. In Morogoro region - Tanzania, P. capensis is used for treatment of aches and 
pains40. In Bukoba region, decoction of P. capensis leaves is used for treating chicken pox and 
back aches41. 
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In Kenya, infusion taken from roots, stem and bark of P. capensis is used for the treatment of 
chronic joints pain in Machakos and Makueni area27. It is also documented that bark or leaves 
decoction is taken with soup to treat stomach problems and diarrhoea28,29.  Kiringe18 reported 
that bark of P. capensis boiled in water and then sieved. The mixture is taken for arthritis 
treatment. Furthermore, roots of P. capensis boiled in water and thereafter mixed with soup 
are used for the treatment of appetite loss and reduced body strength by Morans of Kaijiado18. 
An oral application of P. capensis bark decoction for the treatment of post-partum 
haemorrhage is documented in Machakos district42. Further use of P. capensis roots decoction 
is reported in Machakos for the treatment of morning sickness, typhoid, amoebic dysentery and 
abdominal pains43. In South Africa, oil extracted from the seeds, bark, leaves and roots of P. 
capensis are used for the treatment of ringworm and baldness, venereal diseases, chest 
complaints, sore eyes and constipation44. Moreover, leaves of P. capensis are used for the 
treatment of venereal diseases, painful eyes and as aphrodisiac45. 
2.2.2.3 Phytochemistry and biological activity 
Phytochemical data and information about the pharmacological activity of P. capensis are 
scarce. A phytochemical screening of P. capensis leaves revealed the presence of phenolics, 
flavonoids, gallotannins and condensed tannins45.  
Dichloromethane (DCM) and petrol ether (PE) extracts of P. capensis leaves were found to have 
good anti-inflammatory activity by inhibition of both cyclooxygenases 1 and 2 (COX-1 and COX-
2). In addition, methanolic and water extracts of P. capensis leaves exhibited good anti-HIV-1 
reverse transcriptase activity. DCM, PE, ethanol and water extracts of P. capensis leaves also 
exhibited moderate to high antimicrobial activities against Neisseria gonorrhoeae, Bacillus 
subtilis, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Candida albicans. 
Literature data describing the detailed phytochemical composition and pharmacological activity 
of P. capensis barks and roots are not existing to date. 
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2.2.3 Flacourtia indica (Burm. f.) Merr. 
2.2.3.1 Botany 
Flacourtia indica (Burm. f.) Merr. Also known as alaimoronyai (Maasai), mchongoma or 
mugovigovi (Swahili), governor’s plum (English). It belongs to the genus Flacourtia, family 
Salicaceae and the order Malpighiales. F. indica is a deciduous tree or a bushy shrub often 
grows up to 7 m and sometimes up to 15 m maximum46 (Figure 2.5 Up). It is armed with axillary 
thorns and with tufts of branched thorns on the stem (Figure 2.5 Middle - down). The bark of F. 
indica is usually pale, grey, powdery, may become brown to dark grey and flaking, revealing 
pale orange patches. Leaves are red or pink when young, variable in size, oval to round in 
shape, they are leathery and have toothed edge, contain 4 - 7 pairs of veins clear on both 
surfaces32 (Figure 2.5 Left - down). Flowers are small, cream, and fragrant. Male flowers with 
very many yellow stamens, female flowers with a divided spreading style32,46. Fruits are 
globular, reddish to reddish-black or purple when ripe, fleshy, up to 2.5 cm across, contained up 
to 10 brown flattened, wrinkled seeds (Figure 2.5 Right - down). F. indica grows naturally in dry 
forest, woodland, bushland, thickets and in the wooded grassland. The species is drought 
resistant, prefer full sun for best growth but can tolerate light shading. It is found throughout 
Tanzania46. F. indica is distributed worldwide in the following countries: Botswana, Burundi, 
Cameroon, Democratic Republic of Congo, Eritrea, Ethiopia, India, Kenya, Malawi, Namibia, 
Nigeria, Rwanda, Sierra Leone, Cuba, Dominica, South Africa, Tanzania, Uganda, Zambia, 
Zanzibar, Zimbabwe, Exotic :Antigua and Barbuda, Barbados, China, Dominican Republic, 
Grenada, Indonesia, Jamaica, Madagascar, Malaysia, Puerto Rico, Seychelles, Sri Lanka, St Kitts 
and Nevis, St Lucia, St Vincent and the Grenadines, Trinidad and Tobago, Virgin Islands of 
United States32. 
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Figure 2.5: Up: F. indica tree at kikavu area, Kilimanjaro. Left - down: F. indica leaves. Middle - down: Thorns of F. 
indica. Right - down: F. indica fruits (http://www.especies-seeds). 
 
2.2.3.2 Ethnomedicinal uses 
In other areas of Tanzania fruits of F. indica are used for treatment of jaundice and enlarged 
spleens. Decoction of leaves and roots are taken for the treatment of schistosomiasis, malaria, 
and diarrhoea. Further to this, roots are used for hoarseness, pain reliever, diuretic, 
pneumonia, intestinal worms and as an astringent 46. 
The Lobedu tribe of South Africa takes decoction of root for relief of body pain. Leaves are used 
as expectorant for asthma, pain relievers, treatment of gynaecological complaints, pneumonia 
and ring worms47. 
In India and Bangladesh, fruits are used for treatment of jaundice and enlarged spleen, barks 
are used for the treatment of intermittent fever, roots are applied for treating nephritic colic 
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and gum is used in cholera treatment48. Additionally, bark infusion is suitable as a gargle for 
hoarseness, and roots are used in treatment of skin diseases, pruritus, nephropathy and 
scabies. Gum is administered along with other ingredients in cholera. Ground seeds mixed with 
turmeric and dried ginger is applied in form of a paste on woman body to reduce body pain 
after delivery48–50.  
In Madagascar, the bark is triturated in oil and used as anti-rheumatic liniment, the root and 
ash have been used as remedy for kidney complaints47. 
 
2.2.3.3 Phytochemistry and biological activity 
Phytochemical screening of a methanolic and aqueous extracts of F. indica revealed the 
presence of steroids, alkaloids, tannins, saponins, flavonoids, glycosides, phenolic compounds 
and terpenoids51. Individual structures that were isolated and elucidated from F. indica include 
flacourtin - a phenolic glucoside ester52, pyrocatechol, homaloside D and poliothrysoside53, 
mururin A, coumarin, scoparone and aesculetin54 (Figure 2.6). 
Previous literature reports on biological activity of F. indica in several in-vivo and in-vitro 
testing. In-vitro antioxidant activity of a methanolic and aqueous extract of F. indica leaves was 
evaluated by Tyagi et al.51. They showed, that the two extracts possess potent free radical 
scavenging and antioxidant activity at a concentration of 18 µg/mL. The same group 
investigated the in-vivo anti-asthma activity of the same extract on histamine-induced 
bronchospasm in guinea pigs, and reported that the extract was effective in reducing the 
symptoms of bronchial asthma and also improved the lung function parameters of asthmatic 
subjects55. Kaou et al.53 analysed the anti-malaria activity of the compounds isolated from the 
aerial part of F. indica, i.e. pyrocatechol, homaloside D and poliothrysoside, and discovered that 
poliothrysoside had three times higher activity against the chloroquine-resistant strain of 
Plasmodium falciparum type W2 as compared to pyrocatechol and homaloside D. 
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Figure 2.6: Compounds isolated from F. indica. 1: pyrocatechol, 2: aesculetin, 3: scoparone, 4: coumarin, 5: 
mururin A, 6: homaloside D, 7: poliothrysoside, 8: flacourtin. 
 
 
2.2.4 Vangueria apiculata K. Schum. 
2.2.4.1 Botany 
Vangueria apiculata K. Schum., belongs to the family Rubiaceae and the order Gentianales. It is 
also known as Olgumi (Maasai) and Mviru (Swahili)56. V. apiculata is a deciduous shrub or small 
spreading tree 1.8 - 15 m tall57,58 (Figure 2.7: Left). It has several stems which often branch 
horizontally. Leaves are opposite, elliptic oblong, ovate to lanceolate, up to 17 cm long, 
distinctly acuminate at the apex, glossy green, mostly hairless but sometimes finely pubescent 
beneath. The margin is entire but wavy; petioles are 0.5 - 1.5 cm long (Figure 2.7: Right - up). 
The bark is greyish-brown to reddish-brown, smooth or finely ridged. Flowers are greenish-
white, up to 1 cm in diameter with a conspicuous tuft of fine white hairs in the throat of the 
corolla. They are found in lax to dense untidy axillary heads. Fruits of V. apiculata are 
subglobose, sometimes asymmetric, 1.5 - 2.5 cm in diameter, green to brown, hairless when 
ripe (Figure 2.7: Right - down). They grow in a riverine thicket, evergreen forest, open 
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woodland and montane grassland, often among rocks. The plant is very adaptable, tolerates 
some drought and a wide range of soils57–59. V. apiculata is reported to be found in tropical 
countries of Africa such as Tanzania, Sudan, Ethiopia, Rwanda, eastern DR Congo, Uganda, 
Kenya, Malawi, Mozambique, Zambia and Zimbabwe57,59. 
 
 
Figure 2.7: Left: V. apiculata tree at Monduli district. Right - up: V. apiculata leaves and flowers. Right - down: V. 
apiculata unripe fruits.  
 
2.2.4.2 Ethnomedicinal uses  
In north-western Tanzania, the Haya tribe use decoction made from V. apiculata leaves for the 
treatment of diabetes60. 
In Uganda, decoction of V. apiculata leaves is drunk for the treatment of constipation 61. Boiled 
decoction of V. apiculata roots is drunk three times a day for the treatment of intestinal 
worms62,63. Oral consumption of V. apiculata root juice is used for the induction of labour 
during child birth64. 
In east Africa, leaves of V. apiculata are chewed and juice is swallowed for treatment of 
stomach ache. Leaf infusion is drunk for the treatment of body swelling and warts. Burned stem 
ash are licked for the treatment of tuberculosis62.  
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2.2.4.3 Phytochemistry and biological activity 
Despite their alleged traditional medicinal effectiveness, there is no previous reported study on 
biological activity and chemical constituents of V. apiculata.   
2.3 Description of the surveyed area 
The ethnopharmacological survey was conducted in Arusha and Manyara regions located at the 
corner of north-eastern Tanzania between latitudes 2.07235 S and 5.39669 S south of the 
equator, longitudes 35.48332E and 37.4818E east of prime meridian (Figure 2.8). The area is 
bordered to Kenya in the north; Kilimanjaro and Tanga region in the east; Dodoma in the south; 
Singida, Shinyanga and Mara region in the east. The area is estimated to be 82,428.5 km2 
whereby 3,571 km2 (4.3%) is covered by water bodies and 78,857.5 km2 is land area. The water 
bodies in the area include Lake Eyasi, Lake Manyara, Lake Babati and Lake Natron. The 
population of the area is estimated to be about 3.1 million inhabitants as per Tanzania national 
census of 20121, with about 1.7 million people living in Arusha and about 1.4 million people in 
Manyara region respectively. 
Administratively, the area is divided into eleven districts: Karatu, Arusha, Arumeru Monduli, 
Longido and Ngorongoro in Arusha region; Babati, Simanjiro, Kiteto, Hanang and Mbulu in 
Manyara region.  
Several ethnic groups are found in the area with the Maasai being the main tribe in Kiteto, 
Simanjiro, Monduli and Ngorongoro. The Iraqw tribe is mainly found in Mbulu, Babati, Karatu 
and Hanang districts. The Meru and Arusha tribes are dominating the Arumeru and Arusha 
Municipality. Furthermore, the small tribes of Barbaig, Sonjo and Hadzabe (Tindiga) form a 
minority group which depends on hunting for livelihood. They are located in Hanang and 
Ngorongoro districts65. 
Altitudinal range of the area is estimated to range between 900 and 1,600 m (3,000 - 5,200 ft.) 
in elevation above sea level. The vast altitudinal ranges have contributed to non-uniformity of 
climatic conditions. The area experiences temperatures between 25 - 31οC during the hottest 
season (November - February) and 13 – 20 οC in the coldest season (May - August). 
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Furthermore, the average annual temperature in the highland areas is estimated to be 21 οC 
and 24 οC in the lowlands65.  
Concerning the rainfall, the area is classified as a dry and semi-dry area, with a noticeable dry 
season and a rainy season. Two types of rainfall patterns exist in the area; the monomodal and 
bimodal rainfalls. Monomodal rainfalls are experienced from November to April with an 
average annual rainfall range of about 800 - 1000 mm. This occurs in the southern part of the 
area which includes the districts of Babati, Hanang, Kiteto, Mbulu and Karatu. This type of 
rainfall is generally reliable and has made these districts to be the major cereal crops producers 
of the area. The remaining districts of Ngorongoro, Simanjiro, Arusha, Arumeru, Longido and 
Monduli experience bimodal rainfalls, which are characterized by both a short and a long rain 
period with an annual average precipitation of 1000 - 1200 mm. The short rains normally occur 
from October to December, while the long rains last from February to June. The whole area 
experiences a dry season between July and October65. 
The vegetation of the area is characterized by savannah with high floral diversity. It can be 
divided into four natural vegetation zones, namely wooded bushlands, wooded grasslands, 
bushed grasslands and open grasslands. The latter is estimated to cover 80% of the area.  
 
 
Figure 2.8: Map of Tanzania showing the location of the surveyed area (www.mapsofworld.com - 28.09.2015). 
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2.4 Methods 
2.4.1 Informant selection  
Informant selection was achieved through purposive sampling based on knowledge and 
practices on traditional medicine. Village Executive Officers were involved in obtaining a list of 
highly experienced traditional medicinal practitioners (TMPs) in a particular village and also 
identifying those who use medicinal plants for treatment without witchcrafts. Thereafter, 
identified TMPs were well informed about the study and requested for their participation 
consent. Then appointments for the interviews were planned prior the interview session. In this 
study, 65 TMPs (36 male, 29 female) aged between 50 - 75 years were selected and 
interviewed. Selected TMPs acquired the knowledge from their forefathers and mothers. The 
interviewed TMPS were residing in different villages of the four districts of Arusha (Monduli and 
Ngorongoro) and Manyara (Simanjiro and Kiteto) regions.  
 
2.4.2 Interviews and data collection 
Interviews with TMPs and ethnopharmacological data collection about the four medicinal 
plants Myrica salicifolia, Pappea capensis, Flacourtia indica and Vangueria apiculata was carried 
out from January to March, 2013. The interviews were built on the trust to conserve the 
knowledge of medicinal plants utilization and to improve health care situation not only in 
Maasai area but also in other parts of the country. The interviews were conducted in informal 
meetings with individual TMP and in group discussions as shown in Figure 2.9. Groups of TMPs 
were formed in the area where more than one TMP was willing to participate in the interview. 
The formed groups consisted of either men only or women only. The information to be 
documented from the group of TPMs was taken after consensus was reached between the 
TMPs and was regarded as single information. Interviews were conducted in Maasai language 
and translated to Swahili language with exception of few cases where TMPs understood and 
could speak Swahili. Translation of Maasai to Swahili was done by a person who understood 
both languages Maasai and Swahili. 
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The interviews were guided with a prior prepared semi-structured open ended questionnaire 
(Figure 2.10). TMPs were asked about tradition medicinal use of the selected plants, part(s) 
used, preparations methods, drug administration, diseases treated, side effects and overdose 
control. In addition, TMPs were requested to show the medicinal plants after the interview for 
control as depicted in Figure 2.11. In cases where these plants were found only very far from 
their home, TMPs were asked to collect them for identification by a botanist.  
A global positioning systems (GPS) was used to record the sites where interviewed TMP were 
located and also where plants samples for later phytochemical investigation were collected. 
All collected data were summarized in a Microsoft Excel 2013 sheet. 
 
 
Figure 2.9: Pictorial presentation of how interviews were conducted. Up - left: A group of female TMPs at Enduleni 
village, Ngorongoro district. Up - right: A group of male TMPs at Emairete village, Monduli district. Down - left: 
Individual male TMP (right) and his son (translator), at Esilalei village, Monduli Arusha. Down - right: Individual 
female TMP at Sepeko village Monduli, Arusha. 
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Figure 2.10: Questionnaire used for the interviews of TMPs during the ethnopharmacological survey. 
 
 
 
Figure 2.11: TMP showing V. apiculata, for control at Emairete village, Monduli district- Arusha. 
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2.4.3 Plant identification and preparation of herbarium specimens 
All described and collected plants were identified by the skilled botanists Mr Daniel Sitoni from 
National Herbarium of Tanzania and Mr Canisius J. Kayombo from Olmotonyi Forestry Institute, 
both situated in Arusha, Tanzania. Additionally, plant specimens were collected (Figure 2.12), 
pressed, dried, mounted on a sheet, labelled and kept at National Herbarium of Tanzania and 
Olmotonyi Forestry Institute, Arusha, Tanzania (Figure 2.13, 1 – 4). The voucher number for the 
collected plant specimen are: M. salicifolia (CK 7792), P. capensis (CK 7789), F. indica (CK 7790) 
and V. apiculata (CK 7791). 
 
 
Figure 2.12: Botanist (Mr. Daniel Sitoni) preparing a herbarium specimen of M. salicifolia during field work. 
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Figure 2.13: Herbarium specimens of the four surveyed medicinal plants. 1: M. salicifolia. 2:  P. capensis. 3: F. 
indica and 4: V. apiculata.  
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2.5 Results  
2.5.1 TMPs location and plants samples collection sites 
In this survey, a total of 65 TMPs from 50 villages of the four districts of Arusha and Manyara 
regions were interviewed.  
16 TMPs from 11 villages of Monduli district: Emairete (3), Mti mmoja (3), Mswakini juu (2), 
Esilalei (1), Lemoyoni (1), Makuyuni (1), Lokisale (1), Moita bwawani (1), Engaruka chini (1), 
Engaruka juu (1) and Selela village (1).  
19 TMPs from 14 villages of Ngorongoro district: Osinoni (1), Enduleni (1), Olerobi (2), 
Nainokanoka (2), Erkepus (2), Nakurro (1), Alailalei (1), Ngoile (1), Oloipiri (1), Sakala (1), 
Masurumunyi (1), Samunge (1), Digodigo (1) and Engarasero village (3).  
21 TMPs from 17 villages of Simanjiro district: Narakauo (2), Njiro (2), Laangai (1), Narosoito (1), 
Namalulu (1), Sukuro (2), Terrat (2), Loswaki (1), Ngage (1), Loiborsot B (1), Landanai (1), 
Naberera (1), Rotiana (1), Kitwai A (1), Loibosiret (1), Emboreet (1) and Loibosit A village (1).  
9 TMPs from 8 villages of Kiteto district; Ndedo (1), Ndaleta (1), Mbigiri (1), Kibaya (1), Loolera 
(2), Lembapuli (1), Namelok (1) and Irkiushbor village (1).  
The percentage of TMPs interviewed from each district is summarized in the pie chart below 
(Figure 2.14). All interviewed TMPs were from Maasai ethnic group with exception of 4 TMPs. 2 
of those TMPs were from Sonjo and 2 from Arusha ethnic group, but they all also practiced 
Maasai traditional medicine. 
A GPS was used to determine and record all locations where interviews were conducted as well 
as the plant collection sides (Figure 2.15, Appendix 6.1 and 6.2). 
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Figure 2.14: Percentage of TMPs interviewed in every surveyed district (n = 65). 
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Figure 2.15: A map showing TMPs location (green) and plant sample collection sites (red). 
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2.5.2 Traditional description of the documented diseases 
A number of different diseases were documented to be cured by the four medicinal plants. 
During the survey, TMPs were asked to describe each disease they mentioned and the way they 
diagnose the disease from the patient. TMPs reported, that they mainly diagnose diseases by 
taking a history of the patient in combination with physical diagnosis such as body temperature 
(measured by touching the body), face condition (swollen, pale and/or shine), stomach 
inflammation, hand palm colour, colour of the eyes, colour of the urine and other visible signs 
of inflammation. It was observed, that TMPs have similar description of diseases commonly 
affected their community as summarized in Table 2.1. 
 
Table 2.1: TMPs description of the mentioned diseases. 
Name of a disease Swahili name  Description given by TMPs  
Asthma Pumu Painful and difficult breathing. 
Back pain Maumivu ya mgongo Pain at the back bone. 
Bile oversecretion Nyongo kujaa Feeling nausea in the morning (morning 
sickness) and sometimes associated with 
high body temperature.    
Blood loss Kupungukiwa damu Low blood volume after sickness, poor diet 
and after delivery. This is detected by 
paleness of eyes and hand palm. 
Breast inflammation 
during lactation 
(Mastitis) 
Matiti kujaa maziwa na 
kuuma 
Breast diseases appear especially during 
the first twelve weeks postpartum. 
Diagnosed by painful inflamed breasts. 
Colic Chango Abdominal cramps and pains.   
Diarrhoea Kuharisha Condition of having frequent liquid bowel 
movement. 
Dizziness Kizunguzungu A feeling of faint and unsteady. 
Enlarged spleen Kuvimba bandama Inflamed spleen (diagnosed by inflamed 
stomach).  
Eye infection/sticky eyes Ugonjwa wa macho Yellow/creamy discharge from the eye, 
increased redness of the eye/eyelids. 
Fever Homa High body temperature, shivering and 
headache. 
Gonorrhoea / STDs Kisonono/ Magonjwa ya zinaa Painful and burning sensation during 
urination followed by pus discharge both in 
women and men. 
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Table 2.1 continued 
Name of a disease Swahili name  Description given by TMPs  
Gouts Gauti Painful inflamed knee joint. 
Jaundice Homa ya nyongo ya manjano Yellowish pigmentation of the skin, the 
whites of the eyes and other mucous 
membranes. 
Joint pain Maumivu ya viungo Painful inflamed joint and sometimes 
associated with joint stiffness. 
Libido/Erectile 
dysfunction 
Kupungukiwa na nguvu za 
kiume 
Inability to develop or maintain an erection 
for men during sexual performance. 
Malaria Malaria Body weakness, headache, appetite loss, 
cold sensation, high body temperature, 
headache and nausea. 
Pneumonia Nimonia Severe and painful coughing, chest pain, 
high body temperature, and difficulty 
breathing. 
Phlegmon Jipu la tambazi A painful inflammation (a boil like) which 
spreads on skin, and release pus after some 
days.  
Stomach upset Tumbo kujaa Stomach pain, cramps and a sense of 
fullness. 
Urination problems Matatizo ya mkojo Painful and difficulty urination. 
Running nose/ flue Mafua Continuous light mucus flow from nose. 
Sinus / Tension 
headache 
Kipanda uso Severe pains on the forehead at the upper 
part of the eyes. 
Severe prolonged cough 
/ Tuberculosis 
Kikohozi kisichopona/ Kifua 
kikuu 
Persistent coughing associated with chest 
pain and sputum. 
Tonsillitis Ugonjwa wa mafindofindo Red, swollen tonsils, sore throat, 
experiencing pain during swallowing, high 
body temperature. 
Liver problems Ugonjwa wa ini The liver problem is detected by inflamed 
abdomen and legs (Oedema). In some cases 
the body colour turns to yellowish. 
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2.5.3 Medicinal uses of the selected plants 
It should be noted that for all four surveyed plants the percentage of respondents on every 
mentioned disease was calculated based on the total number of interviewed TMPs (n = 65). The 
reason for the percentage of respondents not to be 100% is due to TMPs do not using the 
particular plant for the treatment of a particular disease. 
 
2.5.3.1  Myrica salicifolia 
M. salicifolia was mainly reported to treat gonorrhoea (81%), running nose (73%), back pains 
(66%), sinus headache (61%), severe cough (55%), joint pains (47%) and immunity boosting 
(46%). Other diseases alleged to be treated by M. salicifolia were reported to be abdominal 
pains, pneumonia, gouts, urination problems, fever, tonsillitis, colic, liver problems, diarrhoea, 
tuberculosis and malaria. Reported diseases which are treated by M. salicifolia are summarized 
in Figure 2.16 and Appendix 6.3.  
 
 
Figure 2.16: Reported diseases treated by M. salicifolia. The chart shows the percentage of responding TMPs that 
use the plant for the treatment of a specific disease. 
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2.5.3.2  Pappea capensis 
The most mentioned diseases to be treated by P. capensis was mainly: enhancement of libido 
(89%), blood loss (72%), joint pains (69%), back pains (58%), general body strength (50%), 
abdominal pains (32%) and malaria (30%). Other diseases reported by TMPs were such as: bile 
over secretion, stomach upset, diarrhoea, gouts, sexual transmitted diseases (STDs), appetizer, 
urination problems, fever and colic. A summary of the reported diseases treated by P. capensis 
is shown in Figure 2.17 and Appendix 6.3. 
 
 
Figure 2.17: Reported diseases treated by P. capensis. The chart shows the percentage of responding TMPs that 
use the plant for the treatment of a specific disease. STDs = Sexual transmitted diseases. 
 
2.5.3.3  Flacourtia indica 
Among others, F. indica was commonly applied to treat fever (92%), malaria (90%), jaundice 
(87%), enlarged spleen (86%), joint pains (75%), pneumonia (73%), stomach upset (69%), 
difficulty breathing (69%) and back pains (66%). Other diseases mentioned to be treated by F. 
indica were; gouts, mastitis breasts, asthma, dizziness, body strength, urination problems, 
diarrhoea, STDs, bile over secretion, phlegmon and burn wounds. In Figure 2.18 and Appendix 
6.3 the diseases which were reported to be treated by F. indica are summarized. 
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Figure 2.18: Reported diseases treated by F. indica. The chart shows the percentage of responding TMPs that use 
the plant for the treatment of a specific disease. STDs = Sexual transmitted diseases. 
 
2.5.3.4  Vangueria apiculata 
The most mentioned applications for V. apiculata were eye infection (73%), diarrhoea (66%), 
stomach upset (64%), reduced milk secretion (50%), general body strength (46%) and joint 
pains (36%). Further mentioned diseases were such as back pain, gouts, malaria and lungs pain. 
Figure 2.19 and Appendix 6.3 shows an overview of the diseases reported to be treated by V. 
apiculata. 
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Figure 2.19: Reported diseases treated by V. apiculata. The chart shows the percentage of responding TMPs that 
use the plant for the treatment of a specific disease. 
 
2.5.3.5 Diseases reported to be treated by all four plants 
Some diseases were reported to be treated by each of the surveyed plants, including joint pain, 
back pain, gouts, diarrhoea, malaria and stomach upset. Also all the four plants were used to 
increase body strength or boost immunity. Figure 2.20 summarizes the diseases treated by all 
four plants and also allows a direct comparison of the frequency of usage a distinct plant. 
Noteworthy is the prominent role of F. indica for treatment of malaria (90.7%) and gouts 
(50.7%), V. apiculata for the treatment of diarrhoea (66.1%) and treatment of stomach upset or 
abdominal problems by F. indica (69.2%) and V. apiculata (64.6%). 
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Figure 2.20: The percentage of responding TMPs that use a specific plant for a specific disease is indicated for each 
plant. 
 
 
2.5.4 Plant parts used and medicinal preparation 
Bark and roots of M. salicifolia were frequently mentioned by TMPs to be utilized for remedy 
preparation. Stems were also mentioned to be used but less often as compared to roots and 
bark. Leaves of M. salicifolia were not reported to be applied in the area for medicinal 
purposes. 
From the survey it was further discovered, that, bark and roots of P. capensis are the most 
utilized plant parts for medicinal purposes. Again, stems are less utilized and leaves were not 
mentioned at all to be used for medicinal purposes. 
Likewise, roots and bark of F. indica are the most frequent utilized parts of the plant followed 
by stems. Leaves were not reported to be used for medicinal purposes. 
V. apiculata turned out to be the only plant among the four surveyed plants whose leaves are 
used for medicinal purposes. Utilization of V. apiculata leaves was mentioned for the treatment 
of eye infection. In addition to that bark, stems and roots were also mentioned to be used for 
remedy preparations. 
The roots and bark which are the most utilized plant parts of all the four plants are believed to 
have stronger medicinal effect as compared to stems. It was further mentioned by TMPs that 
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utilization of stems is opted for, when they do not have possibility of getting bark and roots out 
of the plant. Figure 2.21 and Appendix 6.4 shows the percentage summary of the frequency 
the plant parts of the particular plant were mentioned to be used by interviewed TMPs in 
treatment of different diseases. 
 
 
Figure 2.21: Plant parts used for medicinal purposes of the four plants. 
 
Similar remedy preparation methods of the four medicinal plants were reported during the 
interviews (Appendix 6.5).  The preparation procedure starts by crushing the respective 
(dried/fresh) plant part. The remedy obtained from crushed plant part is prepared by 
decoction, infusion, maceration, mixing drug in a boiling black tea or boiling drugs with a 
mixture of water and ghee. Furthermore, infusions, decoctions, fresh pounded plant parts or 
powder mixed into boiling fatty beef or goat or lamb soup was further reported to be an 
effective preparation method of Maasai drugs. Thereafter, an herbal soup is warm consumed. 
The mentioned methods of herbal remedy preparations are commonly practiced in the area not 
only for the four surveyed medicinal plants but also for other medicinal plants. Decision to use 
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which method was reported to depend on the convenience of the TMPs and the available 
resources. For example, the presence or absence of milk, ghee, and fatty meat for soup can 
determine which remedy preparation method is used. 
Preparation of herbal remedies by infusion method is achieved through mixing crushed plant 
parts in warm water, thoroughly stirring and leaving to stand for few hours before utilization. 
Likewise, decoction is achieved by boiling crushed plant parts with water for some time and 
leaving to cool before utilization.  
A medicinal tea was reported to be prepared by adding one teaspoon of dried powdered herb 
in a boiling tea with milk, leaving to boil for few minutes. Then the tea is filtered and consumed. 
 
 
2.5.5 Drug administration and ethnopharmaceutical information 
Oral consumption of drug remedies was the main reported administration method. Exceptions 
were the inhalation of M. salicifolia bark powder for the treatment of sinus headache and eye 
washing using V. apiculata leaves as remedy for the treatment of eye infection (Appendix 6.5). 
One pinch of fine powder of M. salicifolia bark is placed on the hand of a patient suffering from 
sinus headache, then a patient is required to close one nostril by pressing against the side of 
the nose with a finger and inhale with one hole and the same is done for the other nostril.  The 
administration is usually once followed by multiple sneezes and mucus discharge. 
For the treatment of eye infection, a filtered decoction or infusion of V. apiculata leaves 
(preferably from fresh pounded leaves) is used to wash the infected eyes two to three times a 
day until total recovery is experienced.  
Drug administration by the different interviewed TMPs was not uniform in terms of 
concentration, dosage and application time. There exist no established ratios concerning the 
amount of crushed medicinal plant to that of water used for remedy preparation. 
It was further noted, that children and pregnant women are given less amount of prepared 
drug remedy compared to adult men and women. For example, a child or pregnant woman 
would take about 250 mL as compared to adult men and women who would take about 500 -  
1000 mL of the prepared drug remedy at one time depending on body weight and regardless of 
the concentration.  
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Time for drug remedy administration was also observed not to be uniform. Some TMPs 
reported a certain unit of prepared drug remedy is taken three times a day prior/after food 
consumption and others reported that prepared drug remedy (no amount specified) is taken in 
replacement of water every time a patient is thirsty. Furthermore, duration of prepared drug 
remedy administration was reported by many respondent TMPs to be three to seven days or 
longer until relief or total recovery is experienced. 
Ethnopharmaceutical information such as general accompanying symptoms observed after 
drug remedy administration, severe side effects and contraindications of the four medicinal 
plants were also documented in this survey and summarized in the Table 2.2.  
General accompanying symptoms are those symptoms which are expected by TMPs to happen 
after drug administration to a patient as a result of drug reaction. However, severe drugs side 
effect were not clearly known except for M. salicifolia, which was reported to cause gastric 
ulcers when the patient does not eat well during medication. 
 
Table 2.2: Observed accompanying symptoms following drug administration, severe side effects and reported 
contraindications. 
Plant name Observed accompanying symptoms Severe side 
effects 
Reported 
contraindication 
M. salicifolia Sweating, increased heart beat rate is observed 
following oral consumption. Multiple sneezes and 
nasal mucus discharge is observed immediately after 
inhalation of drug powder for a patient with 
sinus/tension headache. Thick pus, thread like 
discharge followed after urination is observed on 
patient with gonorrhoea after 3 days of treatment and 
that is the marker of recovery from the diseases. 
Gastric 
ulcers may 
develop if a 
patient does 
not eat well. 
Not to be taken 
during 
pregnancy, by 
children under 10 
years and when 
on prescription 
of other 
medication.  
P. capensis Nausea, sweating, frequent urination and fatigue may 
be observed as a result of medicinal reaction of a 
patient, liquid bowel movement may also be observed. 
None 
reported 
Not to be taken 
when using other 
medications. 
F. indica Sweating, dizziness and fatigue are observed. Relief 
and total recovery is observed after 2 - 7 days of 
treatment. 
None 
reported 
None reported 
V. apiculata Fatigue and drowsiness are observed. Relief of the 
mentioned diseases is observed after 2 - 3 days of 
treatment. 
None 
reported 
None reported 
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2.5.6 Traditional management of overdose symptoms 
From the survey, overdose signs following herbal remedy consumption were reported, 
although not occurring very often. However, all interviewed TMPs reported to have 
experienced overdose symptoms from some of their patients. Reported overdose symptoms 
were rise in body temperature, high heart beat rate, body trembling, worsened of patient 
condition few hours following remedy consumption and in some cases unconsciousness and 
even death may occur if the situation is not quickly controlled. 
It was further mentioned that the common methods used by Maasai for management of 
overdose symptoms are cold bath, consumption of cold milk, fatty beef/goat/lamb soup and 
consumption of soup prepared from goat or lambs entrails mixed with fresh animal blood. 
Additionally, it was reported that most overdose cases are experienced when the consumed 
herbal remedies are prepared by decoction or infusion (very strong remedies). Less overdose 
symptoms are experienced when the consumed herbal remedy was prior mixed with fatty soup 
or in tea containing milk. The mechanism on how the overdose symptoms are controlled was 
not reported. 
 
2.5.7 Other uses of the surveyed plants 
In addition to the medicinal uses, also some other, non-medicinal uses of the plants were 
documented in this survey.  
Decoctions or infusion remedies from M. salicifolia bark or roots are used as appetizer during 
Maasai meat festival when huge amounts of meat are consumed. Further to this, is has been 
reported by TMPs, that prolonged intake of the remedies rises anger and aggressiveness and 
lowers sexual desire of Morans as well as elder men. Hence, they use it to get a sense of 
courage and fearlessness towards dangerous wild animals when they are out in the wilderness 
with their cattle.  
The infusion of P. capensis was reported to be used as appetizer, tonic and for thirsty 
prevention especially for Morans (Maasai young men) when they are exposed to the sun for a 
long time in the wilderness feeding cattle. The same infusion remedy is taken by Maasai during 
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dry seasons and in the villages where access to portable water is limited. Fruits of P. capensis 
are edible and leaves are used for ruminant fodder. 
The fruits of F. indica are edible and reported to be very delicious. The thorns of the plant are 
used for traditional ear piercing and the leaves serve as ruminant fodder.  
The fruits of V. apiculata are also edible. The dried stems of the plant are used as fire wood and 
the leaves often serve as ruminant fodder. V apiculata is highly used in the area for making 
walking supporting sticks for elder men as well as Morans. 
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2.6 Discussion 
2.6.1 General observations from the survey  
Maasai ethnic group is well known to have sound knowledge of traditional medicine which is 
among others mainly practiced with the aid of medicinal plants utilization 21,23. The sound 
knowledge concerning traditional medicine was also demonstrated in this study where by 34 
different diseases were reported to be cured by the four surveyed medicinal plants (Appendix 
6.3). 18 diseases were reported to be treated by M. salicifolia (Figure 2.16, ), P. capensis was 
reported to cure 16 diseases (Figure 2.17), 20 diseases were indicated to be cured by F. indica 
(Figure 2.18), and V. apiculata is used to treat 10 diseases (Figure 2.19). Some of the diseases 
were mentioned to be treated by more than one of the surveyed medicinal plants as indicated 
in Figure 2.20. The commonly mentioned diseases treated by all surveyed plants in this study 
were malaria, sexually transmitted diseases, reduced body strength/lower immunity, joint pain, 
back pain, diarrhoea and stomach upset and/or abdominal pain. These diseases often affect the 
Maasai community and are caused by hard physical work, long walking distances, cultural life 
style and hygiene problems to mention a few.  
The hard physical work and frequent long walking distance have often resulted to back and 
joint pain complaints in the Maasai community. Polygamy cultural life style practiced in the 
Maasai culture has been the cause of prevalence of STDs within their community. Further to 
this, frequent consumption of red meat i.e. goat, lamb and beef has contributed to gout 
problems. Lack of portable water and general hygiene problems have also contributed to 
frequent sound diarrhoea, stomach upset and abdominal complaints.  
The majority of the Maasai do not rely on modern medication in the first place to treat these 
common mentioned diseases as well as other diseases affecting them due to their conversancy 
in traditional medicine. Moreover, remoteness of their living premises has caused limited 
accessibility to modern health care facilities. Addition to that, poverty prevalence in many 
Maasai families has prevented them to afford modern medications. Apart from that, even those 
who are in position to pay for the modern health care facilities do often seek for the traditional 
medicine help until when the condition is persistent or worsened. Then this is the time they 
attend to the nearest hospitals to seek for western based consultation and medication. 
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The survey results also showed the inconsistency regarding the amount of remedy 
administered and dosage. Unlike to modern medication where chemical constituents, 
concentration and dosage are uniform and well described to the patient, the active substances 
and their concentration in the traditional remedies are not known by the TMPs, all what they 
know is that the remedy cures. According to the interviewed TMPs, the overdose risk of Maasai 
medicinal remedies exists and sometimes leads to death. However, this survey revealed the 
traditional ways to control overdose symptoms as described in section 2.5.6. Additionally, TMPs 
have knowledge on poisonous plants hence they are not involved in their remedies. They also 
have different methods for remedies preparation which reduce the drug strength, e.g. mixing a 
decoctions or infusions with milk tea or with fatty soup. 
The medicinal potential of the four surveyed medicinal plants was witnessed from the reported 
diversity of the diseases treated by their remedies. Additionally, acquired information exhibited 
that all interviewed TMPs either use two plants or all of the four plants in their remedies and at 
least all TMPs knows about the four plants.  
 
2.6.2 Preservation and transfer of traditional medicinal knowledge in the area 
The current study revealed the threat of disappearance of Maasai medicinal knowledge within 
the area in the future. All interviewed skilled TMPs were in the senior age, majority being in the 
age group between 50 - 75 years and even older. These skilled TMPs are the most consulted in 
case of chronic diseases situation and when home treatments fails.  
The formal western education and religious issues are seen to have an impact on the young 
generation practicing traditional medicinal practices in the Maasai community. The majority of 
the young generation who acquire formal education and have converted to Christianity were 
observed to have only basic knowledge of traditional medicine. Additionally, they do not have 
much time to further acquire the medicinal knowledge from the elders because of their 
engagement in acquiring formal education and most of their time is spent at schools away from 
their homes. Majority of the TMPs interviewed during the survey had the feeling that there is a 
lack of respect and interest among the young generation, especially regarding to those who 
have formal education and/or have converted to Christianity.  
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Moreover, it was observed that medicinal knowledge transfer to the young generation is only 
done by word of mouth from elder men to young men and the same applies from elder women 
to young women. No documentation is done during the knowledge sharing. The continuous 
decrease of the senior population and the seeking of formal education for the young generation 
may contribute to a significant loss of Maasai traditional medicinal knowledge. Therefore, 
detailed knowledge documentation is highly needed for preservation purposes. 
 
2.6.3 Medicinal plants conservation in the area  
It was discovered from the survey that roots and bark are the most utilized plant parts for 
preparation of medicinal remedies of the four investigated plants. It was further revealed that, 
most of the medicinal plants are harvested in the wild area. Only very few families have planted 
some of the medicinal plants in their home surroundings for conservation purposes as well as 
getting them easily without going to the wilderness whenever they need them. Additionally, 
the medicinal plant parts are largely sold in the local markets. The dependency on medicinal 
plants for treatment of diseases and the overuse of the medicinal plants by selling them in the 
market for economic reasons threaten the environment as well as biodiversity. 
The concern of medicinal plants protection is understood to a certain extent in the surveyed 
area. The interviewed TMPs are aware of the need of protecting the medicinal plants. 
Whenever they harvest plant parts they make sure that they leave most of the tree or bush 
behind so that it can survive. They also believe that cutting the whole plant can lead to curse 
generation on a particular person. Addition to that, a group of Maasai youth (Morans) 
responsible for the environment protection were found in villages of Monduli and Ngorongoro 
districts. Their duties were to direct TMPs and other plants harvesters on where to harvest at 
that particular time and make sure that the harvesters do it safely without leaving the 
harvested plant in a dying condition. 
Besides the little conservation efforts by Maasai, several big problems are obvious. Over-
grazing, deforestation, and prolonged drought, which was observed in some village areas of 
Simanjiro and Ngorongoro districts due to climate change, has increased the threat of 
disappearance of some plants in this area. Hence, this calls a need of addressing some 
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intervention strategies before the situation is worsened and Maasai loose the basis for their 
traditional medicinal plant medicine. 
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2.7 Conclusion 
The ethnopharmacological survey of four commonly used medicinal plants (M. salicifolia, P. 
capensis, F. indica and V. apiculata) in the Maasai community of north-eastern Tanzania has 
resulted to documentation of 34 different diseases alleged to be treated by these plants. 
However, the response rate of TMPs on the usage of particular plant against particular diseases 
reflects, that each plant has a strong effect or is highly reliable in treatment of some diseases 
and less in other diseases. The reasons why certain plants are highly used against particular 
diseases and less in treating others could be belief, location and the knowledge transfer from 
one TMP to another.  
It was further observed, that traditional medicine is a preferred form of primary medical care as 
compared to modern health care which is consulted after the traditional medicine fails. This is 
contributed to cultural conservatism, life in the wilderness and poverty. Traditional medicinal 
practices constitute and will remain a key role in Maasai community, including the use of 
medicinal plants for the treatment of various health problems. 
Additionally, threat of disappearance of the bold traditional medicinal skills was evident to the 
young generation of the surveyed area. This is a clear alert signal, that a proper documentation 
to preserve and promote the Maasai ethnomedicinal practices knowledge has to be done. 
There is also the need of thorough phytochemical and pharmacological investigations. This will 
provide scientific medicinal support for the usage of the four surveyed medicinal plants as well 
as improve preparation methods and safe administration of drug remedies in terms of dosage. 
The high dependency on medicinal plants in Maasai area also calls for strategies to protect the 
plants and for measures to promote their sustainable utilization. It was observed that a few of 
the TMPs already have started domesticating some medicinal plant in their homestead and care 
during harvesting of medicinal plants is taken. But the conservation measures which are taken 
at the moment will not suffice in the long term as the demand for medicinal plants is growing. 
Hence, strong conservation strategies are highly recommended, considering that the main 
reported plant parts used for medicinal purposes are roots and bark. 
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3 Phytochemical investigation of Myrica salicifolia A. Rich bark 
3.1 Introduction and background 
3.1.1 The genus Myrica  
The genus Myrica is native to warm temperate and subtropical regions in the world such as 
Africa, Asia, Macaronesian islands, and warm temperate and subtropical North, Central, and 
South America. It belongs to the family Myricaceae and is characterized by shrubs (up to 1 m) 
and small trees (up to 20 m), minority being deciduous and majority being evergreen. The 
species of the genus Myrica grow in nitrogen depleted soil such as gravelly sites and sandy soil 
due to their ability of nitrogen fixation by their root nodules which is induced by the Frankia soil 
actinomycetes66,67. 
In former times the genus Myrica was comprised of about 55 species distributed worldwide67. 
Recently, the genus Myrica is divided into two genera, the Myrica and Morella genus based on 
identified differences in their morphological characteristics as indicated in Table 3.1. Therefore, 
some of the species which belonged to the genus Myrica are now belonging to the genus 
Morella, Myrica salicifolia being among them. Following Myrica genus splitting, the Morella 
genus is now the biggest genus comprising of approximately 50 species distributed in Africa, 
Europe, Asia and America (Figure 3.1). The genus Myrica comprises of the remaining species 
such as M. gale, M. nagi and M. esculenta68.  Distribution is shown in Figure 3.2. The Myrica 
genus reclassification has posed some challenges in natural product research, as most of the 
authors are still using the species former scientific names and some using the current scientific 
names, which is confusing when searching for literature data. In this work the former species 
name M. salicifolia will be used. 
 
 
 
 
 
Phytochemical investigation of Myrica salicifolia A. Rich bark 
46 
 
Table 3.1: Morphological characteristic distinguishing the genera Myrica and Morella69. 
Character Myrica Morella 
Leaves Thin, deciduous, entire or feebly dentate. 
Stomata sunken. 
Leathery, evergreen, entire or dentate. 
Stomata not sunken. 
Flowering Catkins inserted on the deciduous branches.  
Usually 4 stamens.  
Catkins inserted on the growing branches. 
From 4 - 8 (-20) stamens. 
Fruit Subtended by 2 spongiose bracteoles.  
Bracteoles strongly adnate with fruit wall. 
Fruits are in a dense sub cylindric spike. 
Dry and lacking wax.  
Bracteoles absent.  
Bracteoles not adnate with fruit wall. 
Fruits are mainly in a loose cluster. 
Fleshy and mostly waxy. 
 
 
 
Figure 3.1: World map showing distribution of the new genus Morella in shaded areas69. 
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Figure 3.2: World map showing distribution of the current Myrica genus in shaded areas69. 
 
3.1.2 Phytochemical composition of the former genus Myrica 
The Myrica species, not all but quite a number of them, are used for medicinal purposes in the 
countries where they are found. In Japan and China, remedies from different parts of Myrica 
rubra are taken for treatment of gastrointestinal disorders, headaches, burns, skin diseases and 
inflammatory diseases70. Bark, leaves and fruit juices of Myrica esculenta are used in India for 
the treatment of asthma, bronchitis, fever, lung infection, dysentery, toothache, worms, 
jaundice and wounds71–74. Myrica nagi is employed in China, India, Nepal and Pakistan for the 
treatment of cardiovascular diseases, bronchitis, gonorrhoea, diuresis, dysentery, epilepsy, 
gargle, haemoptysis, hypothermia, catarrh, headache, menorrhagia, putrid sores, typhoid and 
wounds75,76. Myrica cerifera is applicable in North America for treating irritable bowel 
syndrome, ulcerative colitis, digestive system disorders, diarrhoea, dysentery, leucorrhoea, 
mucous colitis, colds, stomatitis, sore throat, measles and scarlet fever, convulsions, nasal 
catarrh and jaundice71,77. In southern African countries, Myrica serrata is used for treatment of 
asthma, shortness of breath, painful menstruation, cold, coughs, headaches, enhancement of 
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male sexual performance, management of sugar related disorder and as laxative to treat 
constipation78,79. The leaf extract of M. gale is used as antiviral agent80, addition to that M. gale 
is appropriate for the treatment of ulcers, intestinal worms, cardiovascular disorders and aching 
muscles71,81. 
Owing to its medicinal benefits and other economic importance (not described in this thesis) of 
the Myrica species, studies to investigate Myrica phytochemical constituents are continuously 
conducted for years mainly in Asian countries such as Japan, China, India and few studies from 
Europe. Phytochemical investigation on barks, fruits, leaves and roots of some Myrica species 
revealed the presence of tannins, cyclic diarylheptanoids, flavonoids, triterpenes and others. 
 
3.1.2.1 Tannins 
Tannins constitute a major wide class of plant secondary metabolites normally found in leaves, 
bark, wood, fruits and roots. They form a complex group of water soluble polyphenols 
characterized by higher molecular weight ranging between ≥500 to ≥3000 Dalton and their 
ability to bind to proteins and form tannin protein complexes. Chemically, tannins are classified 
into three main structural groups: hydrolysable tannins (HTs), condensed tannins/ 
proanthocyanidins (PAs) and complex tannins. However, only the two groups of tannins, HTs 
and PAs are reported in Myrica to date. 
HTs are derived from esterification of hydroxyl groups of β-D-glucose with gallic acid (Figure 
3.3). HTs containing mostly a core polyol moiety of β-D-glucose and are further classified as 
ellagitannins and gallotannins based on their structural variations82,83. 
Gallotannins are simple HTs resulting from further attachment of galloyl groups on 
pentagalloylglucose through a characteristic meta-depside bonds (Figure 3.4 A). Unlike 
gallotannins, ellagitannins are esters of hexahydroxydiphenic acid (HHDP) formed after 
oxidative C-C coupling between adjacent neighbouring galloyl moieties of pentagalloylglucose 
molecule (Figure 3.3 and Figure 3.4 B)82,84. The most common linkages occur between galloyl 
groups attached to position C2 and C3 and/or position C4 and C6 of the glucose moiety, but it is 
also possible for the combination of different linkages to occur at other positions84. Apart from 
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ellagitannins containing a glucopyranose ring there are some which contain a unique feature of 
open chain glucose and they have been identified to contain a 2,3- linked HHDP unit84,85. 
 
 
Figure 3.3: 1: gallic acid. 2: meta-depside bond digalloyl ester. 3: pentagalloylglucose. 5: hexahydroxydiphenoyl 
(HHDP) ester formed through oxidative coupling between C-C linkages of the two adjacent galloyl residues (4). 
 
 
Figure 3.4: 1: Gallotannin; 2-O-digalloyl-1,3,4,6-tetra-O-galloyl-β-D-glucopyranose. 2: Ellagitannin; nupharin A. 
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Condensed tannins (syn. proanthocyanidins (PAs)) are polyphenolic secondary metabolites of 
the flavan-3-ols. They are oligomers and polymers built by flavan-3-ol units. PAs are classified 
on the basis of hydroxylation patterns on the B ring of monomeric flavan-3-ol and the linkages 
between flavan-3-ol units. Based on hydroxylation patterns of their constitutive units PAs are 
divided into three groups, namely propelargonidins ((epi-/ent-) afzelechin), procyanidins ((epi-
/ent-) catechin) and prodelphinidins ((epi-/ent-) gallocatechin) as it is indicated in Figure 3.5. 
Further to the hydroxylation pattern, the nomenclature of the monomeric units depends on the 
configuration at position C2 and C386 (Figure 3.6). The configuration determines prefixes to be 
used such as epi- for epimer and ent- for enantiomer. 
 
Figure 3.5: Flavan-3-ol monomeric unit of PAs. R1, R2 = H, propelargonidins; R1 = H, R2 = OH, procyanidins; R1, R2 = 
OH, prodelphinidins. 
 
 
Figure 3.6: Possible configurations of common naturally occurring flavan 3-ol. Example of dihydroxylated flavan-3-
ol. 
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PAs are further classified either as A-type, B-type or C-type PAs depending on their interflavan 
linkages in the PAs chain. The monomeric units of oligomeric and polymeric PAs of the B- and C-
type are single linked by either C4 of an upper unit to C6 or C8 of the lower unit (Figure 3.7, 1 
and 3). The A-type PAs are double linked through additional ether linkage between C2 of the 
upper unit and C5 or C7 of hydroxyl function of an A- ring of the lower unit (Figure 3.7, 2). The 
complete name assignment and absolute configuration of PAs dimers, oligomers and polymer is 
achieved when the position and stereochemistry of the interflavan bond is specified. 
Additionally, PAs can be esterified, glycosydated or methylated with other molecules at position 
C3 or C5. The most common esters of PAs are the 3-O-gallates formed with gallic acid and 
PAs84,86. 
 
Figure 3.7: A-, B- and C-type PAs. 1: B-type, prodelphinidin B1 (epigallocatechin-(4β→8)-gallocatechin). 2: A-type, 
ephedrannin D5 (epigallocatechin-(2β→7,4β→8)-ent-gallocatechin). 3: C-type, procyanidins C1 (epicatechin-
(4β→8)-epicatechin-(4β→8)-epicatechin). 
 
3.1.2.1.1 Tannins from Myrica sp. and their biological activities 
Phytochemical and biological studies on Myrica tannins are limited. However, previous 
phytochemical investigations on different plant parts of few Myrica species revealed the 
presence of both, hydrolysable and condensed tannins. Castalagin, an ellagitannin isolated from 
M. esculenta87 is the only reported hydrolysable tannin from the genus Myrica to date. 
Furthermore, the reported PAs belong to the class of prodelphinidins and a few are 
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procyanidins. The individual monomeric, dimeric and even trimeric PAs of B-type and A-type 
isolated from Myrica are summarized in Table 3.2 and their respective structures in Figure 3.8. 
Tannins are known for their numerous biological activities through conducted in-vitro and/or in-
vivo studies using either a single tannin compound, fractions containing tannin 
polymers/oligomers or extracts rich in tannins. Biological activity investigations on tannins 
isolated from Myrica species are limited. However, some of the tannins isolated from Myrica 
sp. have also been found in other plant species and biological activities of these compounds 
have been reported. 
In-vitro biological activity studies on ellagitannin (castalagin) revealed its antioxidant88, 
antibacterial89, antiviral90 and leishmanicidal activity91. Additionally, PAs were shown to have 
diverse bioactivities such as antioxidant potential and beneficial effect in preventing diseases 
caused by oxidative stress and free radicals71,92–94. They also possess anti-inflammatory95, 
antimicrobial96, anti-adhesive97, antimelanogenic95, wound healing98,99, anticarcinogenic100, 
antidiabetic101, anti-angiogenic102, immunomodulatory103 activities and show cytotoxic activity 
against cancer cell lines94,103–105. 
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Figure 3.8: Structures of reported Myrica tannins. The names of the compounds are indicated in Table 3.2.
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Table 3.2: Reported Myrica PAs and their occurrence within genus. Compounds numbers refers to Figure 3.8. 
 Compound name  Myrica species 
 Monomeric PAs  
1 epigallocatechin M. rubra106, M. gale107 
2 epigallocatechin-3-O-gallate M. rubra var. acuminata108, M. rubra92,106, 
M. esculenta87, M. gale107 
3 gallocatechin M. rubra92, M. gale107 
4 gallocatechin-3-O-gallate M. rubra92 
5 epicatechin-3-O-gallate M. rubra71,93, M. gale107 
6 catechin-3-O-gallate M. gale107 
7 epicatechin M. rubra92,106 
 Dimeric PAs  
8 gallocatechin-(4α→8)-epicatechin M. gale107 
9 gallocatechin-(4α→8)-epigallocatechin, M. gale107 
10 adenodimerin C M. adenophora109 
11 prodelphinidin A-2,3’-O-gallate M. rubra var. acuminata108 
12 prodelphinidin B-2 3,3’-di-O-gallate M. rubra106,110, M. esculenta87 
13 prodelphinidin B-2 3’-O-gallate M. rubra106, M. esculenta87 
14 prodelphinidin B-1 3,3’-di-O-gallate M. rubra106 
15 procyanidin B2 M. rubra71,93  
 Trimeric PAs  
16 gallocatechin-(4α→8)-gallocatechin-(4α→8)-
gallocatechin 
M. gale107 
 Ellagitannin (HTs)  
17 castalagin M. esculenta87 
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3.1.2.2 Diarylheptanoids  
Diarylheptanoids are a group of plants secondary metabolites which occur in root bark, bark, 
inner stem, leaves and twigs111. They have a common structural feature with two aromatic rings 
linked by a linear seven-carbon chain (heptane). Diarylheptanoids are classified into two groups 
as linear and cyclic diarylheptanoids. Linear diarylheptanoids are further divided into acyclic 
diarylheptanoids which contains no oxygenic ring in the chain and epoxy diarylheptanoids 
which contain an oxygenic ring in the chain (Figure 3.9, 1 and 2). Cyclic diarylheptanoids in 
which the two phenyl groups are linked either directly or as a diaryl ether are also divided 
further into two groups depending on the position of the two phenyl groups join with each 
other and with the heptane chain, metametacyclophanes (meta,meta-bridged biphenyl) and 
metaparacyclophanes (meta,para-bridged diphenyl ether) as shown in Figure 3.9, 3 and 4. 
 
 
Figure 3.9: Compound examples for different groups of diarylheptanoids. 1: curcumin: acyclic diarylheptanoid. 2: 
centrolobine: epoxy diarylheptanoid. 3: myricanol: metametacyclophane. 4: platycarynols: metaparacyclophane.  
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3.1.2.2.1 Diarylheptanoids from Myrica sp. and their biological activities 
Cyclic diarylheptanoids are among the groups of compounds isolated over the years from the 
genus Myrica. Phytochemical data reporting the isolation of linear diarylheptanoids from 
Myrica are scarce. However, Myrica species are well known to contain biphenyl cyclic 
diarylheptanoids. The isolated biphenyl cyclic diarylheptanoids from Myrica have structural 
features variations due to the presence of carbonyl group, hydroxylation, methoxylation, and 
glycosydation patterns of the two aromatic rings and the aliphatic chain. Additionally, isolation 
of biphenyl cyclic diarylheptanoids containing galloyl and sulphate groups from M. rubra were 
reported110,112. Apart from the occurrence of biphenyl cyclic diarylheptanoids in Myrica, 
isolation of few diphenyl ethers like galleon, myrica tomentoside, myrica tomentogenin113, 
hydroxygaleon, myricananadiol114,115 and 16-methoxyacerogenin B 9-O-β-D-apianofuranosyl-6)-
β-D-glucopyranoside116 were reported (Figure 3.10). Structures and names of isolated biphenyl 
cyclic diarylheptanoids from Myrica species are shown in Table 3.3 and Figure 3.11. 
The in-vitro or in-vivo biological activity investigations performed on the cyclic diarylheptanoids 
isolated from Myrica species revealed anti-oxidative71,109,110, anti-inflammatory 
71,109,110,112,117,118, neuroprotective119, antitumor-promoting120, melanogenesis inhibitory116, 
hepatoprotective116,121 and antiandrogenic activity122. 
 
Figure 3.10: Diarylheptanoids from Myrica belong to the class diphenyl ethers. 
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Figure 3.11: Some of the isolated biphenyl diarylheptanoids from Myrica. Compound 1-12 and 13-23 are listed in 
Table 3.3. 24: myricanene A 5-O-α-L-arabinofuranosyl (1-6)-β-D-glucopyranoside117,123. 25: myricanene A 5-O-α-L-
arabinofuranosyl (1-6)-β-D-glucopyranoside117,123. 26: neomyricanone-5-O-β-D-glucopyranoside117. 27: 13-
oxomyricanol124. 28: 12-dehydroporson125. 29: myricaborin126. 
 
Table 3.3: Compound 1-12 and 13-23. Compounds numbers refers Figure 3.11. 
 Compound 1-12 (contain no carbonyl substitution at C11) 
  R1 R2 R3 R4 R5 R6 R7 R8 
1 myricanol123 OMe OMe OH H H H OH H 
2 myricananin F127 OH OMe H H H OH H H 
3 myricananin A118  OH OMe H H H H OH OH 
4 myricananin H127 OH OMe OMe H H H OH OH 
5 myricananin G127 OMe OMe OH H H H OH OH 
6 myricanol-11-O-β-D-
glucopyranoside117,127 
OMe OMe OH H H H O-glc. H 
7 myricanol-5-O-β-D-
glucopyranoside 117,127 
OMe OMe O-glc. H H H OH H 
8 11-O-β-D-
xylopyranosylmyricanol126 
OMe OMe OH H H H O-xyl. H 
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  R1 R2 R3 R4 R5 R6 R7 R8 
9 myricanol 
galloylglucoside110,116 
OMe OMe O-glc-
gall. 
H H H OH H 
10 myricanol gentiobioside128 OMe OMe O-glc-(6-
1)-glc 
H H H OH H 
11 myricanol-5-O-β-D-
glucopyranosyl-(1-3)- β-D-
glucopyranoside129 
OMe OMe O-glc-(1-
3)-glc 
H H H OH H 
12 myricanol 5-O-α-L-
arabinofuranosyl (1-6)-β-D-
glucopyranoside129 
OMe OMe O-ara-
(1-6)-glc 
H H H OH H 
 Compound 13-23 (contain carbonyl substitution at C11) 
13 myricanone117 OMe OMe OH H H H H H 
14 myricananin C118 OH OMe H H H H H H 
15 myricananone118,130 OMe OMe OH OH H H H H 
16 myricananin E118 OMe OMe OH H H H OMe H 
17 12-hydroxymyricanone118,125 OMe OMe OH H H H OH H 
18 porson125,130,131  OMe OMe OMe H H H OH H 
19 myricatomentoside II131 OMe OMe O-glc. H H H OH H 
20 myricanone-5-O-β-D-
glucopyranoside117 
OMe OMe O-glc. H H H H H 
21 5- deoxymyricanone131 OMe OMe H H H H H H 
22 myricanone 5-O-α-L-
arabinofuranosyl (1-6)-β-D-
glucopyranoside129 
OMe OMe O-ara-
(1-6)-glc 
H H H H H 
23 myricanone 
galloylglucoside110 
OMe OMe O-glc-
gall. 
H H H H H 
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3.1.2.3 Other groups of compounds from Myrica sp. 
Flavonoids are another group of compounds isolated from Myrica and there are several ones 
isolated from this genus. However, among others, the most frequent reported flavonoids from 
Myrica species are myricetin, kaempferol, myricitrin, quercetin, quercitrin, and myricetin 3-O-
(6″-O-galloyl)-β-D-galactopyranoside71,109,117,128,132,133. The structures of Myrica flavonoids are 
shown in Figure 3.12. 
 
 
Figure 3.12: Structures of flavonoids isolated from Myrica. 
 
Furthermore, identification and isolation of triterpenes from Myrica was reported. Some of the 
reported triterpenes (Figure 3.13) are teraxerol, myricadiol, myricalactone, myricolal, 
rhoiptelenol, ursonic acid, ursolic acid, acetylursolic acid oleanolic acid, oleanolic acid acetate, 
arjulonic acid, alphitolic acid, and maslinic acid117,125,128,134,135. 
Besides flavonoids and triterpenes, sterols, phenolic acids and dihydrochalcones were isolated 
from the genus Myrica. 
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Figure 3.13: Structures of triterpenes isolated from Myrica. 
 
3.1.2.4 Phytochemical investigation and biological activities of Myrica salicifolia 
Myrica salicifolia is a common traditional medicinal plant used for treatment of many ailments 
in Tanzania136 (see also chapter 2) like headache, pain inflammation and respiratory disorders 
in Ethiopia137,138. Despite of many traditional uses of M. salicifolia, literature describing its 
phytochemical characterization and bioactivity tests is scarce. 
Performed phytochemical screening on the extracts of M. salicifolia showed the presence of 
polyphenols, triterpenes, saponins and glycosides37. To date, no literature reports isolation of 
individual compounds from M. salicifolia. 
In-vivo bioactivity investigation on laboratory mice using a methanolic extract of M. salicifolia 
roots revealed potent antipyretic and analgesic activity in this experimental arragements38. 
Moreover, antimicrobial activity against Bacillus cereus, Neisseria gonorrhoea, Shigella 
dysenteriae and Staphylococcus aureus was observed for a methanolic extract of M. salicifolia 
stem bark37. 
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3.2 Materials and Methods 
3.2.1 Chemicals, solvents, reference sugars and enzyme 
Name Manufacturer 
Acetic acid 98 - 100%, for analysis Merck, Darmstadt 
Acetone, for analysis Merck, Darmstadt 
Acetonitrile, HPLC grade Merck, Darmstadt 
Chloroform, for analysis Merck, Darmstadt 
Deuterated acetone - d6, 99.8% Deutero, Kastellaun 
Deuterated chloroform - d1, 99.8% Deutero, Kastellaun 
Deuterated methanol - d4, 99,8% Sigma-Aldrich, Taufkirchen 
Deuterated pyridine-d5, 99,5% Deutero, Kastellaun 
Dichloromethane, for analysis Acros Organics, USA 
Ethanol, absolute Sigma-Aldrich, Steinheim 
Ethylacetate, for analysis Acros Organics, USA 
Formic acid 99%, for analysis Merck, Darmstadt 
Methanol, for analysis Merck, Darmstadt 
Methanol, HPLC grade Merck, Darmstadt 
Methanol, for spectroscopy (Uvasol) Merck, Darmstadt 
(S)-( +)-2-Methylbutyric anhydride, 95% Sigma-Aldrich 
4-Methoxybenzaldehyde, for analysis Merck, Darmstadt 
Diphenylboryloxyethylamine, 95% 
(Natural product reagent) 
Fluka/Sigma-Aldrich, USA  
2-Propanol, for analysis Merck, Darmstadt 
Pyridine, for analysis Merck, Darmstadt 
Sodium acetate, 99% Merck, Darmstadt 
Sodium carbonate, 99.5% Sigma-Aldrich, Taufkirchen 
Sulphuric acid, 95-97%, for analysis Merck, Darmstadt 
Toluene, for analysis VWR Chemicals, France 
Trifluoroacetic acid (TFA), 99% Sigma-Aldrich, Taufkirchen 
D-Arabinose Sigma-Aldrich, Taufkirchen 
L-Arabinose Merck Darmstadt 
D-Galactose Sigma-Aldrich, Taufkirchen 
L-Galactose Sigma-Aldrich, Taufkirchen 
Phytochemical investigation of Myrica salicifolia A. Rich bark 
63 
 
Name Manufacturer 
D-Glucose Sigma-Aldrich, Taufkirchen 
L-Glucose Roth, Karlsruhe  
D-Mannose Merck, Darmstadt 
D-Xylose  Merck, Darmstadt 
β-Glucosidase (Almond)  Roth, Karlsruhe 
 
 
3.2.2 Laboratory equipment 
Equipment  Model Manufacturer 
Analytical HPLC Elite LaChrom HPLC  
Auto sampler: L-2200 
Pump: L-2130 
DAD: L-2455 
Column oven: L-2350 
Software: EZChrom Elite 3.1.7 
VWR, Darmstadt 
CD spectrometer J-710 JASCO, Groß-Umstadt 
Centrifuge Hermle Z 365 Kontron & Hermle KG, 
Switzerland 
CPC SPOT centrifugal partition 
chromatography 
Armen Instrument, Saint-
Avé, France 
Pump: 515 HPLC pump Waters, USA 
Flash chromatography Spot Liquid Chromatography Flash Armen Instrument, Saint-
Avée,  Software: Armen Glider Flash V2.3 
Fraction collector 2111 Superrac LKB Bromma, Sweden 
Freeze dryer Ilmvac 100 with pump 302061 PK8D ILMVAC GmbH, Ilmenau 
Heating plate Thermoplate S Desaga, Nümbrecht 
Mass spectrometer ESI-MS: Finnigan MAT SSQ 710 A  Thermo Quest, Egelsbach  
LC-MS: Thermo Quest Finnigan TSQ 
7000 
Milling machine UZM ZM1 Retsch, Haan 
Yellow line A10 IKA-Werke, Staufen 
NMR spectrometer AVANCE 300 
AVANCE 600  
Software: Top spin 3.2 
Bruker, Ettlingen 
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Equipment  Model Manufacturer 
Oven Memmert Memmert, Schwabach 
Polarimeter UniPol L 1000 Schmidt and Haensch, 
Berlin 
Rotary vacuum 
evaporator 
Laborota 4003-control Heidolph, Schwabach 
Scales Analytical scale Research 160 P Sartorius, Göttingen 
Extend ED 2245 
Semi preparative HPLC ProStar HPLC  
Autosampler: 410 
Two pumps system: 210  
DAD: 335 
Fraction collector: 701 
Software: Galaxie 1.9.302.952 
Varian, Darmstadt 
Semi preparative HPLC 1260 Infinity HPLC 
Binary pump cluster: 2x G1361A 
DAD: G1315D 
Fraction collector: G1364B  
Software: Open LAB CDS Chemstation 
Edition C.01XX 
Agilent Technologies, 
Waldbronn 
TLC Sample application : Linomat 5  
Linomat syringe (100 μl) 
Photo documentation: Reprostar 3 
Software: WinCats 1.4.2 
CAMAG - Muttenz, 
Switzerland 
TLC developing chamber Twin Trough Chamber 20 x 20 cm CAMAG - Muttenz, 
Switzerland Twin Trough Chamber 10 x 10 cm 
Ultrasonic bath VWR Ultrasonic cleaner VWR, Darmstadt 
UV spectrometer Cary 50 Scan  
Software: Cary WinUV 3.00(182) 
Varian, Darmstadt 
Water purifier MembraPure PMA Purification 
Membranes Analytics, 
Hennigsdorf 
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3.2.3 Other laboratory materials 
Material Manufacturer 
Micropipette / capillary tube (5, 10, 20 µL) BRAND, Wertheim 
NMR tubes 507-HP-8 Norell, Landisville (USA) 
Preparative HPLC syringe (manual injection - 5 mL) VWR, Darmstadt 
Quartz cuvettes (1 mm, 10 mm) Hellma, Müllheim  
Silica gel 60 F254 aluminium sheets, 20 × 20 cm Merck, Darmstadt 
Syringe filter (pore size = 0.25 microns) Wicom, Heppenheim 
 
 
3.2.4 Columns used for chromatography 
 Stationary 
phase 
Particle 
size 
Amount 
loaded  
Dimension/ 
volume 
Manual/pre-
packed 
Manufacturer 
C1 Sephadex® 
LH-20  
25 – 100 
µm 
265 g L = 90 cm, Ø 
= 4.76 cm 
Open column 
chromatography. 
Manual packed. 
GE Healthcare 
GmbH, 
München 
C2 RP-18 25 - 40 
µm 
30 g 44 mL Column for flash 
chromatography. 
Manual packed. 
Merck, 
Darmstadt 
C3 RP-18 (SVP 
D40-RP18) 
25 - 40 
µm 
90 g 131 mL Column for flash 
chromatography. 
Pre-packed. 
Merck Chimie 
SAS, France 
C4 MCI- Gel® 
CHP20P 
75 - 150 
μm 
170 g L = 60 cm,  
Ø = 2.5 cm 
Column for flash 
chromatography. 
Manual packed. 
Mitsubishi 
Chemical 
Europe GmbH, 
Düsseldorf 
C5 Silica gel 
(Reveleris 
Flash 
Cartridges) 
20 µm 12 g  Column for flash 
chromatography. 
Pre-packed. 
Grace, 
Deerfield-
Illinois, USA 
C6 RP-18 
(Purospher 
STAR, RP18) 
5 µm  L = 250 mm, 
Ø = 4 mm 
HPLC column. 
Pre-packed. 
Merck, 
Darmstadt 
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 Stationary 
phase 
Particle 
size 
Amount 
loaded  
Dimension/ 
volume 
Manual/pre-
packed 
Manufacturer 
C7 RP-18 (Eclipse 
XDB-C18) 
5 µm  Ø = 9.4 mm, 
L = 250 mm 
HPLC column. 
Pre-packed. 
Agilent 
Technologies, 
USA 
C8 RP-18 (Eclipse 
XDB-C18) 
5 µm  Ø = 21.2 
mm, L = 250 
mm 
HPLC column. 
Pre-packed. 
Agilent 
Technologies, 
USA 
 
3.2.5 Plant material 
The bark of M. salicifolia was collected in February 2013 at Monduli mountain ranges Arusha 
region, Tanzania. Identification of the plant was done by Mr. Daniel Sitoni, senior botanist from 
Tanzania National Herbarium (TNH) and later the specimen was stored at TNH with voucher 
number CK 7792. The collected bark material was spread on a clean cotton cloth under direct 
sunlight with a temperature between 30 – 35 οC until it was completely dried. The dried bark 
material was reduced in size (Figure 3.14) packed and sent to Regensburg, Germany for 
phytochemical investigation. 
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Figure 3.14: A: Collection of M. salicifolia bark. B: Drying. C: The dried M. salicifolia bark. D: The process of size 
reduction. E: M. salicifolia bark after size reduction, before packaging and transport to Regensburg-Germany for 
phytochemical characterization. 
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3.2.6 Extraction of plant material 
Prior to extraction, the dried M. salicifolia bark (390.1 g) was further reduced in size by cutting 
it into small pieces and which were then pulverized using a milling machine. The obtained 
powder was mixed with 400 g of sea sand, packed in a column and macerated overnight with 1 
L of dichloromethane. After maceration, bulk extraction of M. salicifolia bark was performed 
using four different solvents with increasing polarity. The solvents used for the extraction were 
dichloromethane, ethylacetate, methanol 100% and methanol 50%. Approximately 4 litre of 
each extraction solvent was used during extraction. 
At the end of extraction, four crude extracts were obtained (Figure 3.15) and were evaporated 
to complete dryness using a rotary vacuum evaporator at 40 οC. To achieve crude extracts 
homogeneity, the residues recovered after evaporation were mixed in water, completely frozen 
at -20 οC and lyophilized. The dried powder crude extracts were stored at 4 οC in the 
refrigerator. 
 
 
Figure 3.15: Extraction protocol of M. salicifolia bark. 
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3.2.7 Fractionation and isolation 
3.2.7.1  Thin layer chromatography (TLC) 
TLC was performed for control check during the extraction and fractionation steps. In the 
course of extraction, TLC was used to determine the time to change from one extraction 
solvent to another. The solvent change was done following no further detection of spots on a 
TLC sheet when visualized under UV 254 nm. Furthermore, TLC methods utilizing different 
spray reagents were used for preliminary confirmation on the groups of compounds present in 
the extracts. 
Besides, throughout chromatography TLC method was done for determination of identical 
fractions to be combined during and/or after chromatographic run. It was further used for open 
column chromatography where UV detector was not applicable for control check on the time to 
stop chromatography. Lastly, selection and optimization of chromatographic solvent system 
was achieved through TLC. The solvent system was considered optimal for the chromatography 
after migrating the substances of interest between retardation factor (Rf) value of 0.3 – 0.8. 
Retardation factor is defined as the ratio of the distance the compound spot migrated to the 
distance migrated by the solvent front (Formula 1). 
Unless stated otherwise in the text, the analytical TLC parameters and method used in this 
study is described in Table 3.4 below. 
 
Formula 1: Calculation of Retardation factor (Rf). 
𝑅𝑓 =
Distance migrated by the compound
Distance migrated by the solvent font
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Table 3.4: The analytical TLC method and parameters. 
Stationary phase Silica gel 60 F254 aluminium sheets, 20 × 20 cm.  
Mobile phases (MP) MP_1: Ethylacetate : water : acetic acid : formic acid (100:26:11:11) 
MP_2: Toluene : ethylacetate : formic acid (70:30:1) 
Application tools TLC spotting capillaries and Linomat 5 
Sample volume 5 – 40 µL depending on sample concentration 
Application method Either as a narrow band 1 cm wide or as a spot. 
Distance between two bands/spots was set to be 0.5 - 1 cm. 
TLC sheets were allowed to air dry before inserted in a development 
chamber. 
TLC development In a covered twin trough TLC chamber 20 x 20 cm containing mobile 
phase. After development (migration distance 10 cm) TLC sheets were 
left to air dry before detection with spray reagent.  
Spray reagents (SR) SR_1: Anisaldehyde-sulphuric acid reagent (0.5 mL anisaldehyde, 10 mL 
acetic acid, 85 mL methanol, 5 mL concentrated sulphuric acid). 
SR_2: A: Vanillin 1% in methanol. B: Conc. HCl. 
SR_3: Iron (III) chloride (FeCl3) - (2 g FeCl3 in 10 mL water, diluted to 200 
mL by ethanol). 
SR_4: Natural product reagent (1% diphenylboryloxyethylamine in 
methanol solution). 
SR_5: Dragendorff reagent (0.85 g basic bismuth (III) nitrate in 40 mL 
water and 10 mL of acetic acid mixed with a 20 mL solution of potassium 
iodide (400 g/L). 
Detection TLC detection was done using Reprostar 3 under VIS and/or UV 366 nm. 
Detection and photo documentation was done after heating a sprayed 
TLC sheet at 105 οC for 3 – 10 min until maximum visualization of spots 
was observed. 
TLC plates derivatized with vanillin/HCl were not heated. 
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3.2.7.2 Sephadex® LH-20 fractionation 
In the first step, the methanolic extract was subjected to Sephadex® LH-20 column 
chromatography using column (C1) equilibrated with 70% EtOH (v/v). The aim was to separate 
tannins from non-tannin compounds. In the course of fractionation by Sephadex® LH-20, non-
tannins and oligomeric PAs are eluted first with EtOH 70% (v/v). The polymeric PAs adsorb to 
the stationary phase in alcohol and are released in the 70% acetone fraction139. 
In this study, 119 g of crude methanolic extract of M. salicifolia bark was fractionated in several 
runs. In each run, about 12 g of extract was dissolved in 14 mL of 70% EtOH (v/v) and carefully 
applied using pasteur pipettes on the surface of a Sephadex® LH-20 column. Subsequently, 70% 
EtOH (v/v) was added without disturbing the surface level and elution proceeded with a flow of 
0.98 mL/min. Fraction collection was achieved by using a superrac fraction collector. The 
collection time and volume in each test tube was 18 min and 17.6 mL respectively. Fraction 
control was performed on normal phase TLC (NP-TLC) after every 3rd glass until no visible spot 
was observed on the TLC sheet under UV 254 nm. 
Eluent was changed to acetone 70% (v/v) for elution of polymeric tannins which were adsorbed 
on the stationary phase. Prior to solvent change, the length of Sephadex® LH-20 in the column 
was marked due to shrinking and swelling behavior of the Sephadex® LH-20 material with use 
of different solvents. Elution of polymeric tannins from the column was completed following 
observation of a clear Sephadex column and colourless eluent for 1 h. 
Commencement of the subsequent run was done after equilibration of the column with 70% 
EtOH (v/v), swelling of Sephadex® LH-20 material in the column to its original mark before 
elution with acetone 70% (v/v) was achieved and no further acetone was eluted from the 
eluent. 
Fractions separation was done by means of TLC. Test tubes which appeared to have alike 
fingerprints were pooled together to form a fraction. The formed fractions were evaporated 
using a rotary vacuum evaporator at 40 οC until all organic solvent was evaporated. Remained 
aqueous fraction was frozen at -20 οC, lyophilized to complete dryness and then stored at 4 οC 
in the refrigerator. 
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3.2.7.3 Flash chromatography  
Some of the obtained Sephadex® LH-20 fractions and their sub-fractions were further 
fractionated by flash chromatography. Chromatography was preceded by column equilibration 
with starting gradient conditions. The time taken for column equilibration was 10 – 20 min.  
Preparation of fractions to be fractionated using RP-18 columns was done by dissolving the 
sample in MeOH, mixing with RP-18 material in the ratio of 1:2 (m/m) and the solvent was 
carefully evaporated to complete dryness using a rotary vacuum evaporator. The dried 
sample/RP-18 mixture was loaded on the surface of a pre-column packed with stationary 
phase, then chromatography was started. 
In the case of using MCI-Gel® CHP-20P column and silica gel cartridges for chromatography, 
sample was clearly dissolved in solvent (initial condition). The concentrations were varying due 
to solubility but care was taken to achieve a thin starting zone at the column bed. The 
concentrated sample solution was loaded directly to the equilibrated main column. Pre-column 
was not used for this case. 
Different flash columns and methods used in this study are described in the Table 3.5 below. 
Factions were collected with the aid of inbuilt automatic fraction collector, TLC control was 
performed on every test tube. Similar fractions were pooled together, evaporated to complete 
dryness, weighed and stored at 4 οC in the refrigerator. 
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Table 3.5: Flash chromatography methods used. M: method, C: column, MP: mobile phase, G: gradient, t: time 
(min.), F: flow (mL/min), V: volume collected per test tube (mL), D:  UV detector (nm). 
M C MP A MP B G t F V D 
FL-1 C2 water MeOH 20 - 100% B 60 5 10 280 
100% B 15 
FL-2 C4 water MeOH 20% B 40 7.5 15 280 
30% B 40 
40% B 40 
50% B 40 
60% B 40 
100% B 60 
FL-3 C3 water MeOH 20 - 40% B 10 40 23 220 
40 - 100% B 20 
100% B 30 
FL-4 C5 CHCl3 MeOH 30 - 20% B 35 7 5 250 
20 -100% B 1 
100% B 25 
FL-5 C5 CHCl3 MeOH 5 - 12% B 30 15 10 220 
12 - 60% B 1 
60 - 100% B 9 
100% B 10 
FL-6 C5 CHCl3 MeOH 5% B 40 15 10 220 
5 - 100% B 25 
100% B 15 
 
3.2.7.4  Semi preparative HPLC 
Semi preparative HPLC was the final isolation step used to obtain the majority of the isolated 
pure compounds. Prior to every HPLC purification run, numerous trials to find optimal eluents 
were performed on RP-18 TLC aluminium sheets.  
The sample to be purified was applied on several RP-18 TLC sheets, thereafter TLC sheets were 
developed using different mobile phase compositions. The mobile phase which could migrate 
the compounds of interest between Rf value of 0.3 – 0.8 was considered to be optimal for the 
preparative HPLC run.  
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After the optimal mobile phase was found, samples were dissolved in the initial conditions of 
solvent system for the chromatography. The sample solution was filtered using syringe filter 
and manually injected to the HPLC sample loop at room temperature. 
Eluted peaks were manually collected in test tube and completely dried under nitrogen stream. 
Their yield were determined and then stored at 4 οC. Table 3.6 describes HPLC preparative 
methods used in this study. 
 
Table 3.6: Preparative HPLC methods. M: method, C: column, MP: mobile phase, SC: sample concentration 
(mg/mL), IV: injection volume (µL), G: gradient, t: time (min.), F: flow (mL/min), D: UV detector (nm). TFA: 
trifluoroacetic acid. 
M C MP A MP B SC  IV G t F D 
HP-1 C7 Water+ 0.05% 
TFA 
MeCN + 0.05% TFA 10  250 25 – 40% B 30 2 280 
40 – 100% B 5 
100% B 3 
HP-2 C7 Water+ 0.02% 
TFA 
MeCN + 0.02% TFA 10 250 20 – 30% B 15 2 280 
30% B 1 
30 - 70% B 2 
70% B 6 
HP-3 C6 Water+ 0.02% 
TFA 
MeCN + 0.02% TFA 10 10 15 – 19% B 5 1 280 
19 – 23% B 15 
23 – 60% B 2 
60% B 3 
HP-4 C8 Water MeOH  100 500 50 – 70% B 20 20 290 
70 – 100% B 0.1 
100% B 2 
HP-5 C7 Water MeOH  10 250 50 – 70% B 20 3 290 
70 – 100% B 0.1 
100% B 2 
HP-6 C7 Water + 0.02% 
TFA 
 
MeCN + 0.02% TFA 
 
10 250 25 - 35% B 30 2 256 
35 – 65% B 1  
65% B 4 
HP-7 C7 Water MeOH  13 300 50 – 60% B 15 3 250 
60 – 100% B 1 
100% B 4 
Phytochemical investigation of Myrica salicifolia A. Rich bark 
75 
 
M C MP A MP B SC  IV G t F D 
HP-8 C7 Water MeOH  10 200 50 – 60% B 20 2 240 
60 – 100% B 1 
100% B 4 
HP-9 C7 Water MeOH  10 200 75 – 80% B 15 2 250 
80 – 100% 1 
100% B 3 
HP-10 C7 Water MeOH  10 200 70% B 15 2 220 
70 – 100% B 1 
100% B 4 
HP-11 C7 Water MeOH  10 100 60% B 10 2 270 
60 – 100% B 1 
100% B 4 
HP-12 C7 Water MeOH  10 100 75 – 78% B 10 2 250 
78 – 100% B 1 
100% B 4 
 
3.2.7.5 Centrifugal partition chromatography (CPC) 
Preparative liquid/liquid partitioning chromatography was used as a pre-purification step to 
some of the fractions following Sephadex® LH-20 and flash chromatography. A bi-phasic solvent 
system was used during chromatography, one phase as the mobile phase and the other phase 
as stationary phase. 
A bi-phasic solvent system optimal for chromatography was prepared by mixing and shaking 
two immiscible solvents in a separatory funnel. The mixture was left to stand for few seconds 
thereafter separation of the upper phase from lower phase was done. 
The stationary phase (the lower phase) was pumped in the rotor (column). Then the mobile 
phase was pumped into the rotor through the stationary phase while CPC rotation speed was 
800 rpm. This continued until the equilibrium between the two phases was attained. The 
equilibrium between the two phases was observed when the volume of the eluted stationary 
phase remained constant. 
After equilibrium was reached, the sample was prepared by completely dissolving in the 
biphasic system (1:1) at the concentration of 0.25 g/mL. The sample solution was manually 
injected in the CPC sample loop by using a syringe, immediately the chromatography was 
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started. The eluted fractions were collected in test tubes by use of an automatic multrac 
fraction collector. TLC control was performed on every third test tube. 
Elution mode was changed or stopped, when no more spots were detected on a TLC sheet. Two 
elution modes were used for chromatography, i.e. ascending mode when the upper (lighter) 
phase was the mobile phase and descending mode when the lower (heavier) was the mobile 
phase. Fraction cuts were performed in the same way as described in the sections 3.2.7.2 and 
3.2.7.3. The CPC conditions are illustrated hereunder: 
Solvent system: Ethylacetate/water. 
Ascending mode: Ethylacetate-mobile phase. 
Descending mode: Water-mobile phase. 
Rotation: 800 rpm. 
Flow (mL/min): 5 mL/min. 
Volume collected: 10 mL/ test tube. 
 
3.2.8 Structure elucidation 
3.2.8.1 NMR spectroscopy 
Isolated pure compounds were dissolved in 600 µL of deuterated solvent, filled in the NMR 
tubes (507-HP-8) prior to NMR spectra measurement. Deuterated NMR solvents such as 
methanol, acetone, chloroform and pyridine were used in this study (quality of solvents: 
chapter 3.2.1). 
Two NMR spectrometers of the Central Analytics, Department of NMR spectroscopy, Faculty of 
Chemistry and Pharmacy, University of Regensburg were used for recording of one dimensional 
(1D) and two dimensional (2D) NMR spectra. 
The NMR spectra for compounds with low yields < 5 mg were recorded using Bruker Avance 
600 (600.25 MHz for 1H and 150.93 MHz for 13C, 298.0 K) and for compounds with higher 
amount > 5 mg, Bruker Avance 300 (300.13 MHz for 1H and 75.47 MHz for 13C, 296.1 K) was 
used. The NMR spectra were referenced to tetramethylsilane (TMS). 
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Recorded NMR data were: 1H and 13C for 1D-NMR spectra, Heteronuclear Single Quantum 
Coherence (HSQC), Heteronuclear Multiple Bond Correlation (HMBC), 1H-1H Correlation 
Spectroscopy (COSY), Nuclear Overhauser Enhancement Spectroscopy (NOESY)/Rotational 
Overhauser Enhancement Spectroscopy (ROESY) for the 2D-NMR spectra respectively. 
Analysis of NMR spectra data for the determination of structure was performed using Topspin 
3.2 (Bruker, Ettlingen) software. 
 
3.2.8.2 Mass spectrometry 
Molecular mass and molecular formula of isolated compounds were confirmed by mass 
spectrometry. Samples were submitted to the Department of Mass Spectrometry, Faculty of 
Chemistry and Pharmacy, University of Regensburg for measurement. Liquid chromatography 
LC-MS and low resolution ESI-MS were measured on TSQ 7000 (Thermo Quest, Finnigan). High 
resolution ESI-MS were measured on a MAT SSQ 710 A (Finnigan). 
 
3.2.8.3 UV-VIS spectroscopy 
A concentration of 0.06 mg/mL in methanol (for spectroscopy) of each compound was 
prepared. Sample solution was filled in a quartz cuvette with 1 cm path length. The cuvette 
containing the sample solution was placed in the spectrophotometer. An absorption spectrum 
was recorded as a plot of the light absorbed by that compound (A) against wavelength (nm) 
following measurement of pure methanol as blank. All UV measurements were performed at 
room temperature with a wave length range from 200 – 500 nm. 
Absorbance and its corresponding UV-maximum were recorded for calculation of molar 
extinction coefficient (ε) using Lambert beer’s equation as described below: 
 
Formula 2: Calculation of absorbance. 
𝐴 =  𝜀 ×  𝑐 ×  𝑙 
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Formula 3: Calculation of molar extinction coefficient. 
𝜀 =  
𝐴
𝑐 ×   𝑙
 
 
𝜀: Molar extinction coefficient [L/(mol × cm] 
𝐴: Absorbance 
𝑐: Concentration [mol/L] 
𝑙: Length of the quartz cuvette [l = 1 cm] 
 
3.2.8.4 Polarimetry 
Isolated compounds were subjected to optical rotation measurement. 1 mg of each substance 
was dissolved in 1 mL of methanol (for spectroscopy, Uvasol). The sample solution was carefully 
filled in the polarimetry cell (l = 5 cm) and placed in the polarimeter for measurement. 
Observed optical rotation (α) was recorded six times and the average was calculated. In all 
cases measurement conditions were: temperature range was from 22 – 26 °C, wave length = 
589 nm (D-line of the sodium lamp). The average optical rotation was used for calculations of 
specific rotation as described in the formula below: 
 
Formula 4: Calculation of optical rotation. 
[∝]𝐷
𝑇 =  
∝
𝑐 ×  𝑙
 
 
∝: Observed optical rotation [ο] 
𝑇: Temperature [°C] 
𝑙: Length of the tube [dm] 
𝑐: Concentration [g/mL] 
 
3.2.8.5 Circular dichroism (CD) spectroscopy  
CD spectra measurements were performed at the Department of Analytical Chemistry- 
University of Regensburg. Each isolated compound (0.6 mg) was dissolved in 10 mL of methanol 
(for analysis), filled in the quartz cuvette with 0.1 cm path length and placed in the CD 
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spectrometer for measurement at room temperature. All CD spectra were recorded after 
subtraction of the instrument base line which was recorded using only solvent (methanol) prior 
to sample measurement.  
Data recording was done using a Microsoft Excel sheet and graphically presented in terms of 
molar ellipticity (degrees·cm2·decimole−1) as a function of wave length (nm). On the other hand, 
molar ellipticity could be calculated using the following formula: 
 
Formula 5: Calculation of optical rotation. 
[𝜃]𝑀 =
𝜃 ×   𝑀
100 ×   𝑐 ×   𝑙
 
 
[𝜃]𝑀: Molar ellipticity, expressed in degrees·cm
2·decimole−1 
𝜃: Ellipticity value [0] 
𝑀: Molar mass [g/mol] 
𝑐: Concentration [g/mL] 
𝑙: Optical path of the cell [dm] 
 
3.2.8.6 Determination of type and absolute configuration of glycosides 
Determination of the glycoside type and their respective absolute configuration was achieved 
by recording the 1H NMR spectra of their per-O-(S)-2-methylbutyrate (SMB) derivatives140. 
1 mg of each compound containing a sugar moiety was hydrolyzed using 200 µL of 2 N 
trifluoroacetic acid (TFA) at 121 °C for 90 min in a Wheaton vials sealed with teflon lined screw 
cap. After hydrolysis, the solvent was evaporated to complete dryness under nitrogen stream. 
100 µL of (S)-(+)-2-methylbutyric anhydride and 100 µL of pyridine were added to the mixture 
and incubated at 121 °C for 4 h. The mixture was dried under nitrogen stream for about 8 h and 
300 µL of toluene was added to the residue and evaporated. The residue was dissolved in 1 mL 
of dichloromethane and extracted three times with a 2 mL of 2 M Na2CO3 solution and one time 
with 2 mL of water. The dichloromethane phase containing the SMB derivatives was 
concentrated using nitrogen stream, then completely dried by addition of 300 µL of 2-propanol 
and evaporation. 
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Preparation of samples for NMR measurement was done by dissolving each of the obtained 
SMB derivative in 0.6 mL of deuterated acetone. The mixture was transferred to the NMR tube 
and their 1H NMR spectra were recorded at 300 MHz, 298 K. 
The same procedure was applied to reference monosaccharides with the exception of hydrolysis 
reaction. Absolute configuration and the type of glycoside was confirmed by comparing 
chemical shifts and coupling constants of anomeric proton resonances of the SMB derivative to 
that of reference monosaccharides SMB derivative. For compounds with two sugar 
substitutions, 1H NMR of SMB derivatives were compared to a 1H NMR of the SMB derivative of 
a mixture of the two concerning reference sugars. 
 
3.2.8.7 Enzymatic deglycosydation of cyclic diarylheptanoid glycoside 
Enzymatic hydrolysis was done using β-glucosidase (almond) to obtain the aglycone by 
deglycosidation of cyclic diarylheptanoid glycosides123. The enzyme hydrolysis was conducted as 
follows: 
21.0 mg (0.040 mmol) of a compound was dissolved in 3.0 mL of 0.2 M acetate buffer (0.2 M 
acetic acid + 0.2 M sodium acetate, pH 4.4). The solution was treated with 40 mg of β-
glucosidase and stirred. The mixture was incubated while stirring in the ultrasonic water bath at 
38 °C for 2 days. After incubation, the reaction mixture was mixed with 10 mL of absolute EtOH 
and evaporated to dryness by using a vacuum rotary evaporator. The residue was dissolved in 
chloroform/water (1:1), thoroughly mixed, left to settle and finally the two phases were 
separated. The obtained upper and lower phase were dried and separately purified by (semi) 
preparative HPLC method HP-11 (Table 3.6). 
The peaks obtained from HPLC purification of the upper and lower phase were subjected to 1H 
NMR measurement. Prior to 1H NMR measurement, the samples were dissolved in 0.6 mL 
deuterated methanol, filled in the NMR tubes followed by measurement at 300 MHz. The 
recorded 1H NMR spectra data of the obtained peaks were compared with the existing data to 
identify which peak stands particularly for the aglycone. 
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3.2.8.8  CD spectra simulation 
0.6 mg of the obtained myricanol aglycone from enzymatic deglycosydation was dissolved in 10 
mL methanol and submitted for CD spectra measurement to the Department of Analytical 
Chemistry, University of Regensburg. The recorded CD data of the aglycone were submitted to 
Prof. Dr. Thomas Schmidt - Institute of Pharmaceutical Biology and Phytochemistry, University of 
Münster, for performing electronic CD spectra simulation using time-dependent density 
functional theory (TDDFT) quantum mechanics. 
At the University of Münster, molecular models of the R-enantiomer of myricanol were 
generated with the software package MOE (CCG, Montral, Canada). After a low-mode-dynamics 
conformational search (default settings), three conformations were obtained within an energy 
window of 3 kcal/mol of which conformer 1 corresponded to the 11R,Ra and conformers 2 and 
3 to two slightly different 11R,Sa forms. The 3D structures were exported to the software 
Gaussian 03W and completely energy minimized using the B3LYP Density Functional and the 6-
31D (d,p) basis set. According to these calculations, conformer 3 was the energetically most 
favourable form, conformer 1 being 2.01 and conformer 2 even 3.31 kcal/mol higher in energy. 
These energy differences would indicate that conformer 3 would strongly dominate (>97%) in a 
conformational equilibrium. Indeed, the geometry of conformer 3 is in very good agreement 
with the crystal structure of myricanol as published by Begley et al.141.  
Electronic CD spectra were simulated by performing a time-dependent DFT (TDDFT) calculation 
for the first 30 electronic transitions of each of the three conformers using the same basis set as 
mentioned above. The resulting transition vectors (R, length) were used to simulate the CD 
spectra for each form by multiplying them with Gaussian functions of width of 0.1 eV and 
summing the resulting curves up over the whole energy/wavelength scale. Furthermore, an 
averaged spectrum was generated for the theoretical equilibrium mixture corresponding to 97% 
R,Sa and 3% R,Ra-myricanol. The resulting spectra were compared with the experimental CD 
spectrum of myricanol and the obtained results were used to confirm the absolute 
configuration of the aglycone myricanol and other isolated diarylheptanoids. 
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3.3 Results  
3.3.1 Extraction and preliminary investigation of M. salifolia bark  
The bark of M. salicifolia is the most reported plant part used for medicinal purposes by 
Maasai. In the course of investigating its phytochemical composition, four crude extracts were 
obtained by increasing polarity of extraction solvents: dichloromethane, ethylacetate, methanol 
100% and methanol 50% extract. 
Control TLCs of the four crude extracts provided a preliminary reflection of the compounds and 
their distribution within the extracts (Figure 3.16). It was also detected that the methanolic 
extract of M. salifolia bark seemed to contain more interesting compounds than the methanol 
50%, dichloromethane and ethylacetate extracts. This was further supported by extraction 
yields of the crude extracts (Table 3.7). The high content of compounds in the methanolic 
extract demonstrated that the majority of M. salicifolia bark compounds are polar compounds. 
This is in agreement with the decoction and infusion methods being used as the major 
traditional medicinal preparations of this plant part, which leads to the extraction of most of its 
ingredients (Chapter 2). 
Additionally, to get an idea about compound groups present in crude extracts TLC sheet were 
sprayed with different spray reagents. Visualization of red spots (VIS) after spraying with 
Vanillin/HCl reagent, black spots after spraying with FeCl3 and orange spots after spraying with 
anisaldehyde-sulphuric acid reagent, were a hint for the presence of condensed tannins in 
methanol and methanol 50% crude extracts. They were the dominant group of compounds in 
these two extracts (Figure 3.17). 
Alkaloids were below detection limits due to the lack of orange colored spots when TLC was 
visualized under visible light following TLC spraying with Dragendorff reagent as described in 
the method section 3.2.7.1. Few blue fluorescent spots were detected under UV 366 nm after 
spraying the TLC sheet containing four crude extracts with natural product reagent. The blue 
fluorescent spots observed could be phenolic acids, coumarins and/or plant acids present in all 
four extracts. 
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In this study, the methanolic extract was selected for further fractionation and phytochemical 
characterization based on the obtained preliminary phytochemical investigation results of M. 
salicifolia bark. 
 
Figure 3.16: TLCs displaying compounds distribution within M. salicifolia bark extracts. A: NP-TLC developed with 
TLC mobile phase MP_2. B: TLC developed with mobile phase MP_1. D: CHCl2 extract. E: EtOAc extract. M: MeOH 
extract. M/W: MeOH/H2O extract. All TLCs were derivatized with anisaldehyde-sulphuric acid reagent. Detection 
VIS (left) and UV 366 nm (right). 
 
 
Figure 3.17: Preliminary confirmation of compound groups’ composition of M. salicifolia bark extracts. NP-TLC 
derivatized with A: Natural products reagent (UV 366 nm), B: Vanillin/HCl (VIS), C: Ferric (III) chloride (VIS), D: 
Dragendorff reagent (VIS). 
 
 
Table 3.7: Extraction yields of M. salicifolia bark (390.1 g). 
Extract Empty glass (g)  Glass + Extract (g)  Extract wt. (g)  Yield (%)  
Dichloromethane 134.87 142.58 7.71 1.90 
Ethylacetate 129.52 130.57 1.05 0.27 
Methanol 328.85 491.31 162.46 41.64 
Methanol/water 292.83 318.69 25.86 6.62 
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3.3.2 Fractionation and chromatography of M. salicifolia bark crude methanolic extract 
M. salicifolia bark crude methanolic extract was subjected to further fractionation. In a first 
step, Sephadex® LH-20 open column chromatography was used to separate tannins from non-
tannin phenolics. Two eluents were used, ethanol 70% and acetone 70% as described in 
materials and methods 3.2.7.2. Seven fractions (S1-S7) were obtained. Fractions S1-S6 were 
eluted with ethanol 70%. Fraction S7, which comprised of PAs polymers, retained in the column 
and could not be eluted with ethanol 70%. Its elution was achieved by acetone 70%. 
All seven fractions (S1-S7) obtained from Sephadex® LH-20 open column chromatography were 
made up by several compounds (Figure 3.18). Therefore, fractions separation was achieved by 
selection of marker compound spots for each fraction. A deep blue spot having Rf value 
between 0.5 – 0.6 was selected as a marker for fraction S2. All compounds eluted before this 
compound were combined in fraction S1, and those fractions containing this compound were 
grouped in S2. Furthermore, all compounds eluted after the deep blue compound and before 
elution of a deep orange compound with Rf value of 0.8 were combined in fraction S3 and all 
those containing the deep orange compound in fraction S4. The marker spot for fraction S5 was 
the deep orange compound with Rf value of 0.4 and those eluted afterwards with ethanol 70% 
until no compound was detected on the TLC sheet were combined in fraction S6. 
 
Figure 3.18: Control TLC of Sephadex® LH-20 chromatography of M. salicifolia bark methanolic extract. NP-TLC 
developed with mobile phase MP_1 and sprayed with anisaldehyde-sulphuric acid reagent. Detection VIS (left) and 
UV 366 nm (right). 
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3.3.3 Fractionation and preparative isolation of tannins 
PAs presence in the obtained Sephadex® LH-20 fractions was confirmed by TLC method. A TLC 
silica sheet spotted with the seven fractions S1-S7, was developed with TLC mobile phase 
MP_1. The developed TLC sheet was sprayed with vanillin/HCl without heating (Figure 3.19). 
Subsequently, deep red spots on TLC fingerprints of fractions S4-S7 and colourless on fraction 
S1-S2 fingerprints were detected under VIS, hence a confirmation of PAs presence in these 
fractions. Traces of red colour were detected in fraction S3 concluding that PAs are present in 
low concentrations. Additionally, catechin was below detection limits due to none of the 
compound spots appeared to have the same Rf value as that of catechin when it was used as a 
reference substance. 
Isolation of tannins was achieved by further fractionation or purification of the PAs containing 
fractions as summarizes in the fractionation scheme (Figure 3.25). 
 
 
Figure 3.19: NP-TLC overview of fractions S1-S7 after spraying with Vanillin/HCl, a confirmation of fractions 
containing PAs. Cat = catechin (reference substance). Detection VIS. 
 
3.3.3.1 Fraction S4 
Fractionation of S4 (0.4 g) was performed by RP-18 flash chromatography using method FL-1. 
Five fractions S4.1-S4.5 (Figure 3.20) were obtained and subjected to 1H NMR (300 MHz, 
methanol - d4). S4.1 was observed to be impure and discarded due to its very low yield (26.0 
mg). S4.5 was identified as plasticizer and was also discarded. Fractions S4.2-S4.4 were pure 
and possessed the same proton spectra, hence resulted in isolation of compound 1 (0.2 g). 
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Figure 3.20: TLC overview of S4.1 – S4.5 fractions (NP-TLC). TLC mobile phase: MP_1. Detection VIS (left) and UV 
366 nm (right). 
 
3.3.3.2 Fraction S5 
Fraction S5 (0.32 g) was fractionated by means of MCI-Gel® CHP-20P flash chromatography 
method FL-2. A step gradient with increasing methanol concentration in 10% steps was 
performed. Good separation was achieved resulting in twelve fractions S5.M1-S5.M12 (Figure 
3.21). Fractions were obtained with the aid of TLC control performed on every second glass and 
selection of a marker compound for each fraction. 
 
 
Figure 3.21: TLC overview of S5 MCI-Gel® CHP-20P fractions. NP-TLC developed with mobile phase MP_1 and 
sprayed with anisaldehyde-sulphuric acid reagent. Detection VIS. 
 
The four fractions containing tannins, S5.M4 (9.0 mg), S5.M6 (9.4 mg), S5.M9 (17.0 mg) and 
S5.M11 (2.6 mg) were subjected to a purification step on preparative RP-18 HPLC using method 
HP-1. 
In the process of separation and purification of S5.M4 two peaks were collected (Figure 3.22 A). 
The collected peaks were subjected to 1H NMR (300 MHz, methanol-d4) for purity control. The 
first peak with tR = ~ 5 min was pure, hence resulted in isolation of compound 3 (2.3 mg). The 
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second peak eluted at 7.5 min was impure and due to small yield no further purification step 
was possible. The hip observed from 15.8 - 23 min was considered as impurities and discarded. 
Purification process of S5.M6 (Figure 3.22 B) lead to collection of three eluted peaks. 1H NMR 
(300 MHz, methanol-d4) of the collected peaks were recorded and it was observed that the 
peak eluted at 6.5 min was pure (compound 9, 1.6 mg). The peak which eluted at 19 min in all 
cases was identified as plasticizer, therefore discarded. 
Similarly, RP-18 preparative HPLC purification of fractions S5.M9 (Figure 3.22 C) and S5.M11 
(Figure 3.22 D) resulted in isolation of pure compound 6 (6.0 mg) with tR = 7 min and compound 
7 (0.7 mg) with tR = 8 min respectively. In both cases no further purification steps were 
performed on the impure collected peaks due to their low yields. 
 
 
Figure 3.22: Preparative RP-18 HPLC chromatograms (method HP-1) monitored by UV detection at 280 nm. A: 
Fraction S5, B: Fraction S5.M6, C: Fraction S5.M9, D: Fraction S5.M11. 
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3.3.3.3 Fraction S6 
S6 was subjected to MCI-Gel® CHP-20P flash chromatography using the same chromatographic 
conditions as for fraction S5 (FL-2). At the end of chromatography thirteen fractions S6.M1-
S6.M13 were obtained as depicted in Figure 3.23. 
 
Figure 3.23: TLC overview of S6 MCI-Gel® CHP-20P fractions. NP-TLC developed with mobile phase MP_1 and 
sprayed with anisaldehyde-sulphuric acid reagent. Detection VIS. 
 
 
Two fractions, S6.M6 (32.0 mg) and S6.M13 (16.0 mg), out of thirteen obtained fractions were 
subjected to the purification steps by RP-18 preparative HPLC using method HP-2. HPLC 
separation and purification of S6.M6 resulted in collection of three eluted peaks at 6.5, 7.5 and 
10.7 min (Figure 3.24 A), hence isolation of compound 4 (12.5 mg), compound 5 (9.1 mg) and 
compound 8 (2.56 mg) respectively. 
Separation and purification of compounds from fraction S6.M13 (Figure 3.24 B) was not 
accomplished by RP-18 preparative HPLC method HP-2. Further purification of the collected 
double peak with tR = ~ 10 min was attempted using HP-3 method on analytical HPLC operated 
in a semi preparative way. Two clear sharp peaks with tR = ~ 8 and 9 min were collected (Figure 
3.24 C), which led to isolation of compound 2 (1.8 mg) and re isolation of compound 8 (0.7 mg) 
respectively. 
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Figure 3.24: Preparative RP-18 HPLC chromatograms monitored by UV detection at 280 nm. A: Fraction S6.M6 
(method HP-2), B: Fraction S6.M13 (method HP-2), C: Fraction S6.M13-separation and purification by analytical 
HPLC (method HP-3). 
 
3.3.3.4 Fraction S7 
Fraction S7 contained polymeric proanthocyanidins. Therefore, long 13C NMR spectrum (2048 
scans) of this fraction was recorded to get fundamental information on the composition. 
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Figure 3.25: Fractionation and isolation scheme of tannins from crude methanolic extract of M. salicifolia bark.  
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3.3.4 Fractionation and preparative isolation of non-tannin compounds 
Sephadex® LH-20 fractions S1 and S2 (Figure 3.18 and 3.19) contain non-tannin compounds. S3 
contained non-tannins and traces of tannins (Figure 3.19). Therefore, fractionation and 
isolation was performed on fraction S2 as summarized in the fractionation scheme Figure 3.34. 
Fractions S1, S3 which also contain non-tannin compounds were not investigated in this study 
due to time limitations. 
Additionally, it was observed from Sephadex® LH-20 TLC control that fraction S2 contained 
sugars. Therefore, in the first step fraction S2 (15.7 g) was fractionated by means of RP-18 flash 
chromatography method FL-3 aiming to separate sugars from other compounds. Seven 
fractions F1–F7 were obtained at the end of chromatography. The gradient starting at polar 
conditions resulted in elution of most of the sugars at the beginning of the chromatography 
(fraction F1), hence their separation from other compounds. Fractions F4–F6 (Figure 3.26) 
which contained several compounds were further purified to isolate individual compounds. 
 
 
Figure 3.26: NP-TLC control of fraction S2 RP-18 flash chromatography. Mobile phase MP_1, sprayed with 
anisaldehyde-sulphuric acid reagent. Detection VIS (left) and UV 366 nm (right). 
 
3.3.4.1 Fraction S2.F4 
S2.F4 (0.76 g) was fractionated by centrifugal partition chromatography (CPC) as described in 
the material and method section 3.2.7.5. The CPC separation of S2.F4 resulted in six fractions 
F4.C1-F4.C6 (Figure 3.27). The obtained CPC fractions F4.C2 (49.8 mg), F4.C3 (53.9 mg) and 
F4.C6 (288.0 mg) were separated and purified on preparative RP-18 HPLC. No further 
separation was done on fractions F4.C1, F4.C4 and F4.C5 due to time limitation. 
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Figure 3.27: Control NP-TLC of S2F4 CPC fractionation. Mobile phase MP_1, sprayed with anisaldehyde-sulphuric 
acid reagent. Detection VIS (left) and UV 366 nm (right). 
 
Separation and purification of fraction F4.C2 with method HP-8 (Figure 3.28 A), lead to isolation 
of compounds 29 (8.0 mg, tR = ~ 12.2 min), 30 (1.4 mg, tR = ~ 9.6 min), and 31 (0.6 mg, tR = ~ 16 
min). F4.C3 (Figure 3.28 B) was also separated by the same method and resulted in compound 
32 (8.1 mg, at tR = ~ 8 min), 33 (3.7 mg at tR = ~ 9 min), 34 (2.4 mg at tR = ~ 10.4 min) and 
reisolation of compound 29 (10.6 mg, at tR = ~ 12.2 min). The peak eluted at tR = ~ 19.6 min in 
both fractions F4.C2 and F4.C3 could not be identified due to solubility problems. Following 
evaporation of the eluent, several attempts to dilute it with different solvents were done 
without success. 
Likewise, separation of F4.C6 (Figure 3.28 C) on preparative HPLC (HP-8) resulted in isolation of 
compound 28 (6.0 mg, tR = ~ 15.8 min) and reisolation of compounds 26 (2.1 mg) and 22 (4.1 
mg). 
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Figure 3.28: Preparative RP-18 HPLC chromatograms. A: Fraction F4.C2 (HP-8), UV 298 nm. B: Fraction F4.C3 (HP-
8), UV 255 nm. C: Fraction F4.C6 (HP-8), UV 240 nm.  
 
3.3.4.2 Fraction S2.F5 
TLC control (Figure 3.26) depicted the presence of several compounds on fraction S2.F5. 
Optimal separation method of this fraction was achieved after several attempts with different 
stationary phases and mobile phases. Among other methods, CPC was found to be the best 
method, the same parameters and conditions were used as for the separation of S2.F4. 
Therefore, CPC fractionation of S2.F5 resulted to nine fractions F5C1-F5C9 (Figure 3.29). 
 
 
Figure 3.29: Control NP-TLC of S2.F5 CPC fractionation. Mobile phase MP_1, sprayed with anisaldehyde-sulphuric 
acid reagent. Detection VIS (left) and UV 366 nm (right). 
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Fractions F5.C1-F5.C5 and F5.C7-F5.C8 were further separated and isolation of individual 
compounds was achieved. The small yields obtained and the presence of several compounds in 
the fractions F5.C6 (9.8 mg) and F5.C9 (8.5 mg) made them impossible for further fractionation 
steps. 
F5.C1 (79.5 mg) was subjected to preparative HPLC using method HP-5 (Figure 3.30 A). Four 
peaks eluted, however two peaks resulted to isolation of compounds 21 (3.1 mg, tR = ~ 12 min), 
and 13 (6.5 mg, tR = ~ 13.3 min). The third peak at tR = ~ 11 min (2.0 mg) and the fourth peak at 
tR = ~ 14 min (42.9 mg) were not pure, hence required a subsequent purification step which was 
not possible to the third peak due to its low yield. 
The fourth peak was further detected by TLC (Figure 3.30 B) to contain several compounds. 
Thereafter, an optimal separation method for these compounds was investigated and found to 
be silica gel flash chromatography method FL-6. Successful separation and purification of the 
fourth peak (42.9 mg) was achieved and resulted to isolation of compounds 14 (10.2 mg, Rf = 
0.60), 19 (13.3 mg, Rf = 0.81) and 20 (5.8 mg, Rf = 0.60) as depicted in Figure 3.30 C. 
 
 
Figure 3.30: A: Preparative RP-18 HPLC chromatogram of fraction F5.C1 monitored by UV detector at 274 nm (HP-
5). B: TLC control of the fourth peak (from A) at tR = ~ 14 min depicting the presence of more than one compound. 
C: Control TLC of flash chromatography of the fourth peak tR = ~ 14 min. NP-TLCs were developed using mobile 
phase MP_1 and sprayed with anisaldehyde-sulphuric acid reagent. Detection VIS (left) and UV 366 nm (right). 
 
 
F5.C2 (1.13 g) was purified using HPLC method HP-4 and resulted in reisolation of compound 13 
(77.0 mg). Similarly, separation and purification of F5.C3 (21.8 mg) using HPLC method HP-5 
lead to isolation of compounds 18 (0.7 mg, tR = ~ 7.5 min), 17 (0.6 mg, tR = ~ 5.8 min) and 
reisolation of 13 (1.81 mg) as depicted in Figure 3.31 A. Separation of F5.C4 (22.7 mg) by 
preparative HPLC method HP-6 resulted in compound 27 (0.6 mg, tR = ~ 16 min) and 24 (0.9 mg, 
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tR = ~ 24.2 min) as depicted in Figure 3.31 B. Separation of F5.C5, (15.5 mg) by method HP-7 
(Figure 3.31 C) led to isolation of compound 16 (2.5 mg, tR = ~ 10.5 min) and 25 (2.2 mg, tR = ~ 
14 min). F5.C7 (39.5 mg) and F5.C8 (11.0 mg) were separated using method HP-7 and resulted 
in compounds 10 (1.0 mg, tR = ~ 6.3 min), 26 (2.6 mg, tR = ~ 11.9 min) and 22 (1.0 mg, tR = ~ 10.5 
min) for F5.C7 (Figure 3.31 D). F5.C8 resulted in reisolation of 18 (1.8 mg, tR = ~ 12 min) and 22 
(4.2 mg, tR = ~ 10.5 min) and compound 23 (0.9 mg, tR = ~ 17.1 min) (Figure 3.31 E). 
 
 
Figure 3.31: Preparative RP-18 HPLC chromatograms. A: Fraction F5.C3 (method HP-5), UV detection at 222 nm. B: 
Fraction F5.C4 (method HP-6), UV detection at 255 nm C: Fraction F5.C5 (method HP-7), UV detection at 291 nm. 
D: Fraction F5.C7 (method HP-7), UV detection at 236 nm. E: Fraction F5.C8 (method HP-7), UV detection at 230 
nm. 
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3.3.4.3 Fraction S2.F6 
S2.F6 was fractionated on silica gel flash chromatography using method FL-5 which resulted to 
ten subfractions F6.1–F6.10 (Figure 3.32). 
 
Figure 3.32: Control NP-TLC of S2.F6 silica gel flash chromatography. Mobile phase MP_1, sprayed with 
anisaldehyde-sulphuric acid reagent. Detection VIS (left) and UV 366 nm (right). 
 
 
Subfractions F6.3 (43.4 mg), F6.5 (1.8 mg) and F6.10 (8.2 mg) were subjected to preparative RP-
18 HPLC using method HP-9, HP-10 and HP-11 respectively. After chromatography, compounds 
11 (30.5 mg, tR = ~ 10.5 min) and 12 (6.6 mg, tR = ~ 11.8 min) were obtained from F6.3 (Figure 
3.33 A), compound 15 (0.7 mg, tR = ~ 11 min) from F6.5 (Figure 3.33 B) and compound 27 (0.9 
mg, tR = ~ 5.9 min) from F6.10 (Figure 3.33 C) respectively. 
 
 
Figure 3.33: Preparative RP-18 HPLC chromatograms. A: Fraction F6.3, UV 306 nm (method HP-9). B: Fraction F6.5 
(method HP-10), UV 220 nm. C: Fraction F6.10 (method HP-11), UV 269 nm. 
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Figure 3.34: Fractionation and isolation scheme of non-tannin compounds obtained from Sephadex® LH-20 
fraction S2 from crude methanolic extract of M. salicifolia bark. 
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3.3.5 Structure elucidation of the isolated compounds 
Structure elucidation of the isolated compounds was accomplished in two steps. In the first 
step, the relative stereochemistry of the isolated compounds was attained. Thereafter, 
determination of the absolute configuration was done. 
 
Determination of relative configuration of the isolated compounds 
The relative configuration of the isolated compound was achieved by the aid of 1D NMR (1H 
and 13C) and 2D NMR (HSQC, HMBC, COSY, and NOESY/ROESY). Molecular mass and molecular 
formula of the structure were achieved by mass spectroscopy (LC-MS, HRESI-MS). Additionally, 
UV measurements to determine the absorption maxima were performed. 
1H NMR spectrum is the starting point for many structure determinations. The spectrum 
provides important information on chemical shifts which gives a hint to the kind of hydrogens, 
for example alkane, alkene, benzene or aldehyde. It also provides the relative number of (not 
exchangeable) protons which are obtained by integral of a peak/peaks signals generated by 
different hydrogens in a compound. In addition to that, the number of hydrogens on the 
neighbouring carbon atom are obtained through observation of signal splitting/multiplicity 
caused by interactions with neighbouring hydrogens. 
13C spectra measurement gives information on the number of carbons by observing the number 
of signals generated, and chemical shift values (ppm) are telling something about the type of 
carbons that are present in the compound of interest. 
The HSQC spectrum shows heteronuclear correlation between a proton and its direct attached 
carbon. The spectrum gives information on single bond linkages (1JH,C) within the molecule. It 
also provides information about the group of protons attached to the particular carbon. The 
HSQC experiment relies on magnetization transfer from the proton to its attached carbon and 
back to the proton, therefore signals for non-protonated carbons, e.g. carbonyl group and 
signal of H attached to another heteroatom other than carbon e.g. OH, are not displayed. 
The HMBC experiment provides heteronuclear correlation information on long-range couplings 
between 1H-13C connectivity, i.e. proton and its neighbouring carbons that are separated from 
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each other by two, three, and sometimes four bonds (2JH,C and 3JH,C or 4JH,C). Additionally, HMBC 
is often used in structure elucidation for assignment of the quaternary and carbonyl carbons, as 
well as assignment of the linkage position between two substructures in a compound, e.g. 
position assignment of glycosidic linkages between aglycone and its sugar moiety. 
COSY is a homonuclear 2D NMR experiment which provides information on which protons are 
coupled with each other (H-H coupling). COSY determines the protons coupling through the 
bonding electrons hence provides effective way of assigning connectivity when a numerous 
coupling networks need to be identified. The H-H coupling can either be vicinal H-H or germinal 
H-H coupling. In vicinal H-H coupling, protons coupled with each other are separated by three 
bonds (3JH-H) proton resonances located on the adjacent carbon nuclei and in geminal coupling, 
protons coupled with each other through two bonds (2JH-H) or they are defined as proton 
resonances located on the same carbon nuclei. Signals of protons that are more than three 
bonds away cannot be detected in this case because coupling to their neighbours is too small to 
affect their spin. 
NOESY and ROESY experiments give information on interaction between protons that are close 
to each other through the space. In the NOESY experiment, the observed nuclear overhauser 
cross relaxation between nuclear spins in the mixing period is used to create the correlations. 
The NOESY spectrum is comparable to COSY in terms of diagonal peaks and cross peaks. 
Although, in NOESY the cross peaks connect resonances from nuclei that are spatially close 
rather than those nuclei which are coupled to each other through bond. 
The ROESY is similar to NOESY experiment. However, ROESY measures the homonuclear NOE 
effects under spin-locked conditions by an external magnetic field so that it is not rotating. In 
ROESY the mixing time is the spin-lock period where by spin exchange occurs among spin-
locked magnetization components of different nuclei. ROESY is suitable for those molecules 
whose rotational correlation time falls in a range where the nuclear overhauser effect is too 
weak to be detected. 
Molecular mass and molecular formula of the isolated compounds were measured by LC-MS 
and/or HRESI-MS. The LC-MS is a HPLC system coupled with a mass detector. Consequently, the 
compounds are separated through the column that is packed with a suitable stationary phase. 
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As the compounds eluted from the column to the mass detector, the solvent is completely 
removed, the residues are ionized to generate charged molecules. Thereafter, mass detector 
scans every molecule ion in the vacuum by mass to charge ratio (m/z) and produces a spectrum 
depicting all ions with different masses. In this study, the LC-MS was used to confirm the 
molecular mass of isolated compound for easier structure elucidation and also to detect the 
existence of isomers, which could have same molecular weight but having slight differences in 
retention time. 
Molecular formula of the new isolated compounds and the compounds whose mass did not fit 
to the prior elucidated structure (by using NMR data) were confirmed by HRESI-MS. HRESI-MS 
gives information of the elemental composition of a compound by providing m/z values with 
four decimal numbers which match with only one molecular formula. 
 
Absolute stereochemistry of the isolated compounds 
The absolute stereochemistry of the isolated compounds was determined based on the 
elucidated relative configuration. Absolute stereochemistry of the isolated tannins was 
achieved mainly through optical rotation, CD spectra measurement and comparison with 
literature values. 
The absolute stereochemistry and the type of the sugar moieties attached to the compounds 
was attained by recording the 1H NMR of the SMB derivatives of glycosides and comparing their 
chemical shifts and coupling constants of the anomeric proton to that of reference sugars 
(materials and methods 3.2.7.5). Likewise, the absolute configuration of the aglycone (cyclic 
diarylheptanoids) was obtained following detachment of the linked sugar by enzyme hydrolysis 
recording CD spectra data and comparing the experimental data versus CD spectra simulated by 
TDDFT (materials and methods 3.2.8.6 and 3.2.8.8). 
Detailed structure elucidation of individual compounds is described and discussed in the 
following paragraphs. 
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3.3.5.1 Tannins 
Nine compounds belonging to the group of tannins (PAs and HTs) were isolated and their 
structures elucidated. Among the isolated tannins, two compounds were flavan-3-ol monomers 
with a trihydroxylated B-ring, three dimeric B-type prodelphinidins, three dimeric-A-type 
prodelphinidins and one ellagitannin. The isolated tannin compounds were obtained from 
further fractionation of the fractions S4, S5 and S6 as indicated in the fractionation scheme 
(Figure 3.25). The overview of the isolated tannin compounds are depicted in the control TLC 
(Figure 3.35). All isolated PAs changed to deep orange colour after sprayed with anisaldehyde-
sulphuric acid reagent which is characteristic for the PAs142. This was not the case with the 
isolated ellagitannin under the same conditions. 
 
 
Figure 3.35: NP-TLC overview of the isolated tannins compounds 1 -9. Mobile phase MP_1. Detection: VIS. 
Spraying reagent: anisaldehyde-sulphuric acid reagent. 
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3.3.5.1.1 Proanthocyanidins  
Monomeric flavan-3-ols 
 
Figure 3.36: Structures of (+)-gallocatechin (1) and (-)-epigallocatechin-3-O-gallate (2). 
 
Compound 1((+)-gallocatechin) and 2 ((-)-epigallocatechin-3-O-gallate) (Figure 3.36) were 
isolated as light orange amorphous powders from fractions S4 and S6.M13.3 as illustrated in 
the fractionation scheme (Figure 3.25). The two compounds were identified by their NMR data 
(Table 3.8) and confirmed by comparing with the published data for compound 192,143,144 and 
compound 292,108,143,145. 
The observed singlet signals on the aromatic region of 1H NMR of the compound 1 (δH 6.39 
ppm) and 2 (δH 6.47 ppm) integrating for two protons indicated the trihydroxylated B-ring. 
Compound 2 had an extra singlet observed on 1H NMR spectrum at δH 6.95 ppm, integrating for 
two protons. The observed HMBC long range correlation between this proton and carbonyl 
carbon at δC 167.6 ppm indicated that compound 2 possibly contain a gallate moiety. The 
gallate moiety was assigned to position 3C based on HMBC long range correlation between H-
3C (δH 5.50 ppm) and the carbonyl carbon C-7” at δC 167.6 ppm. 
Additionally, the 2,3 cis orientation of compound 2 was concluded by H-2C signal on 1H NMR 
spectrum of 2 at δH 4.95 ppm (s) and H-3C (δH 5.50 ppm, brs) together with their respective 
carbons at δC 78.6 and 69.9 ppm which is characteristic in case of a cis orientation99,146. The 
optical rotation of compound 2 was [α]D
25 = -96.8 (c 0.1, MeOH) and UV maximum emerged at 
275 nm. The ESI-MS exhibited ions at m/z 459.092 [M+H]+ in the positive mode and m/z 
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457.076 [M-H]– in the negative mode calculated for mass of 458 Da which fits with the 
molecular formula of epigallocatechin-3-O-gallate (C22H18O11). Overall, compound 2 was 
confirmed to be (-)-epigallocatechin-3-O-gallate (2S,3S). 
The 2,3 trans orientation of 1 was deduced from the chemical shifts of H-2C (δH 4.52, d) and H-
3C (δH 3.96, td) with J2,3 > 7 Hz which is characteristic of trans orientation. ESI-MS exhibited ions 
at m/z 307.08 [M+H]+ in the positive mode and m/z 305.07 [M-H]– in the negative mode 
calculated for mass of 306.27 Da and molecular formula of C15H14O7. The optical rotation for 
compound 1 was [α]D
22.4 = +25.06 (c 0.1, MeOH) and UV maximum was at 270 nm. Hence, the 
absolute configuration of compound 1 was deduced to be (+)-gallocatechin compared to 
literature data. 
 
Table 3.8: NMR data for compound 1: 1H NMR (300 MHz), 13C NMR (75 MHz), MeOH-d4, 294 K and 2: 1H NMR (600 
MHz), 13C NMR (150 MHz), MeOH-d4, 278 K. 
Position  1 2 
δC (ppm) δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
2C 82.5 4.52, (1H, d, J = 7.1) 78.6 4.95, (1H, s) 
3C 68.3 3.96, (1H, td, J = 5.3, 7.4) 69.9 5.50, (1H, brs) 
4C 28.0 2.80, (1H, dd, J = 5.3, 16.1) 
2.49, (1H, dd, J = 7.8, 16.1) 
26.8 2.96, (1H, dd, J = 4.6, 17.2) 
2.81, (1H, dd, J = 2.3, 17.3) 
5A 156.5  157.2  
6A 96.9 5.91, (1H, d, J= 2.3) 96.1 5.93, (1H, d, J = 2.2) 
7A 157.1  157.6  
8A 96.1 5.85, (1H, d, J = 2.3) 95.7 5.92, (1H, d, J = 2.2) 
9A 157.0  157.3  
10A 101.4  99.1  
1’B 131.5  130.6  
2’B 107.9 6.39, (1H, s) 106.6 6.47, (1H, s) 
3’B 146.7  146.4  
4’B 134.0  133.9  
5’B 146.7  146.4  
6’B 107.9 6.39, (1H, s) 106.6 6.47, (1H, s) 
1”G   121.2  
2”G/6” G   110.1 6.92, (1H, s) 
3”G/5”G   147.1  
4”   140.4  
7”   167.6  
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Dimeric B-type prodelphinidins 
 
Figure 3.37: Structures of epigallocatechin-(4β→8)-gallocatechin (3), epigallocatechin-3-O-gallate-(4β→8)-
gallocatechin (4) and epigallocatechin-(4β→8)-gallocatechin-3-O-gallate (5). 
 
Dimeric B-type prodelphinidins with and without gallate moiety were also isolated from the 
Sephadex® LH-20 fractions S5 and S6 of the methanolic extract of M. salicifolia bark. These 
compounds were identified as prodelphinidin B1 (epigallocatechin-(4β→8)-gallocatechin (3), 
epigallocatechin-3-O-gallate-(4β→8)-gallocatechin (4) and epigallocatechin-(4β→8)-
gallocatechin-3-O-gallate (5) (Figure 3.37). The 1H and 13C NMR data of the three compounds 
are summarized in the Table 3.9. 
The NMR measurement of these compounds were performed at low temperature (233 K) 
because of the broadening of 1H NMR signals due to rotational isomerism caused by steric 
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interactions in the vicinity of the interflavanoid bond of freely rotating flavan-3-ol units when 
measurements are performed at room temperature86,147. 
 
Table 3.9: 1H and 13C NMR of compounds 3, 4 and 5. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 233 K. 
Pos.  3 4 5 
δC 
(ppm) 
δH (ppm), m, J (Hz)  δC 
(ppm) 
δH (ppm), m, J (Hz) δC 
(ppm) 
δH (ppm), m, J (Hz) 
2C 76.8 4.96, (1H, brs) 74.8 5.26, (1H, brs) 75.7 5.25, (1H, brs) 
3C 72.8 3.88, (1H, brs) 74.3 5.37, (1H, brs) 75.5 5.31, (1H, brs) 
4C 36.7 4.58, (1H, brs) 34.3 4.60, (1H, brs) 34.6 4.59, (1H, brs) 
5A 156.1   155.7   155.4  
6A 95.8 5.95, (1H, dd, J = 9.4, 
2.3) 
106.1 6.27, (1H, s) 105.7 6.26, (1H, s) 
7A 154.3  153.9   154.2  
8A 95.8 5.95, (1H, dd, J = 9.4, 
2.3) 
106.2 6.31, (1H, s) 105.7 6.26, (1H, s) 
9A 157.9  156.2   157.9  
10A 101.4  102.4   102.7  
1’B 131.8  131.8   137.8  
2’B 106.4 6.38,(1H, s) 109.8 6.36, (1H, s) 106.0 6.36, (1H, s) 
3’B 146.4  146.5   146.6  
4’B 133.6  133.4   132.8  
5’B 146.4  146.5   146.6  
6’B 106.4 6.38, (1H, s) 109.8 6.36, (1H, s) 106.0 6.36, (1H, s) 
Lower        
2F 82.3 4.71, (1H, d, J = 6.2) 81.9 4.83, (1H, d, J = 5.4) 81.9 4.83, (1H, d, J = 5.4) 
3F 68.2 4.05, (1H, m) 68.4 4.04, (1H, m) 68.9 4.04, (1H, m) 
4F 27.3 2.76, (1H, m) 
2.57, (1H, m) 
26.7 2.96, (1H, m) 
2.70, (1H, dd, J = 
5.3, 16.1) 
27.3 2.94, (1H, dd, J = 5.6, 
16.6) 
2.78, (1H, dd, J = 5.3, 
16.1) 
5D 152.9  152.0   151.2   
6D 96.7 5.82,(1H, s) 107.4 6.12, (1H, s) 106.9 6.12, (1H, s) 
7D 156.3  157.6   156.6   
8D 107.4  107.8   107.6   
9D 150.2  156.2   156.1   
10D 100.9  102.4   102.0   
1’E 124.0  131.8   130.9   
2’E 106.6 6.49, (1H, s) 106.3 6.75, (1H, s) 106.0 6.75, (1H, s) 
3’E 146.8  146.5   146.3   
4’E 133.6  133.7   132.8   
5’E 146.8  146.5   146.3   
6’E 106.6 6.49, (1H, s) 106.3 6.75, (1H, s) 106.2 6.75, (1H, s) 
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Pos.  3  4  5 
δC 
(ppm) 
δH (ppm), m, J (Hz)  δC 
(ppm) 
δH (ppm), m, J (Hz) δC 
(ppm) 
δH (ppm), m, J (Hz) 
1”G   121.1   121.0  
2”G   109.9 6.85, (1H, s) 109.3 6.85, (1H, s) 
3”G   146.2   145.0  
4”G   139.4   139.7  
5”G   146.2   145.0  
6”G   109.9 6.85, (1H, s) 109.3 6.85, (1H, s) 
7”   166.2   166.0  
 
Compound 3, prodelphinidin B1 (epigallocatechin-(4β→8)-gallocatechin) was isolated as 
amorphous light orange powder, with [α]D
25 = -15.33 (c 0.1, MeOH) and UV maximum at 270 
nm. The ESI-MS exhibited ions at m/z 611.14 [M+H] + in the positive mode and m/z 609.12 [M-
H]– in the negative mode calculated for 610 Da which fits to the molecular formula of C30H26O14. 
The compound exhibited positive cotton effect in the region 213-243 nm of CD spectrum. This 
confirms a 4β-interflavanol linkage with 4R configuration of the upper unit148–151. The 1H and 13C 
NMR data are summarized in Table 3.9. 
Prodelphinidin B1 is a known compound, however the complete published 1H and 13C NMR 
literature data are of the peracetylated derivative152–155 and the data of free phenolic 
compound are not complete, hence they could not fit exactly with the obtained data of 3. The 
NMR data for 3 were almost comparable to the published data of non-acetylated but 
methylated prodelphinidin B199. The observed difference between both compounds are the 
carbon shifts of the lower unit E-ring where the hydroxyl group at C-4’ is replaced by a methoxy 
group. The carbon shift values of the E-ring containing methoxy group which are different from 
the isolated prodelphinidin B1 are δC 137.1 ppm (C-1’) and 151.6 ppm (C-3’ /C-5’) while those of 
prodelphinidin B1 are δC 124.0 ppm (C-1’) and 146.8 ppm (C-3’ /C-5’). 
Compound 4 (epigallocatechin-3-O-gallate-(4β→8)-gallocatechin) was isolated as amorphous 
orange powder with [α]D
25.4 = +168 (c 0.1, MeOH) and UV maximum at 275 nm. The upper unit 
was identified as epigallocatechin, because of the observed chemical shift of H-2C (δH 5.26 
ppm), and H-3C (δH 5.37), both broad singlets which is characteristic for 2,3 cis orientation. The 
lower unit was identified as gallocatechin by the chemical shifts of H-2F (δH 4.83, d) and H-3F 
(4.04, d) with J2,3 = 5.4 Hz and also by their carbon signals 2F (δC 81.9) and 3F (δC 68.4) which is 
Phytochemical investigation of Myrica salicifolia A. Rich bark 
107 
 
characteristic of the 2,3 trans orientation156. Assignment of the galloyl moiety to upper unit was 
based on HMBC long correlation between H-3C (δH 5.37) to carbon C-7” (δC 166.2). The ESI-MS 
exhibited ions at m/z 761.1533 [M-H]– in the negative mode, calculated for 762 Da and the 
molecular formula C37H30O18. 
Positive cotton effects were observed in the region 225 - 250 nm of the CD spectrum which 
confirms a 4β-flavanol linkage with 4R configuration. From the obtained data of 4, it was 
concluded that it is epigallocatechin-3-O-gallate-(4β→8)-gallocatechin. Compound 4 is a known 
compound, previously reported by, Danne et al.154, Hartisch and Kolodziej157. The published 
data reported on the acetylated derivative and could not exactly match with free phenolic 
compound 4. No literature is available to this free phenolic prodelphinidin derivative. 
Compound 5 (epigallocatechin-(4β→8)-gallocatechin-3-O-gallate) was isolated as amorphous 
orange powder with [α]D
25 = +220 (c 0.1, MeOH) and UV maximum at 275 nm. The obtained 
mass spectrometry data were the same as for the compound 4, exhibiting ions m/z 761.1487 
[M-H]– in the negative mode and calculating for the molecular formula C37H30O18. 
The NMR data of the two compounds 4 and 5 were similar, but a difference was noted in their 
retention time (Figure 3.24 A). Thus, the structural difference is likely the position of the galloyl 
moiety. Assignment of galloyl moiety of compound 5 was not clear due to broad 1H NMR signal 
even after measurement at -40 οC. The recorded broad 1H NMR signals caused overlapping of 
some cross peaks in the lower field of the HMBC experiment. Additionally, there was no HMBC 
correlation observed between H-3C (δH 5.31 ppm) and the carbonyl carbon at δC 166.0 ppm (C-
7”) which could prove that the galloyl moiety is not attached to the upper unit, and gave a clue 
that attachment of the galloyl moiety could be linked to the lower unit of compound 5 as 
shown in Figure 3.38. 
A positive cotton effect in the region 210 -254 nm was observed in the CD spectrum of 5 which 
confirmed a 4β-interflavanol linkage with 4R configuration. From the obtained data, compound 
5 was identified as epigallocatechin-(4β→8)-gallocatechin-3-O-gallate. The isolation of 5 was 
hitherto not reported, however further investigations have to be done to provide a proof of the 
galloyl position. 
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Figure 3.38: Part of the HMBC spectrum, A: Showing correlation between H-3C and the carbonyl carbon of the 
gallate moiety for compound 4 and B: No correlation was observed to proof the attachment of gallate moiety for 
compound 5. 
 
Dimeric A-type prodelphinidins 
The compounds 6 - 8 were isolated and identified as A-type prodelphinidins. The identification 
of these compounds was mainly based on obtained NMR data (Tables 3.10 and 3.11) in 
comparison to literature data on the A-type PAs. The characteristics of the A-type PAs which 
were observed from recorded NMR spectra data are: the characteristic of C ring protons (H-3C, 
H-4C) which possess small coupling constants between 3-4 Hz158. The NOESY/ROESY correlation 
between H-3C and H-6D is an indicative feature for assigning the configuration of position 3C. 
The presence of a NOESY correlation between H-3C and H-6D confirms the 3,4 trans relative 
configuration and the lack of a NOESY correlations confirms the 3,4 cis relative 
configuration158,159. The double linkages of either (2β,4β) or (2α,4α) of these compounds were 
confirmed by CD spectra measurements, as the high amplitude of positive cotton effect at 200-
240 nm confirms (2β,4β) orientation and the negative cotton effect at 240 nm confirms 
(2α,4α)148,149,151. 
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Myricedin (7) 
 
Figure 3.39: Structure of myricedin: (+)-gallocatechin-(2β→O→7,4β→8)–gallocatechin (7). 
 
 
Compound 7, myricedin ((+)-gallocatechin-(2β→O→7,4β→8)–gallocatechin) (Figure 3.39), was 
isolated as amorphous light orange powder. It displays an orange spot on the TLC sheet after 
spraying with anisaldehyde-sulfuric acid reagent (Figure 3.35), an Rf value of ~ 0.8 and optical 
rotation [α]D
25 = -22.6 (c 0.1, MeOH). The HRESI-MS exhibited ions at m/z 607.1099 [M-H]– in 
the negative mode correlating with molecular formula of C30H23O14. The UV spectrum of 7 
display a maximum at wavelength 279 nm corresponding to those of PAs. 
Two singlets δH 6.33 and 6.71 were observed in the aromatic region of the 1H NMR spectrum, 
all integrating for two protons indicating the presence of two trihydroxylated flavan-3-ol units. 
The AB coupling system was detected at δH 4.0 - 4.5 with J3,4= 3.5 Hz, characteristic for the C-
ring protons of A-type PAs151,158,159. The doubly linked dimeric structure was demonstrated by 
one acetal carbon at δC 100.3 ppm which was detected from the long range HMBC correlation 
between δH 4.06 (H-3C), δH 4.23 (H-4C) and δC 100.3 ppm (C-2). In addition to this, the meta-
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coupled doublets of the A ring were observed at δH 5.99 ppm (H-6A) and 6.05 ppm (H-8A), each 
doublets, integrated for one proton with J = 2.2 Hz and 2.1 Hz respectively. 
The absolute configurations at position 2C and 4C were established by CD spectra 
measurements. The detected positive cotton effects in the wavelength region of 226 - 255 nm 
indicated the (2β, 4β) configuration. The absence of ROESY correlation between H-3C (δ H 4.06 
ppm) and H-6D (δH 6.07 ppm) indicates the 3,4 cis configuration of ring C. Hence the upper unit 
was identified to be (+)-gallocatechin. 
The lower unit was identified as gallocatechin from the chemical shifts δH 4.62, d (H-2F) and δH 
4.01, dd (H-3F) with J2,3 > 6 together with their corresponding carbon signals at δC 84.7 and δC 
68.1 ppm which is characteristic of 2,3 trans orientation99,146. Together with the 2D NMR data 
compound 7 was therefore deduced to be (+)-gallocatechin-(2β→O→7,4β→8)-gallocatechin. It 
is not yet described in literature and was named myricedin. 
 
Table 3.10: 1H NMR, 13C NMR and HMBC correlation of compound 7. 1H NMR (600 MHz), 13C NMR (150 MHz), 
MeOH-d4, 278 K. 
Position δC (ppm) δH (ppm), m, J (Hz) HMBC 
Upper     
2C 100.2   
3C 68.3 4.06, (1H, d, J = 3.5) 2C, 10A, 8D, 4B, 9A 
4C 29.3 4.23, (1H, d, J = 3.5) 3C, 2C, 10A, 8D, 5A, 10D 
5A 153.5   
6A 96.8 5.99, (1H, d, J = 2.2) A8/A6, 10A, 7A 
7A 157.9   
8A 96.4 6.05, (1H, d, J = 2.1) 3C, 6A, 2C, A10, 5A, 7A 
9A 152.7   
10A 103.5   
1’B 131.4   
2’B 107.8 6.71, (1H, s) 2C, 2’B/6’B, 1’B, 4’B, 3’B/5’B 
3’B 145.8   
4’B 135.3   
5’B 145.8   
6’B 107.8 6.71, (1H, s) 2C, 2’B/6’B, 1’B, 4’B, 3’B/5’B 
Lower     
2F 82.5 4.62, (1H, d, J = 6.1) 4F, 3F, 2’E/6’E, 1’E, 7D 
3F 68.6 4.01, (1H, dd, J = 6.3, 11.5) 10D, 9D 
4F 27.6 2.74, (1H, dd, J = 4.9, 16.5) 
2.61, (1H, dd, J = 6.5, 16.4) 
3F, 2F, 9D. 
5D 155.2   
Phytochemical investigation of Myrica salicifolia A. Rich bark 
111 
 
Position δC (ppm) δH (ppm), m, J (Hz) HMBC 
6D 96.6 6.07, (1H, s) 10D, 8D, 9D, 5D 
7D 154.2   
8D 107.2   
9D 151.3   
10D 103.9   
1’E 131.7   
2’E 106.6 6.33, (1H, s) 2F, 2’E/6’E, 4’E, 3’E/5’E 
3’E 147.1   
4’E 133.1   
5’E 147.1   
6’E 106.6 6.33, (1H, s) 2F, 2‘E/6‘E, 4‘E, 3‘E/5‘E. 
 
 
 
Figure 3.40: Absence of ROESY correlation of H-3 of ring C to H-6 of ring D, an important indication for the 3,4 cis 
configuration of ring C for compound 7158,159. 
 
Phytochemical investigation of Myrica salicifolia A. Rich bark 
112 
 
Figure 3.41: 1H NMR spectrum of compound 7. MeOH-d4, 600 MHz, 298 K. LU = lower unit, UU = upper unit. 
 
 
Ephedrannin D5 (6) and adenodimerin C (8) 
 
Figure 3.42: Structures of ephedrannin D5 (6) and adenodimerin C (8). 
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Compound 6 (epigallocatechin-(2β→O→7,4β→8)-gallocatechin) (Figure 3.42), was isolated as 
amorphous light orange powder with optical rotation value [α]D
25 = -82.4 (c 0.1, MeOH). It 
appeared as deep orange spot on the TLC sheet with the same Rf value as that of compound 7 
(Figure 3.35). Compound 6 exhibited a UV maximum at 270 nm. The ESI-MS exhibited ions at 
m/z 609.1246 [M+H]+ in the positive mode and m/z 607.1085 [M-H]– in the negative mode, 
calculating for molecular mass of 608 Da which corresponds to molecular formula of C30H24O14, 
which is the same like that of 7. 
The NMR data of compound 6 were comparable to those of 7 in terms of coupling constants 
and chemical shifts of carbons (Table 3.11). The difference between the two compounds was 
clearly observed on their 1H NMR spectrum on the arrangement of the signals of H-3C, H-4C 
and H-3F as it is depicted in Figure 3.46. For compound 6, the multiplet for H-3F (lower unit 
(LU)) was in the middle of H-4C and H-3C, both doublets (upper unit (UU)), while for compound 
7, the H-3C doublet (UU) was in the middle of the multplet of H-3F (LU) and H-4C doublet (UU). 
The difference was further observed in the ROESY experiment as there was a ROESY correlation 
between H-3C (δH 4.04) and H-6D (δH 6.07), an indication for the 3,4 trans configuration of the C 
ring (Figure 3.43). 
The absolute configurations at C-2 and C-4 in the upper unit were established from the 
detected positive cotton effects of the CD spectrum in the wavelength region 209 - 251 nm, 
indicating the 2β,4β-configuration148–150. Therefore, the upper unit was concluded to be 
epigallocatechin unlike gallocatechin for the compound 7. 
The lower unit was identified as gallocatechin (2,3 trans) from the detected chemical shifts and 
coupling constants of H-2F (δH 4.67, d, J = 7.6 Hz) and H-3F (4.11, m) and their corresponding 
carbon signals at δC 84.7 and 68.1 respectively. The obtained data of 6 are in agreement with 
the published data of ephedrannin D5 isolated from Ephedra sinica160. Hence, it was concluded 
that 6 is also epigallocatechin-(2β→O→7,4β→8)-gallocatechin (ephedrannin D5). 
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Figure 3.43: Presence of a ROESY correlation between H-3C and H-6D of the compound 6, indicating the 3,4 trans 
configuration of ring C. 
 
Compound 8 (Figure 3.42) was isolated as an amorphous orange powder, showing optical 
rotation [α]D
25 = +20.5 (c 0.1, MeOH), orange spot on TLC sheet with Rf value ~ 0.8 (Figure 3.35) 
and UV maximum (MeOH) at 275 nm. The recorded NMR data were almost similar to that of 
compounds 6 and 7 with exception of an extra singlet proton signal at δH 6.71 signal integrating 
for two protons. This signal has a long range HMBC correlation with a carbonyl carbon at δC 
166.2 indicating that there was a galloyl moiety attached to this compound. In addition to this, 
HMBC experiments showed a correlation between H-3C (δH 5.58 ppm) and the carbonyl carbon 
at δC 166.2 ppm (Figure 3.44) providing a proof of galloyl moiety’s attachment to the upper 
unit. The absolute configurations at C-2 and C-4 of ring C of the upper unit were deduced from 
CD spectrum showing the strong positive cotton effects in the wavelength region between 219 - 
258 nm indicating the (2β,4β)-configuration148–150. Moreover, there was no ROESY correlation 
between H-3C (δH 5.38 ppm) and H-6D (δH 5.94 ppm) of compound 8 (Figure 3.45), a diagnostic 
feature of the 3,4 cis configuration in the C-ring. From the obtained NMR data of 8 (Table 3.11) 
and the CD data, the upper unit was identified as gallocatechin-3-O-gallate and the lower unit 
as gallocatechin. Hence, compound 8 was also based on 2D NMR data identified as 
gallocatechin-3-O-gallate (2β→O→7,4β→8)–gallocatechin (Figure 3.42). This was further 
verified by mass spectrometry data due to exhibited ions at m/z 761.1343 [M+H]
+
 in the positive 
mode and m/z 759.1206 [M-H]
–
 in the negative mode, calculating for molecular formula of 
C37H28O18. The obtained data of compound 8, were in agreement with the existing literature of 
adenodimerin C isolated from Myrica adenophora109.  
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Figure 3.44: Part of HMBC spectrum of compound 8 showing a long range coupling between H-3C (δH 5.58) and the 
carbonyl carbon (δC 166.2), a proof of the attachment of the galloyl moiety to the upper unit. 
 
 
 
Figure 3.45: Lack of a ROESY correlation between H-3C (δH 5.38) and H-6D (δH 5.94) of compound 8, a diagnostic 
feature of the 3,4 cis configuration of ring C. 
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Table 3.11: 1H NMR and 13C NMR of compounds 6 and 8. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 278 K. 
 6 8 
Position δC (ppm) δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
Upper      
2C 100.3  99.0  
3C 67.8 4.04, (1H, d, J = 3.6) 69.0 5.38, (1H, d, J = 3.6) 
4C 29.2 4.21, (1H, d, J = 3.6) 27.2 4.48, (1H, d, J = 3.5) 
5A 156.6  154.3   
6A 98.2 5.95, (1H, d, J = 2.3) 96.3 6.11, (1H, s) 
7A 158.2  158.1   
8A 96.5 6.05, (1H, d, J = 2.3) 96.3 6.11, (1H, s) 
9A 151.8  152.0  
10A 104.1  104.0   
1’B 131.5  130.4   
2’B 107.5 6.71, (1H, s) 107.2 6.69, (1H, s) 
3’B 146.4  146.6   
4’B 134.7  134.8   
5’B 146.4  146.6   
6’B 107.5 6.71, (1H, s) 107.2 6.69, (1H, s) 
Lower      
2F 84.7 4.67, (1H, d, J = 7.6) 84.4 4.72, (1H, d, J = 7.2) 
3F 68.1 4.11, (1H, m) 68.2 4.10, (1H, td, J = 7.4, 5.5) 
4F 28.7 2.91, (1H, dd, J = 16.4, 5.5) 
2.56, (1H, dd, J = 16.4, 8.1) 
28.3 2.88, (1H, dd, J = 5.3, 16.4) 
2.58, (1H, dd, J = 7.8, 16.3) 
5D 156.0  156.6  
6D 96.5 6.07, (1H, s) 98.0 5.94, (1H, s) 
7D 156.8  158.6  
8D 106.9  105.8  
9D 151.4  151.6   
10D 103.0  103.4  
1’E 130.0  129.3  
2’E 107.8 6.48, (1H, s) 107.6 6.45, (1H, s) 
3’E 147.0  146.9  
4’E 134.6  134.4  
5’E 147.0  147.7  
6’E 107.8 6.48, (1H, s) 107.6 6.45, (1H, s) 
Galloyl     
1”G   120.8  
2”G   110.3 6.71, (1H, s) 
3”G   146.0  
4”G   140.5  
5”G   146.0  
6”G   110.3 6.71, (1H, s) 
C=O   166.2  
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Figure 3.46: Part of the 1H NMR spectra of compounds 6 - 8 showing the positions H-3C, H-4C of the upper unit and 
H-3F of the lower unit. A preliminary observation of either 3,4 trans or 3,4 cis configuration of a ring C of the upper 
unit. UU = upper unit and LU = lower unit. 
 
3.3.5.1.2 13C NMR analysis of polymeric PA fraction of M. salicifolia 
Oligomeric PAs containing more than four flavan-3-ol units are very difficult to isolate and to 
elucidate. Based on isolation difficulties of the individual oligomeric PA compounds, fractions 
containing oligomeric and even polymeric PAs were processed by chromatography using 
Sephadex® LH-20139,161. The 13C NMR spectrum of the isolated polymeric fraction was measured 
and extensively analyzed to determine their composition and to get more structure 
information. Based on 13C NMR spectra, structural elucidation of oligomeric or polymeric 
fraction of the PAs can be achieved in dependence of three criteria: the ratio of procyanidin to 
proanthocyanidin units, the stereochemistry of the heterocyclic ring (2,3 cis/trans) of the 
monomeric units, and the middle length chain weight139. 
The polymeric fraction of M. salicifolia bark methanolic extract was analyzed by measuring a 
long 13C NMR spectrum (2048 scans). The 13C NMR spectrum resonance assignment (Figure 
3.47) was based on the available literature for isolated PAs polymer fractions87,139,162–165. From 
the 13C NMR spectrum it was observed that the dominant polymeric proanthocyanidins of M. 
salicifolia bark are of the prodelphinidin type due to observed unsubstituted B ring carbon at δC 
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106.7 ppm (C-2’, C-6’). There were no detectable signals assigned for procyanidins at the region 
of 116 - 117 ppm (C-2’, C-5’), demonstrating their concentration below detection limit.  
The relative amount of 2,3 cis or trans isomer was found to be 36:1 indicating the dominance of 
2,3-cis configuration. The said ratio was attained by integrating the signals of the upper units for 
the C-2 of 2,3 cis units observed in the region of 76.8 ppm and very weak signal for C-2 of 2,3 
trans units in the region of δC 82.3 ppm.  
The estimated average degree of polymerization was obtained to be 16 flavan-3-ols units 
obtained from the ratio of 15:1 following integration of the C-3 resonances of the extender 
units at δC 73.3 ppm and the resonances of C-3 of terminal units at δC 68.3 ppm. Likewise, the 
same ratio of 15:1 was obtained by integrating C-4 signals of the upper units (δC 35.2 – 37.4 
ppm) and that of terminal unit (δC 29.6 ppm). 
Occurrence of the signals at δC 110.6, 121.8, 139.7, 146.5 ppm and the carbonyl carbon at δC 
166.3 ppm was indication of the presence of 3-O-gallate units 87,165 in the polymeric fraction of 
M. salicifolia bark. This was further evidenced by the presence of upfield C-4 (δC 35.1 ppm) in 
addition to the normal C-4 (δC 37.4 ppm) of the extender units165. 
 
 
Figure 3.47: 
13
C NMR spectrum of general features of Myrica salicifolia polymeric flavan-3-ol fraction measured at 
273 K, 150 MHz, MeOH-d4. A: Carbonyl carbon, C=O (166.32 ppm), B: Oxygenated A ring carbons, C-5, C-7, C-9 
(154.8 – 156.6 ppm), C: C-3 and C-5 of the B ring (145.6 – 146.5 ppm), D: C-4 of the galloyl ring (139.2 - 139.7 ppm), 
E: C-1 and C-4 of B ring (131.7 – 133.7 ppm), F: C-1 of the galloyl ring (121.8 ppm), G: Unsubstituted gallate carbons 
(110.6 ppm), H: Unsubstituted B-ring carbon (106.7 ppm), I: C-2 of the C ring for A type prodelphinidins (100.9 
ppm), J: Unsubstituted A-ring carbons (96.5 -97.5 ppm), K: C-2 of prodelphinidin units, 2,3- trans configured units 
(82.3 ppm), L: C-2 of 2,3-cis configured units (76.8 ppm), M: C-3 of all extender units (73.4 ppm), N: C-3 of terminal 
units (68.3 ppm), O and P: C-4 of the extender units with and without gallate substituent (35.1 -37.4 ppm), Q: C-4 
of terminal units (29.6 ppm). 
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3.3.5.1.3 Ellagitannin 
 
Figure 3.48: Structure of castalagin (9). 
 
Compound 9 was isolated from fraction S5 (Figure 3.25) as an off-white amorphous powder 
with the optical rotation value [α]D
25 = +15.6 (0.1, MeOH), thereafter identified as castalagin (an 
ellagitannin) by comparing obtained 1 and 2D NMR spectral data with existing literature 
data87,166,167. 
From the 1H NMR spectrum, three singlets signals at δH 7.13, 6.78 and 6.60 ppm in aromatic 
region were observed, each integrating for one proton. These protons were assigned as two 
protons (δH 7.13 and 6.60 ppm) for biphenyl group and one proton (δH 6.78 ppm) for triphenoyl 
group. The carbonyl carbon signals at δC 163.2, 166.5, 166.3, 166.5 and 165.9 ppm observed in 
the long range heteronuclear correlation HMBC between the three aromatic and the glucose 
protons evidently show the presence of five ester linkages.  
The cross signal was observed in the heteronuclear experiment HSQC between the anomeric 
proton at δH 5.70 ppm and carbon at δC 67.0 ppm and not in the downfield at δC ~ 100 ppm. The 
presence of the hemiacetal carbon at δC 67.0 ppm signifies that the glucose moiety is present in 
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an open chain. Furthermore, the open chain glucose moiety was deduced with aid of the 
proton coupling networks from COSY experiment. The obtained coupling constant of 3J1,2 = 4.6 
Hz is the characteristic which led to confirmation of castalagin in comparison to its epimer 
which has 3J1,2 < 2166. 
Attachment of one ring of the nonahydroxytriphenoyl group to C-1’ of the glucose moiety 
through a C-C bond was observed in the long range correlation HMBC spectrum between H-1’ 
at δH 5.70 ppm and and four aromatic carbons at δC 115.0 ppm (C-1A), 104.1 ppm (C-2A/6A), 
133.2 ppm (C-4A) and 142.6 ppm (C-3A). The 1H and 13C NMR data of this compound are 
summarized in the Table 3.12. 
Further confirmation of castalagin was deduced by mass spectrometry data. The molecular 
mass of 9 was exhibited by ESI-MS ions at m/z 933.08 [M-H]- in the negative mode, calculated 
for 934 Da which adheres to the molecular formula of C41H26O26.  
The CD spectrum exhibited positive cotton effects in the wavelength 233 and 289 nm and 
negative cotton effects at 213 and 260 nm. The obtained CD data are in accordance with the 
literature data by Matsuo et al.168, which reports positive cotton effects in the wavelengths 240 
and 295 nm and negative cotton effects at 218 and 263 nm, confirming the S,R-configuration of 
the triphenoyl moiety (Figure 3.48).  
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Table 3.12: 1H and 13C NMR data for compound 9 1H NMR (600 MHz), 13C NMR (150 MHz), acetone-d6, 278 K. 
Position  δC (ppm)  δH (ppm), m, J (Hz) 
1E 114.2  
2E 107.3  
3E 144.4  
4E 135.8  
5E 144.4  
6E 107.3 6.60, (1H, s) 
E (C=0) 165.9  
1D 114.3  
2D 108.2 7.13, (1H, s) 
3D 145.1  
4D 136.0  
5D 145.1  
6D 108.2  
D(C=0) 166.5  
1C 114.2  
2C 108.6  
3C 144.5  
4C 136.0  
5C 144.5  
6C 108.6 6.78, (1H, s) 
C (C=0) 166.3  
1B 110.5  
2B 108.6  
3B 144.5  
4B 136.0  
5B 144.5  
6B 108.6  
B (C=0) 166.5  
1A 115.0  
2A 104.1   
3A 142.6  
4A 133.2  
5A 142.6  
6A 104.1  
A (C=0) 163.2  
Sugar   
1’ 67.0 5.70, (1H, d, J = 4.6) 
2’ 74.0 4.96, (1H, dd, J = 1.4, 4.6) 
3‘ 66.2 4.99, (1H, dd, J = 1.1, 7.0) 
4‘ 69.3 5.25, (1H, t, J = 7.1) 
5‘ 70.9 5.61, (1H, brd) 
6’a 65.0 5.12, (1H, dd, J = 2.6, 12.9) 
6’b 65.0 3.99, (1H, d, J = 12.8) 
 
 
T1: S4-F3. 
T2: S5-M4.1. 
T3: S5-M9.1. 
Phytochemical investigation of Myrica salicifolia A. Rich bark 
122 
 
3.3.5.2 Cyclic diarylheptanoids 
Cyclic diarylheptanoids were isolated following further fractionation of S2 subfractions as 
indicated in Figure 3.34. A total of 17 cyclic diarylheptanoids belonging to the subgroup of 
meta-meta cyclophanes were isolated and their structures elucidated to complete 
stereochemistry. Among the isolated diarylheptanoids, 3 compounds were aglycones, 6 were 
monoglycosides, 3 were galloyl-glycosides and 5 were diglycosides. 
The TLC overview of the isolated diarylheptanoids is given in Figure 3.49. From the TLC it was 
discovered that all isolated cyclic diarylheptanoids which contain carbonyl group (C=O) at 
position C-11 changed to yellow-brownish colour after derivatization with anisaldehyde-
sulphuric acid reagent followed by plate heating at 100 οC for 3 min. The yellow-brownish 
colour was visualized at day light. Additionally, a fluorescent yellow-brownish colour was 
observed under UV 366 nm. No detection was possible prior to derivatization with 
anisaldehyde-sulphuric acid reagent at 366 nm and daylight. In addition to that, blue to deep 
purple blue colour was detected for the isolated diarylheptanoids which contain either an OH 
group or a sugar moiety at position C-11. 
 
 
Figure 3.49: TLC overview (NP-TLC) of the isolated cyclic diarylheptanoid compounds 10 - 26. Mobile phase MP_1. 
Detection: VIS (upper) and UV 366 nm (lower). Spray reagent: anisaldehyde-sulphuric acid. 
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3.3.5.2.1 Determination of absolute configuration of isolated cyclic diarylheptanoids  
The isolated cyclic diarylheptanoids were categorized in two groups: those without sugar 
substitution, such as compound 10, 11 and 12, and those with sugar substitution (mono- and di-
glycosides), which comprised the rest of the isolated cyclic diarylheptanoids. Therefore, 
determination of the absolute configuration of the two identified groups was done for 
complete provision of their full stereochemistry. 
Confirmation of the glycoside type and its absolute configuration 
Compounds identified to contain glycoside substitution were subjected to confirmation and 
determination of the absolute configuration of the particular glycoside by recording 1H NMR 
spectra of their per-O-(S)-2-methylbutyrate derivative (SMB) in comparison to 1H NMR of the 
SMB derivatives of reference sugars as described in the material and methods section 
3.2.8.6140. The reference sugars used in this study were: D- and L-glucose, D- and L-arabinose 
and D- and L-xylose. The recorded 1H NMR spectra of the SMB references (D and L) were 
overlaid to observe their differences as indicated in Figure 3.50. The overlaid spectra of the D- 
and L SMB derivatives of sugars provide a clear significant difference between the two through 
their small chemical shift differences. Therefore, this technique proved that the diastereomeric 
SMB derivatives of D- and L-monosaccharides can be distinguished and the spectra of the SMB 
derivatives of their mixture can be clearly analysed 140. 
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Figure 3.50:  Part of overlaid 1H NMR spectra (300 MHz, acetone-d6, 298 K) of the D- and L-SMB derivatives of 
reference sugars showing a clear significant difference between the two through their small chemical shift 
differences. A: D- and L-glucose. B: D- and L-arabinose esters. 
 
 
 
In the first step, absolute configuration of the glycoside moiety of the particular compound was 
confirmed by overlaying 1H NMR spectra of SMB derivatives of particular compound to that of 
reference monosaccharides (Figure 3.51 – 3.53). When the two spectra were superimposable 
then the second step was comparison of their chemical shifts (ppm) and coupling constants (J 
(Hz)) of anomeric proton resonances (Table 3.13). Anomeric proton resonances of the SMB 
derivatives were identified by their characteristic downfield shifts and coupling patterns140. 
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Figure 3.51: Part of 1H NMR spectrum (300 MHz, acetone-d6, 298 K) of the SMB derivative of compound 13 (top) 
and overlaid spectra of SMB derivatives of 13 (blue - down) and SMB derivative of D-glucose (red - down). 
Representative example of how absolute configuration of D-glucose substitution was attained in all isolated 
compounds containing D-glucose i.e. mono- and di-glucoside substitution. 
 
 
Figure 3.52: Part of 1H NMR spectrum (300 MHz, acetone-d6, 298 K) of the SMB derivative of compound 15 (top) 
and overlaid spectra of SMB derivative of 15 (red - down) and SMB derivative of D-xylose (blue - down). 
Representative example of how absolute configuration of D-xylose substitution was attained in all isolated 
compounds containing D-xylose. 
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Figure 3.53: Part of 1H NMR spectrum (330 MHz, acetone-d6, 298 K) of the SMB derivative of compound 25 (top) 
and overlaid spectra of SMB derivative of 25 (blue - down) and SMB derivative of the mixture of D-glucose and L-
arabinose (red - down). Demonstration of how the absolute configuration of sugar substitution was accomplished 
in compounds 25 and 24. 
 
 
Table 3.13: Representative data showing comparison of anomeric SMB derivative proton resonances of isolated 
compounds and the reference monosaccharides. 
Representative 
compounds 
Sugar 
geometry 
Configuration at 
position 1 and 2 
Compound - SMB 
derivative 
Reference sugar - SMB 
derivative 
δH 
(ppm) 
3J1,2 (Hz) δH (ppm) 3J1,2 (Hz) 
14, 19, 22, 17, 
18,  30 and 31 
β-D-glucose 
(pyranose) 
1S, 2R 5.94 
 
8.3 
 
5.94 
 
8.3 
 
15, 27 and 29 β-D-xylose 
(pyranose) 
1S, 2R 5.85 
 
7.2 
 
5.85 
 
7.2 
 
24 and 25  α-L-arabinose 
(furanose) 
1S, 2R 6.17 brs 6.17 brs 
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Absolute configuration of myricanol and other isolated diarylheptanoids 
The absolute configuration of isolated cyclic diarylheptanoids was achieved through electronic 
CD spectra simulation as described in the materials and method section 3.2.8.8. Recorded 
experimental CD spectra of the isolated diarylheptanoids and the aglycone obtained from 
enzyme hydrolysis of myricanol 5-O-β-D glucose (13) are shown in Figure 3.54. Similarity of the 
CD spectra graph was observed on graph 1-12, hence concluding that the attached sugar and 
sulphate moieties had no influence on the conformation of the aglycone and its chromophore. 
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Figure 3.54: Recorded experimental CD spectra of isolated diarylheptanoids (molar ellipticity vs. wavelength (nm). 
 
 
Myricanol structure contains one chiral centre at position 11 which is axially dissymmetric due 
to the twisted biphenyl. Therefore, the structure of myricanol can occur as two pairs of 
enantiomers i.e. (R,Ra ), (S,Sa) and (R,Sa ), (S,Ra), where “a” stands for the chirality of the 
axially dissymmetric biphenylic-system169,170. Generated molecular models of the R-enantiomer 
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of myricanol resulted in three conformations corresponding to the 11R,Ra and the 11R,Sa (a) 
and 11R,Sa (b) forms as described in the material and methods section 3.2.8.8 (Figure 3.55 A-
C). The 11R,Sa (b) conformation corresponds to the X-ray structure determined by Begley et 
al.141. 
 
 
Figure 3.55: 3D-structures of the conformations of R-myricanol. A: 11R,Ra myricanol. RB3LYP/6-31G(d,p) Energy: - 
1192.01521911 a.u. Energy difference from lowest conformer: 2.01 kcal/mol. B: 11R,Sa myricanol (a). RB3LYP/6- 
31G(d,p) Energy: -1192.01342066 a.u. Energy difference from lowest conformer: 3.31 kcal/mol. C: 11R,Sa 
myricanol (b). Conformation corresponds to the X-ray cystal structure141. RB3LYP/6-31G(d,p) Energy: -
1192.01842217 a.u.Energy difference from lowest conformer: 0.000 kcal/mol. With kind permission from Prof. T. 
Schmidt (Universität Münster). 
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The simulated CD spectrum of the energetically most favourable 11R,Sa-myricanol (conformer 
C, Figure 3.55 C) was found to be similar to the experimentally determined spectrum (Figure 
3.56 C). The major cotton effects are of equal sign indicating that the compound has indeed the 
11R,Sa-configuration, as would also be expected based on its reported crystal structure. The 
spectrum would appear exactly opposite if the 11S,Ra-enantiomer were present. 
The spectrum for the less favourable 11R,Ra-atropisomer (conformer 1, Figure 3.55 A) shows 
almost entirely opposite sign (Figure 3.56 A). Since its internal energy is predicted to be more 
than 2 kcal/mol, it was neglected. The two conformers (2 and 3, Figure 3.55 B and C) show 
similar signs with experimental spectrum (Figure 3.56 B and C) which gives a hint to 
confirmation of 11R,Sa-configuration. Additionally, an averaged spectrum generated for the 
theoretical equilibrium mixture corresponding to 97% R,Sa and 3% R,Ra-myricanol was 
compared with the experimental CD spectrum of myricanol (Figure 3.56 D). The results 
presenting a very good match with the experimental spectrum. According to these calculations, 
natural myricanol was concluded to be 11R and very predominantly Sa-configured. This 
corresponds to the X-ray structure and matches the CD data of myricanol reported in 
literature131,141. It is possible that a very small amount of the Ra-atropisomer is present in the 
conformational equilibrium. 
In another case, the experimental CD spectrum showed a good match with the calculated CD 
spectrum of the S,Sa- enantiomer (averaged CD spectrum of S,Sa (87%) and S,Ra form (13%)) as 
shown in Figure 3.56 E. This was not concluded to be the absolute configuration of the natural 
myricanol due to its much higher energy content which is identical to that of conformer 1. 
A slight inconsistency which was observed in the 230 nm range (Figure 3.56, B - D), can be 
explained by an exchange of two electronic transitions very close to each other, at 217 and 223 
nm. However, this does not change the general picture of the main bands at long and short 
wavelength being of the same sign. 
Finally, a confirmation of the 11R-configuration to the isolated diarylheptanoids demonstrated 
the same experimental CD spectra (Figure 3.54, 1 – 12) as to that of myricanol was established. 
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Figure 3.56: A: Conformer 1: 11R,Ra myricanol. Blue: Experimental CD spectrum of myricanol. Red: CD spectrum 
simulated for conformer 1 by TDDFT: RB3LYP/6-31G(d,p), nstates=30. No shift, no scaling of calculated spectrum. 
B: Conformer 2: 11R,Sa-myricanol (a). Blue: Experimental CD spectrum of myricanol. Red: CD spectrum simulated 
for conformer 2 by TDDFT: RB3LYP/6-31G(d,p), nstates=30 No shift, no scaling of calculated spectrum. C: 
Conformer 3: 11R,Sa-myricanol (b), conformation corresponds to the X-ray structure. Blue: Experimental CD 
spectrum of myricanol. Red: CD spectrum simulated for conformer 3 by TDDFT: RB3LYP/6-31G(d,p), nstates=30 No 
shift, no scaling of calculated spectrum. D: Blue: Experimental CD spectrum of myricanol. Red: Averaged CD 
spectrum for the R,Sa (97%) and R,Ra form (3%). TDDFT: RB3LYP/6-31G(d,p), nstates=30. Calculated spectrum was 
red-shifted by -0.15 eV and scaled by factor 0.5. E: Blue: Experimental CD spectrum of myricanol. Red: Averaged 
CD spectrum for the S,Sa (87%) and S,Ra form (13%). TDDFT: RB3LYP/6-31G(d,p), nstates=30. Calculated spectrum 
was red-shifted by -0.15 eV and scaled by factor 0.67. With kind permission from Prof. T. Schmidt (Universität 
Münster).
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3.3.5.2.2 Cyclic diarylheptanoids without glycoside moiety 
 
Figure 3.59: Structures of juglanin B-sulphate (10), myricanol (11) and myricanone (12). 
 
Compounds 10, 11 and 12 (Figure 3.59) were isolated from S2 subfractions F5C7 and F6.3 as 
illustrated in Figure 3.34. Compounds 10 and 12 were isolated as off-white amorphous powder 
while 11 was a white amorphous powder. The optical rotations values of 10 and 11 were [α]D
25 = 
-12.5 (c 0.1, MeOH) and [α]D
25 = -76.5 (c 0.1, MeOH) respectively. They exhibit UV maxima 
(MeOH) at 254 and 300 nm (10), 260 and 298 nm (11) and 260 and 300 nm (12). The three 
compounds were identified following comparison of obtained 1D and 2D NMR data with the 
available literature data of these compounds, as juglanin B-sulphate (10)110,112, myricanol 
(11)87,119,141,169 and myricanone (12)87,141. The 1H and 13C NMR data of these compounds are 
summarized in Table 3.14. 
It was observed from 13C NMR spectrum that compounds 11 and 12 possess similar carbon 
chemical shifts in the aromatic region and both contain two methoxy groups assigned to 
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position 20 and 21. The difference was observed in their six methylenes carbons shifts at 
position 7, 8, 9, 10, 12 and 13 which could be attributed by the change of attachment of oxygen 
bearing methine (δH 3.96 ppm) at position 11 of compound 10 to carbonyl carbon (δC 212.9 
ppm) of compound 12. 
The chemical shifts and coupling patterns observed in NMR spectra of 10 were comparable to 
that of 11. The difference between the two compounds was one extra proton singlet observed 
at δH 6.71 ppm which was assigned to position 5 and only one methoxy proton assigned to 
position 20 was observed at δH 3.86 ppm. A downfield shift of +δH 0.85 ppm for the proton and 
+δC 10.8 ppm for the carbon at position 11 compared to compound 11 was observed. The 
changes in chemical shifts gave an alert that the group attached to position 11 is a substituent 
which could not be detected from the NMR spectra. HRESI-MS concluded the presence of 
sulphate group by exhibiting ions at m/z 407.1174 [M-H]- in the negative mode calculated for 
molecular formula of C20H24O7S. Likewise, the molecular masses for compound 11 and 12 were 
calculated to be 358 Da and 356 Da following the ESI-MS ions exhibited at m/z 357.17 [M-H]-
and at m/z 355.15 [M-H]- in the negative mode respectively. Their molecular formula were 
deduced to be C21H26O5 (11) and C21H24O5 (12) respectively. For determination of absolute 
configuration of 10 and 11 see section 3.3.5.2.1. 
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Table 3.14: 1H and 13C NMR data for compounds 10 –12. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. 10 11 12 
δC 
(ppm) 
δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
1 129.0  125.8  126.4  
2 127.5  123.5  123.3  
3 143.6  147.6  147.8  
4 149.9  140.3  140.4  
5 112.1 6.71, (1H, brs) 149.7  149.9  
6 130.8  123.9  124.2  
7 31.6 2.95-2.92, (1H, m) 
2.51-2.46, (1H, m) 
26.3 2.76–2.72, (1H, m) 
2.53–2.48, (1H, m) 
27.5 2.67, (2H, m) 
8 27.1 2.29-2.19, (1H, m) 
1.80-1.77, (1H, m) 
26.5 1.94–1.85, (2H, m) 25.2 1.92, (2H, m) 
9 24.2 1.80-1.77, (1H, m) 
1.51-1.47, (1H, m) 
23.8 1.68–1.61, (1H, m) 
1.51–1.44, (1H, m) 
22.8 1.77, (2H, m) 
10 34.6 2.29-2.19, (1H, m). 
1.92–1.87, (1H, m) 
40.4 1.83–1.78, (1H, m) 
1.57–1.53, (1H, m) 
45.7 2.74, (2H, m) 
11 78.9 4.81, (1H, m) 68.1 3.96, (1H, t, J = 9.8) 212.9   
12 37.6 2.14-2.10, (1H, m) 
1.86-1.82, (1H, m) 
35.4 2.29–2.24, (1H, m) 
1.68–1.61, (1H, m) 
42.6 2.82, (2H, m) 
13 27.8 3.08-3.03, (1H, m 
2.78–2.75, (1H, m) 
27.6 2.94–2.88, (1H, m) 
2.83–2.79, (1H, m) 
28.9 2.93, (2H, m) 
14 132.3  131.6  133.1  
15 130.3 6.99, (1H, brd, J = 
7.3) 
130.3 7.02, (1H, dd, J = 2.3, 
8.2) 
129.4 7.02, (1H, dd, J = 8.1, 
2.4) 
16 117.3 6.74, (1H, d, J = 8.1) 117.2 6.78, (1H, d, J = 8.2) 117.2 6.76, (1H, d, J = 8.1) 
17 152.9  152.3  152.7  
18 134.1 7.21, (1H, s). 134.1 7.19, (1H, brs) 133.3 6.74, (1H, d, J = 2.2) 
19 126.9 6.89, (1H, brs) 129.9 6.88, (1H, s) 129.4 6.58, (1H, s) 
20 56.7 3.86, (3H, s) 61.6  3.86, (3H, s) 61.6 3.81, (3H, s) 
21   61.4 3.89, (3H, s) 61.4 3.88, (3H, s) 
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3.3.5.2.3 Cyclic diarylheptanoid monoglycosides 
Compounds 13, 14 and 15 
 
Figure 3.60: Structures of myricanol 5-O-β-D-glucoside (13), myricanone 5-O-β-D-glucoside (14) and myricanol 11-
O-β-D-xylopyranoside (15). 
 
Compounds 13 and 15 (Figure 3.60) were isolated as white amorphous powders and 14 as off-
white amorphous powder. On NP-TLC, compound 13 (Rf ~ 0.68) and 15 (Rf ~ 0.85) were 
detected as deep purple blue spots while compound 14 (Rf ~ 0.67) was detected as a yellow-
brownish spot (Figure 3.49) under day light after derivatization with anisaldehyde-sulphuric 
acid reagent and mobile phase MP_1. 
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The three diarylheptanoids monoglycosides were confirmed to be myricanol 5-O-β-D-glucoside 
(13), myricanone 5-O-β-D-glucoside (14), and myricanol 11-O-β-D-xylopyranoside (15) by 
comparing their NMR and MS data with the available literature data of Matsuda et al.123, Tene 
et al.126 for 13, Tao et al.117 for 14 and Tene et al.126 for 15. 1H and 13C NMR data for these 
compounds are summarized in Table 3.15. The absolute configuration of these compounds 
were determined as described in section 3.3.5.2.1. 
 
Table 3.15: NMR data for compounds 13–15. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K). 
Pos.  13 14 15 
δC 
(ppm) 
δH (ppm), m, J (Hz) δC  
(ppm) 
δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
1 126.6  126.5  126.7  
2 129.8  129.3  123.5  
3 149.3  149.3  148.3  
4 146.5  146.3  140.6  
5 149.8  149.8  150.5  
6 131.1  131.7  131.5  
7 27.5 2.95–2.90, (1H, m) 
2.71–2.66, (1H, m) 
28.2 2.76, (2H, m) 26.6 3.01–2.98, (1H, m) 
2.93–2.86, (1H, m) 
8 27.1 1.93–1.83, (2H, m) 22.8 1.72, (2H, m) 25.9 2.16–2.12, (1H, m) 
1.82–1.75, (1H, m) 
9 24.0 1.58–1.51, (2H, m) 25.5 1.89, (2H, m) 23.2 1.82–1.75, (1H, m) 
1.41–1.37, (1H, m) 
10 40.4 1.93–1.83, (2H, m) 45.9 2.64, (2H, m) 36.5 2.10–2.04, (1H, m) 
1.90–1.85, (1H, m) 
11 69.3 3.90, (1H, m) 215.8   76.3 4.43, (1H, t, J = 9.3) 
12 35.8 2.28–2.23, (1H, m) 
1.67–1.62,(1H, m) 
42.8 2.86, (2H, m) 34.0 2.36–2.32, (1H, m) 
2.10–2.04, (1H. m) 
13 28.2 2.87–2.81, (2H, m) 28.9 2.94, (2H, m) 27.6 3.42–3.37, (1H, m) 
2.93–2.86, (1H, m) 
14 132.0  132.8  131.4  
15 131.0 7.03, (1H, dd, J = 
2.1, 8.2) 
129.6 7.03, (1H, brd, J = 
8.2) 
130.1 7.19, (1H, m) 
16 117.3 6.77, (1H, d, J = 8.2) 117.2 6.77, (1H, d, J = 
8.22) 
117.5 7.19, (1H, m) 
17 153.0  152.9  152.8  
18 135.0 7.09, (1H, brs) 133.9 6.65, (1H, brs) 134.2 7.47, (1H, brs) 
19 130.5 6.83, (1H, s) 129.9 6.58, (1H, s) 130.5 7.15,(1H, s) 
20 61.6  3.88, (3H, s) 61.4 3.81, (3H,s) 61.0 3.94, (3H, s) 
21 62.0 3.96, (3H, s) 61.7 3.93, (3H, s) 60.7 3.74, (3H, s) 
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 13 14 15 
 δC 
(ppm) 
δH (ppm), m, J (Hz) δC  
(ppm) 
δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
Gl.       
1’ 105.4 5.00, (1H, d, J = 7.3) 105.0 5.00, (1H, d, J = 7.2) 103.2 4.79, (1H, d, J = 7.3) 
2’ 75.8  3.45–3.43,(1H, m) 75.5 3.45, (1H, m) 75.0 3.98, (1H, td, J = 11.8, 
4.36) 
3’ 78.3 3.25–3.22, (1H, m) 78.3 3.22, (1H, m) 71.1 4.16–4.11, (1H, m) 
4’ 71.5 3.40–3.37, (1H, m) 71.3 3.39, (1H, m) 78.4 4.16–4.11,(1H, m) 
5’ 78.0 3.45–3.43, (1H, m) 78.0 3.46, (1H, m) 67.1 4.59, (1H, dd, J = 
11.5, 4.6) 
3.47, (1H, dd J = 9.6, 
11.3) 
6’ 62.7 3.79, (1H, dd, J = 
2.3, 11.9) 
3.66, (1H, dd, J = 
5.3, 11.9) 
62.4 3.78, (1H, d, J = 2.4) 
3.67, (1H, dd, J = 
11.7, 5.4) 
  
 
 
Compound 16 
 
Figure 3.61: Structure of salicimeckol: 7-hydroxymyricanol 5-O-β-D-glucoside (16). 
 
Compound 16 (Figure 3.61) was identified as new cyclic diarylheptanoid glycoside and was 
named salicimeckol (7-hydroxymyricanol 5-O-β-D-glucoside). The compound was isolated as 
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white amorphous powder with [α]D
25= -56 (c 0.1, MeOH). It was detected as deep purple blue 
spot on TLC with Rf value ~ 0.45 (Figure 3.49) after derivatization with anisaldehyde-sulphuric 
acid reagent (mobile phase MP_1). In the negative mode HRESI-MS exhibited ions at m/z 
581.2257 [M+HCOO-] and 1071.4445 [2M–H]- are consistent with the molecular formula of 
C27H36O11. The UV spectrum (MeOH) of compound 16 showed absorption maxima at 213, 250 
and 295 nm which are typically for biphenyl type diarylheptanoids117,171.  
The 1H NMR spectrum of compound 16 showed four aromatic protons at δH 7.02, 6.77, 6.88 
(2H) ppm assigned to position 15, 16, 18, and 19. Two methoxy groups resonating at δH 3.95 
ppm, integrated for 6H, can be assigned to positions 20 and 21. Five methylenes were observed 
in the highfield 1H NMR region between δH 1.12 -2.88 ppm and assigned to position 8, 9, 10, 12 
and 13 of the aglycone determined by COSY experiments. Two methine bearing a hydroxyl 
group at δH 3.84 and 4.92 ppm assigned to position 7 and 11 following proton coupling network 
from COSY experiment and HMBC long range correlation. 
Anomeric proton for glucose moiety was observed at δH 5.04 ppm with coupling constant of 7.4 
suggestive for the β-configuration of a sugar moiety. The position of the glycosidic linkage was 
elucidated from HMBC long-range correlation between the anomeric proton at δH 5.05 and the 
C-5 carbon of the aglycone moiety δC 150.0 ppm (Figure 3.59). Other sugar protons at position 
2’, 3’, 4’, 5’ and 6’ were assigned based on homonuclear COSY experiments. Their respective 
carbons were determined by HSQC through direct correlation of the particular proton to its 
respective carbon. The NMR data of 16 are summarized in Table 3.16 and its proton spectrum 
in Figure 3.58. Absolute configuration of 16 was completed as described in section 3.3.5.2.1. 
From the obtained data compound 16 was concluded to be 7-hydroxymyricanol 5-O-β-D-
glucose (salicimeckol). 
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Table 3.16: NMR data summary for compound 16. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC 
(ppm) 
δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 126.8     
2 120.2     
3 147.0     
4 152.2     
5 150.0     
6 131.0     
7 66.7  4.92, (1H, dd, J = 3.6, 11.4) 9, 8, 6, 5 8 9, 8, 18, 19 
8 35.6 2.19–2.07, (1H, m) 
2.01–1.94, (1H, m) 
9, 10, 7 9, 7 9, 12, 13, 11, 18, 19 
9 21.8 1.55–1.48, (1H, m) 
1.18-1.12, (1H, m) 
8, 10, 7, 11 8, 10 8, 11, 7, 18.19 
10 40.0 1.82–1.77, (1H, m) 
1.55–1.48, (1H, m) 
9, 12, 11 9, 11 9, 8, 11,  18, 19 
11 68.9 3.84, (1H, m) 29, 13, 12, 10 12, 10 9, 12, 10, 8, 13, 18, 
19 
12 35.5 2.19–2.07, (1H, m) 
1.65–1.60, (1H, m) 
13, 11, 14 13, 11 9, 13, 11, 18, 19 
13 27.7 2.88-2.79, (2H, m) 12, 11, 14, 18 12 12, 11 
14 131.3     
15 131.0 7.02, (1H, dd, J = 2.2, 8.2) 13, 16, 1, 18, 17 16 13, 16 
16 117.1 6.77, (1H, d, J = 8.2) 1, 14, 17 15 10, 13, 15 
17 153.1     
18 135.8 6.87, (1H, brs) 13, 1, 17  9, 10, 12, 13, 11, 15  
19 130.8 6.87, (1H, s) 7, 2, 1, 6, 3, 5, 4, 17  9, 10, 12, 13, 11, 15 
20 61.1 3.95, (3H, s) 3   
21 61.9 3.95, (3H, s) 4   
Glu.      
1’ 104.8 5.05, (1H, d, J = 7.4) 4‘, 5 2‘ 8, 5‘, 6‘, 7 
2‘ 75.5 3.52-3.49, (1H, m) 4‘, 1‘ 1‘, 3‘ 1‘ 
3’ 71.4 3.39, (1H, m) 6‘, 4‘ 4‘, 2‘  
4’ 77.7 3.47, (1H, m) 3‘, 2‘ 3‘, 5‘ 1‘ 
5‘ 78.5 3.32, (1H, m) 3’, 1’  6’, 1’ 
6‘ 62.1 3.80, (1H, dd, J = 2.4, 11.8) 
3.64, (1H, dd, J = 5.7, 11.8) 
3‘, 5‘ 5’ 5’ 
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Figure 3.62: 1H NMR spectrum of compound 16. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
 
 
Figure 3.63: Part of the HMBC spectrum depicting a long correlation between anomeric proton H-1’ (δH 5.05 ppm) 
and C-5 (δC 150 ppm), a proof of assignment of glycosidic bond to position 5 of compound 16. 
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Compound 17 
 
Figure 3.64: Structure of salicireneol A: juglanin B 3-O-β-D-glucoside (17). 
 
Compound 17 (Figure 3.64), a new cyclic diarylheptanoid monoglycoside was identified as 
juglanin B 3-O-β-D-glucoside and given the name salicireneol A. It was isolated as white 
amorphous powder with an optical rotation value  [α]D
25= -49 (c 0.1, MeOH) and gave a blue 
spot on a TLC after derivatization with anisaldehyde-sulphuric acid reagent with Rf value ~ 0.6, 
mobile phase MP_1 (Figure 3.49). HRESI-MS exhibited ions at m/z 489.2137 [M-H]- and m/z 
979.4324 [2M- H]- corresponding to molecular formula of C26H33O9. The UV spectrum (MeOH) 
showed absorption maxima at 214, 254 and 285 nm, indicative of biphenyl cyclic 
diarylheptanoids. 
The 1H NMR spectrum of 17 showed five aromatic protons at δH-5 6.85, brs, δH-15 7.04, dd, δH-16 
6.78, d, δH-18 7.07, brs and δH-19 6.76, brs. The spectrum also included signals attributable to six 
aliphatic methylenes at δH 1.41 – 2.99 ppm assigned to position 7, 8, 9, 10, 12 and 13. One 
methoxy group at δH 3.88 ppm, s, integrated for 3H, assigned to position 20 and one methine 
bearing a hydroxyl group δH 3.91 ppm, m, integrated for 1H, assigned to position 11. Anomeric 
carbon for sugar moiety was observed at δH 4.99 ppm, d, J = 7.3 Hz and other five sugar protons 
between δH 3.07 - 3.45 ppm. The position of the glycosidic linkage was elucidated to be at 
position 3 of the aglycone from long-range correlation HMBC experiment between the 
anomeric proton δH 4.99 ppm, d, J = 7.3 (H-1’), and the δC 140.9 ppm (C-3) of the aglycone 
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moiety. The confirmation of sugar and its absolute configuration was achieved as described in 
section 3.3.5.2.1. 
The 1D and 2D NMR data for 17 are summarized in the Table 3.17. The carbon data of 17 are in 
agreement with the published data of juglanin B 172,173, with the exception that compound 17 
has the sugar substitution at position 3 of the aglycone. Therefore, compound 17 was 
concluded to be juglanin B 3-O-β-D-glucoside (salicireneol A). 
 
Table 3.17: NMR data for compound 17. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC 
(ppm) 
δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 128.0     
2 128.2     
3 140.9     
4 152.7     
5 113.6 6.85, (1H, brs) 7, 20, 19, 3, 4 7, 19, 20 20 
6 131.8     
7 31.6 2.99–2.97, (1H, m) 
2.57–2.51, (1H, m) 
7 7, 8  
8 27.5  2.00–1.95, (1H, m) 
1.85–1.80, (1H, m) 
 8, 9, 7, 7  
9 23.8 1.64–1.58, (1H, m) 
1.48–1.41, (1H, m) 
   
10 40.2 1.85–1.80, (1H, m) 
1.55–1.49, (1H, m) 
 10, 11, 10  
11 69.1 3.91, (1H, m)  12, 10  
12 35.5 2.26–2.20, (1H, m) 
1.67–1.62, (1H, m) 
   
13 27.9 2.87–2.82, (1H, m) 
2.04–2.00, (1H, m) 
1, 15 12  12, 15 
14 132.0     
15 130.6 7.04, (1H, dd, J = 2.3, 8.2) 13, 16, 18, 17 16 13, 16 
16 117.2 6.78, (1H, d, J = 8.2) 2, 14, 17 15  
17 152.1     
18 135.0 7.07, (1H, brs) 13, 16, 2, 15, 18, 17 13 12, 13, 19 
19 127.6 6.76, (1H, brs) 7, 5, 19, 1, 6, 3 7, 3 18, 8, 9 
20 56.6 3.88, (3H, s) 4  3 
Gluc.      
1’ 104.8 4.99, (1H, d, J = 7.3) 3 2’ 4’ 
2’ 75.3 3.38, (1H, m) 1’, 3’ 1’, 3’  
3’ 71.1 3.20, (1H, m) 4’ 4’, 2’  
4’ 77.5 3.07, (1H, m) 6’ 3’,5’ 1’ 
5’ 78.6 3.29, (1H, m)  4’, 5’  
6’ 62.6 3.45, (2H, m)  5’  
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Figure 3.65: 1H NMR spectrum of compound 17 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
 
 
 
Figure 3.66: Part of the HMBC spectrum of 17 showing a long correlation between anomeric proton H-1’ (4.99 
ppm) and C-3 (140.9 ppm), a proof of assignment of glycosidic bond to position 3. The carbon signals are not 
clearly seen due to the low amount of 17. 
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Compound 18 
 
Figure 3.67: Structure of salicireneol B: 16-hydroxyjuglanin B 17-O-β-D-glucoside (18). 
 
Compound 18 (Figure 3.67) was isolated as a white amorphous powder with a negative optical 
rotation[α]D
25= -33.6 (c 0.1, MeOH). A purple blue spot was detected on TLC after derivatization 
with anisaldehyde-sulphuric acid reagent with Rf value of ~ 0.58 (mobile phase MP_1, Figure 
3.49). Molecular mass of 18 were realized from HRESI-MS ions at m/z 505.2078 [M-H]- and 
551.2137 [M+HCOO-] calculated for molecular formula of C26H34O10. The UV spectra (MeOH) of 
18 showed absorption maxima at the wavelengths 216, 253, and 298 nm suggestive of biphenyl 
type of diarylheptanoid117,171. 
The 1H NMR of 18 showed four aromatic protons, at δH-5 7.04 ppm, brs, δH-19 6.87 ppm, brs, δH-
18 6.65 ppm, brs and δH-15 5.66 ppm, brs. Furthermore, signals attributed to six aliphatic 
methylenes were detected between δH 0.90 – 2.78 ppm and were assigned to position 7, 8, 9, 
10, 12 and 13 (Table 3.18). One methoxy group was observed at δH 3.80 ppm, s, 3H, assigned to 
position 20 and one oxymethine at δH 3.05 ppm, m for position 11. A glucopyranosyl moiety 
was observed at δH-1’ 5.00 ppm, d, J = 7.6 Hz and the glycosidic linkage of 18 was elucidated by 
HMBC experiment. The long range correlation was observed between the anomeric proton (H-
1’) and the C-17 of the aglycone moiety (δH 144.7 ppm). The position of the hydroxyl group at C-
11 was deduced from only H-H COSY experiment due to invisible long range correlation signals 
in the upper field of the HMBC experiment. Finally, the absolute configuration of 18 was 
achieved as previously described in section 3.3.5.2.1. 
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Compound 18 was concluded to be 16-hydroxyjuglanin B 17-O-β-D-glucoside, a new compound 
and named salicireneol B. 
Table 3.18: NMR data for compound 18 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC (ppm) δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 126.2     
2 131.5     
3 144.8     
4 154.0     
5 115.3 7.04, (1H, brs) 7, 19, 2, 6, 3, 4  8, 7, 5, 20, 1’, 15 
6 137.9     
7 36.2 2.78, (1H, m) 
2.64, (1H, m) 
 8, 7 18, 13, 7 
8 31.2 1.74, (1H, m) 
1.59, (1H, m) 
 7  
9 23.4 1.27, (1H, m) 
1.03, (1H, m) 
 11, 10  
10 39.5 1.27,(1H, m) 
0.90, (1H, m) 
 11  
11 72.2 3.05, (1H, m)  10, 12 10, 9, 12, 15 
12 37.4 1.43, (1H, m)  11 10, 11, 15 
13 29.3 2.64, (1H, m) 
2.60, (1H,m) 
 7, 8 12, 18 
14 136.3     
15 115.2 5.66, (1H, brs) 13, 18, 2, 14, 17, 16 18 10, 9, 12, 13, 11 
16 151.6     
17 144.7     
18 122.7 6.64, (1H, brs) 13, 18, 17, 16 15 13, 15 
19 124.2 6.87, (1H, brs) 6, 5, 1, 2, 3  5, 7, 8, 9 
20 56.4 3.80, (3H, s) 4  5 
Glu.      
1’ 102.9 5.00, (1H, d, J = 7.6) 17 2’ 2’ 4’,5 
2’ 74.7 3.54, (1H, m) 3', 1’ 1’  
3’ 77.8 3.49, (1H, m) 4’   
4’ 71.1 3.42, (1H, m) 3’  1’ 
5’ 78.0 3.42, (1H, m) 3’   
6’ 62.3 3.89, (1H, brd, J = 12.3  
3.71, (1H, dd, J = 4.0, 1.8) 
5’, 1’ 3’  
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Figure 3.68: 1H NMR spectrum of compound 18 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
 
 
 
Figure 3.69: Part of the HMBC spectrum of 18 showing a long correlation between anomeric proton H-1’ (5.00 
ppm) and C-3 (144.8 ppm), a proof of assignment of glycosidic bond to position 17. 
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3.3.5.2.4 Galloylated cyclic diarylheptanoid glycosides 
 
Figure 3.70: Myricanol 5-O-β-D-(6'-O-galloyl) glucoside (19 and 20) and myricanone-5-O-β-D-(6'-O-galloyl) 
glucoside (21). 
 
Compounds 19, 20 and 21 (Figure 3.70) were isolated and elucidated to be myricanol 5-O-β-D-
(6'-O-galloyl) glucoside (19 and 20) and myricanone-5-O-β-D-(6'-O-galloyl) glucoside (21). 
The spectroscopy data of 21 was in agreement with published data by Yoshimura et al.110. 
Confirmation of compound 21 was further supported by the following obtained data: off-white 
amorphous powder, yellowish-green spot on TLC after derivatization with anisaldehyde-
sulphuric acid reagent with Rf value ~ 0.80 (mobile phase MP_1, Figure 3.49), ESI-MS exhibited 
ions at m/z 671.23 [M+H]+ in the positive mode and at m/z 669.21 [M-H]-
 
in the negative mode, 
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calculated for molecular formula of C34H38O14, optical rotation: [α]D
25= -44 (c 0.1, MeOH) and UV 
maxima (MeOH) at wavelengths 213, 255, 280 nm. 
Likewise, the data obtained for compound 19 and 20 were in accordance with the proton and 
carbon NMR data published by Yaguchi et al.128. The two compounds were isolated from 
fraction S2 subfraction F5.C1.5. During the purification step of F5.C1.5 on the silica gel flash 
chromatography (FL-6), the two compounds exhibit different retention times, compound 19 
eluted earlier with methanol/chloroform and compound 20 eluted later in the washing step 
with methanol. Furthermore, compound 19 was isolated as deep green amorphous powder 
while compound 20 as yellow amorphous powder. On TLC (Figure 3.49 and 3.30 C), both 
compounds were detected as purple-blue spots on visualization under visible light (VIS) with 
different Rf values ~ 0.75 (19) and 0.62 (20), mobile phase MP_1. On the other hand, the 1D and 
2D-NMR data for compound 19 and 20 could not pronounce their differences, as all the 
obtained spectra data were very similar. Additional characteristics of the two compounds which 
were also similar are: Mass data, ESI-MS ions at m/z 673.24 [M+H]+ in the positive mode and 
m/z 671.23 [M-H]-
 
in the negative mode, calculated mass of 672 Da and a molecular formula of 
C34H40O14. Optical rotation was [α]D
25= -52.7 (19) and -33.6 (20), (c 0.1, MeOH). UV spectra 
(MeOH) for both displays absorption maxima at 213, 255 and 298 nm. CD spectra exhibited 
positive cotton effect in the wave length region of 205-225 nm (19) and 203 - 223 nm (20), 
negative cotton effect at 227 - 265 nm, 285 - 305 nm (19) and 203 - 223 nm, 285 - 309 nm (20) 
respectively. The CD data of the two compounds concluded that they are 11R-configured. 
Based on the obtained data, a structural difference between 19 and 20 could not be figured 
out. Further investigations to discover their differences was unachievable due to the acquired 
low yields for the two compounds.  
The 1D and 2D NMR data of compound 19, 20 and 21 are summarized in the below Table 3.19.  
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Table 3.19: NMR data for compound 19 (MeOH-d4), 20 (MeOH-d4/CDCl3 - 1/1 (v/v)) and 21 (MeOH-d4). 1H NMR 
(600 MHz), 13C NMR (150 MHz), 298 K. 
Pos. 19 20 21 
δC 
(ppm) 
δH (ppm), m, J (Hz) δC 
(ppm) 
δH (ppm), m, J (Hz) δC 
(ppm) 
δH (ppm), m, J (Hz) 
1 125.6  126.5  126.4  
2 129.2  129.7  129.8  
3 148.0  149.0  149.0  
4 145.8  146.5  146.7  
5 149.3  149.8  149.9  
6 131.5  131.7  130.0  
7 27.1 2.85-2.82, 1H, m) 
2.54-2.49, (1H, m) 
27.5 2.88-2.82, (1H, m) 
2.57-2.52, (1H, m) 
27.8 2.95-2.88, (2H, m) 
8 26.4 1.73-1.68, (1H, m) 
1.58-1.53, (1H, m) 
26.8 1.64-1.57, (1H, m) 
1.77-1.69, (1H, m) 
25.6 1.88-1.82, (1H, m) 
1.67, (1H, m) 
9 23.6 1.52-1.48, (1H, m) 
1.35-1.31, (1H, m) 
24.0 1.51-1.41, (1H, m) 
1.34-1.29, (1H, m) 
23.4 1.51-1.45, (2H, m) 
10 40.0 1.78-1.73, (1H, m) 
1.45-1.41, (1H, m) 
40.4 1.77-1.69, (1H, m) 
1.51-1.41, (1H, m) 
44.7 2.64-2.54, (1H, m) 
2.27-2.24, m 
11 69.0 3.87, (1H, m) 69.4 3.84, (1H, m) 215.0  
12 35.4 2.22-2.16, (1H, m) 
1.65-1.61, (1H, m) 
35.8 2.25-2.16, (1H, m) 
1.64-1.57, (1H, m) 
42.2 2.95-2.88, (1H, m) 
2.64-2.54, (1H, m) 
13 27.8 2.85-2.82, (2H, m) 28.2 2.88-2.82, (2H, m) 27.9 
 
2.85-2.81, (1H, m) 
2.64-2.54, (1H, m) 
14 131.8  132.0  132.5  
15 130.7 7.03, (1H, brd) 130.5 6.78-6.75, (1H, m) 130.0 7.01, (1H, brd, J = 
8.2) 
16 117.0 6.78, (1H, m) 117.2 6.78-6.75, (1H, m) 117.4 6.75, (1H, d, J = 8.2) 
17 152.0  152.8   152.9  
18 134.4 7.06, (1H, brs) 135.0 7.04, (1H, brs) 134.0 6.50, (1H, brs) 
19 130.1 6.77, (1H, s) 131.0 7.02, (1H, s) 129.9 6.49, (1H, s) 
20 61.8 3.85, (3H, s) 61.7 3.86, (3H, s) 62.0 3.84, (3H, s) 
21 62.1 3.95, (3H, s) 62.1 3.94, (3H, s) 62.0 3.92, (3H, s) 
Glu.       
1’ 105.3  4.83, (1H, d, J = 7.4) 105.6 4.90, (1H, d, J = 7.3) 105.0 5.04, (1H, d, J = 6.7) 
2’ 75.0 3.53-3.47, (1H, m) 75.6 3.50, (1H, m) 75.5 3.51-3.48, (1H, m) 
3’ 75.1  3.53-3.47, (1H, m) 75.6 3.50, (1H, m) 77.7 3.51-3.48, (1H, m) 
4’ 71.1 3.53-3.47, (1H, m) 71.6 3.50, (1H, m) 71.7 3.51-3.48, (1H, m) 
5’ 77.3 3.53-3.47, (1H, m) 77.7 3.50,(1H, m) 75.7 3.51-3.48, (1H, m) 
6’ 64.0 4.49, (1H, d, J = 11.6) 
4.40, (1H, dd, J = 
11.7, 4.4) 
64.2 4.46, (1H, brd, J = 
11.5) 
4.38, (1H, brd, J = 
8.7) 
64.8 4.37, (2H, m) 
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 19 20 21 
 δC 
(ppm) 
δH (ppm), m, J (Hz) δC 
(ppm) 
δH (ppm), m, J (Hz) δC 
(ppm) 
δH (ppm), m, J (Hz) 
Gal.       
1’’ 120.9  120.0   120.2  
2’’/6” 109.9 7.01, (2H, s) 109.9 7.01, (2H, s) 110.0 6.98, (2H, s) 
3’’/5” 145.8  146.7  146.8  
4’’ 139.2  140.0  139.2  
C=O 167.9  168.5  168.5  
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3.3.5.2.5 Cyclic diarylheptanoid di-glycosides 
Compounds 22 and 23 
 
Figure 3.71: Structures of saliciclaireone A: myricanone 5-O-β-D-glucopranosyl-(1-6)-β-D-glucopyranoside (22) and 
saliciclaireone B: neomyricanone 5-O-β-D-glucopranosyl-(1-6)-β-D-glucopyranoside (23). 
 
Compounds 22 and 23 (Figure 3.71) were identified as new compounds and isolated as white 
amorphous powder both with negative optical rotation,  [α]D
25= -51.6 (c 0.1, MeOH) and [α]D
25= 
-43.1 (c 0.1, MeOH) respectively. The two compounds depict yellow-brownish spot on the TLC 
detected under VIS and fluorescent yellow-brownish under UV 366 nm with the same Rf value 
of ~ 0.30. HRESI-MS of 22 and 23 exhibited ions at m/z 679.2682 [M-H]– and m/z 679.2622 [M-
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H]– with the common molecular formula of C33H44O15 and calculated mass of 680 Da. The UV 
spectra (MeOH) of 22 and 23 displays absorption maxima at 214 250, and 300 nm as well as 
214, 250 and 298 nm which is a characteristic of biphenyl cyclic diarylheptanoids117,171. 
The 1H NMR of 22 showed signals at δH 3.94 and 3.80 ppm both singlets, integrated for three 
protons each which were assigned to two methoxy group at C-20 and C-21. Four aromatic 
protons assigned to position C-15, C-16, C-18 and C-19 of the aglycone. Six methylenes assigned 
to position C-7, C-8, C-9, C-10, C-12 and C-13. Carbonyl group at δC 217.2 ppm assigned to 
position C-11 was deduced from HMBC experiment due to long range correlation between H-9, 
H-10, H-12, H-13 and the carbonyl carbon. Further confirmation was achieved from 1H-1H COSY 
experiment due to observed cross peaks between H-7and H-8, H-8 and H-9, H-9 and H-10, H-12 
and H-13.  
Two anomeric protons for two glucose moiety observed at δH-1’ 4.99 ppm, d, J =7.2 Hz and δH-1” 
4.28 ppm, d, J =7.8 Hz. The position of two glycosidic linkages were elucidated from HMBC 
experiment. Long-range correlation was observed between anomeric proton (H-1’) and C-5 of 
the aglycone and anomeric proton H-1” to C-6’ of the glucose. Therefore, two sugar groups are 
attached to C-5 of the aglycone and they were confirmed to be two D-glucose (section 
3.3.5.2.1). Hence, the structure of 22 was confirmed to be myricanone 5-O-β-D-glucopranosyl-
(1-6)-β-D-glucopyranoside (saliciclaireone A). 
The carbon data for 23 was found to be similar to the published data of neomyricanone 5-O-β-
D-glucopyranoside117 except that compound 23 was found to have two glucose moieties 
attached to C-5. In the same manner, NMR data of 23 were similar to 22 in terms of having two 
methoxy groups at position C-20 and C-21, four aromatic protons at position C-15, C-16, C-18 
and C-19 and two glucose moiety attached at C-5. The difference between two compounds was 
observed during assignment of the six methylenes at position C-7, C-8, C-10, C-11, C-12 and C-
13 based on proton coupling network from 1H-1H COSY experiment due to cross peaks between 
H-7 and H-8, H-10 and H-11, H-12 and H-11, H-13 and H-12. Further difference was observed on 
the HMBC for the assignment of carbonyl carbon position, the long range HMBC correlation 
was observed between H-7, H-8, H-10 and the carbonyl carbon. Therefore, compound 23 was 
found to be neomyricanone 5-O-β-D-glucopranosyl-(1-6)-β-D-glucopyranoside (saliciclaireone 
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B). The summarized 1 and 2D NMR data for 22 and 23 can be found in Table 3.20 and 3.21 
respectively.  
 
Table 3.20: NMR data for compound 22. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC (ppm) δH (ppm), m, J (Hz) HMBC COSY ROESY 
1 126.7     
2 129.4     
3 146.6     
4 149.2     
5 149.8     
6 131.8     
7 28.4 2.94-2.88, (1H, m) 
2.83-2.72, (1H, m) 
8, 9, 19, 6, 5 8 18, 9, 1’, 19 
8 25.7 1.90-1.88, (2H, m) 6, 7, 9, 10 9, 7 7, 19 
9 22.9 1.72-1.68, (2H, m.) 7, 8, 10, 11 8, 10 7, 10 
10 46.2 2.83-2.72, (1H, m.) 
2.68-2.61, (1H, m) 
9, 8, 11 9 9, 8, 19 
11 217.2     
12 43.1 2.94-2.88, (1H, m) 
2.83-2.72, (1H, m) 
11, 14  19, 15, 18, 19 
13 29.1 2.94-2.88, (1H, m) 11, 14  19, 15, 18, 19 
14 133.2     
15 130.2 7.05, (1H, dd, J = 2.1, 8.2) 13, 16, 1, 18, 17 16, 13 
16 117.5 6.80, (1H, d, J = 8.2) 1, 2, 14, 17,  15 15 
17 152.8     
18 133.9 6.64, (1H, brs) 13, 16, 17, 19   9, 13, 19 
19 130.0 6.57, (1H, s) 1, 2, 7, 18, 3, 4  8, 9, 10, 12 
20 62.3 3.94, (3H, s) 3   
21 61.8 3.80, (3H, s) 4   
Sug.      
1’ 105.0 4.99, (1H, d, J = 7.2) 5’, 5 2’ 7, 2’ 
2’ 75.4 3.54-3.46, (1H, m) 4’, 2’, 5’, 1’ 1’ 1’, 6’ 
3’ 77.0 3.54-3.46, (1H, m) 
4’ 71.0 3.54-3.46, (1H, m) 
5’ 77.5 3.44-3.38, (1H, m)  4’, 6’ 1’, 4’ 
6’ 69.5 4.08, (1H, dd, J = 1.8, 11.5) 
3.79-3.77, (1H, m) 
5‘, 1“ 5‘ 5‘, 1“ 
1’’ 104.4 4.28, (1H, d, J =7.8) 6’, 2’ 2” 5”, 4”, 6’ 
2’’ 75.0 3.19-3.16, (1H, m) 5”, 1” 33”, 1” 1” 
3’’ 77.7 3.30, (1H, m) 4”, 2” 2”  
4” 71.4 3.27-3.23, (1H, m) 5”, 4”  6”, 1” 
5” 77.7 3.27-3.23, (1H, m) 
6’’ 62.6 3.85-3.82, (1H, m) 
3.63, (1H, dd, J = 11.9, 5.2) 
4”, 5” 5” 4”, 5” 
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Table 3.21: NMR data for compound 23. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC (ppm) δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 125.4     
2 129.6     
3 148.3     
4 146.3     
5 148.7     
6 131.9     
7 23.6 3.19, (1H, m) 
2.99-2.94, (1H, m) 
8, 2, 6, 9 8 19, 6” 
8 41.8 2.88-2.86, (2H, m) 7, 6, 9 7 7, 9 
9 215.8     
10 44.6 2.78-2.72, (1H, m) 
2.68-2.60, (1H, m) 
9, 12 11 11, 12 
11 22.7 1.77-1.70, (1H, m)  12, 10 12, 13, 19, 18 
12 26.2 1.98-1.95, (1H, m)  11, 13 11, 13, 18 
13 31.8 2.78-2.72, (1H, m) 
2.68-2.60, (1H, m) 11, 12, 14 
12 11, 12 
14 132.1     
15 130.9 7.00, (1H, d, J = 8.2, 2.2) 13, 18, 17 16 13, 16 
16 117.4 6.82, (1H, d, J = 8.2) 1, 14, 17 15 15 
17 152.2     
18 133.7 6.87, (1H, d, J = 1.9) 13, 2, 15, 17  11, 12, 13, 19 
19 129.5 6.42, (1H, s) 7, 1, 2, 4, 3  11, 8, 7, 18 
20 62.1 3.84, (3H, s) 3   
21 62.2 3.95, (3H, s) 4  1’ 
Sug.      
1’ 105.2 4.88, (1H, d, J = 7.6) 5 2’ 3’ 
2‘ 74.8 3.54-3.51, (1H, m) 6’, 5’, 1’ 1’, 3’  
3‘ 76.3 3.41-3.38, (1H, m)  2‘/4‘ 1', 6‘ 
4‘ 70.5 3.55-3.52, (1H, m)  3‘, 5‘ 1', 6‘ 
5’ 77.0 3.48-3.45, (1H, m) 4‘, 2‘   
6’ 69.3 4.11, (1H, dd, J = 11.2, 2.2) 
3.80-3.78, (1H, m) 
4‘, 3‘  3‘, 1“ 
1’’ 103.8 4.25, (1H, m) 6‘ 2“ 6“, 2“ 
2‘‘ 74.3 3.24, (1H, m) 4“, 5“, 1“ 1“  
3‘‘ 77.0 3.22, (1H, m) 4“, 1“, 5“   
4‘‘ 70.8 3.27, (1H, m) 4“, 2“, 5“   
5’’ 77.2 3.27, (1H, m) 4“, 2“, 5“   
6’’ 62.2 3.81, (1H, dd, J = 11.9, 2.5) 
3.63, (1H, dd, J = 11.9, 5.4) 
4“, 5“ 5“ 4“/5“, 1“ 
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Figure 3.72: 1H NMR spectrum of compound 22. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
 
 
Figure 3.73: 1H NMR spectrum of compound 23. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
 
 
Figure 3.74: Part of the HMBC spectrum showing a long range correlation between anomeric proton H-1’ and C-5 
(for the first glucose) and between H-1”and C-6’ (for the second glucose) a proof of attachment of two glucose 
moieties to position C-5 for compound 22. (The same was observed for compound 23). 
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Compound 24 
 
Figure 3.75: Structure of saliciclaireone C: myricanone 17-O-α-L-arabinofuranosyl-(1-6)-β-D-glucopyranoside (24). 
 
Compound 24 (Figure 3.75), a new compound named saliciclaireone C, was isolated as off-
white amorphous powder, yellow-brownish spot on TLC visualized under VIS and fluorescent 
light yellow-greenish under UV 366 nm with Rf value ~ 0.43 (mobile phase MP_1). Optical 
rotation was [α]D
25= -36 (c 0.1, MeOH). The HRESI-MS exhibited ions at m/z 649.2509 [M-H]- in 
the negative mode consistent with the molecular formula of C32H41O14. The UV spectrum 
(MeOH) showed absorption maxima at the wavelengths 215, 252 and 295 nm, a characteristic 
of biphenyl type cyclic diarylheptanoid. 
The 1H NMR spectrum shows two methoxy groups at δH 3.81 and 3.93 ppm singlets, integrating 
for 3H each, assigned to position C-20 and C-21. Four aromatic protons assigned to position C-
15, C-16, C-18 and C-19 of the aglycone. Six methylenes assigned to position C-7, C-8, C-9, C-10, 
C-12 and C-13. Carbonyl group at δC 216.1 ppm was assigned to position C-11 based on HMBC 
experiment due to long range correlation between δH-10 2.77/2.64 ppm, δH-12 2.93/2.80 ppm, 
δH-13 2.95 ppm and the carbonyl carbon at δC 216.1 ppm. Two anomeric protons observed at δH-
1’ 4.97 ppm, d, J = 7.2 Hz and δH-1” 4.83 ppm, brs, indicating the presence of two sugar moieties 
with a β-D and α-L-configuration. The position of glycosidic linkages were elucidated from 
HMBC experiment. Long-range correlation was observed between δH-1 4.97 ppm and C-17 (δC 
152.7 ppm) of the aglycone as well as δH-1” 4.83 ppm and a C-6’ (δC 68.0 ppm) of the glucose. 
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Therefore, it was concluded that, the two sugar groups are attached to C-17 of the aglycone. 
The NMR signals of the aglycone were similar to those of myricanone (compound 12). 
The attached glycosides were confirmed to β-D-glucopyranoside and α-L-arabinofuranoside as 
described in section 3.3.5.2.1. The furan ring of the α-L-arabinose was concluded based on its 
carbon chemical shifts as described by Beier and Mundy174.  
Based on the obtained data, compound 24 was identified to be myricanone 17-O-α-L-
arabinofuranosyl-(1-6)-β-D-glucopyranoside and named saliciclaireone C. The 1D and 2D-NMR 
data of compound 24 are summarized in Table 3.22. 
 
Table 3.22: 1D and 2D NMR data for compound 24. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC (ppm) δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 126.5     
2 129.6     
3 146.5     
4 148.9     
5 149.9     
6 127.6     
7 28.2 2.75-2.71, (1H, m) 
2.98-2.94, (1H, m) 
 8  
8 25.6 1.92-1.87, (2H, m)  9, 7 19, 7, 9 
9 22.9 1.77-1.72, (2H, m)  18, 10  
10 45.8 2.83-2.78, (1H, m) 
2.64-2.58, (1H, m) 
11, 8 9 7 
11 216.1      
12 42.7 2.81-2.77, (1H, m) 
2.93, (1H, m) 
13, 15, 14, 18, 11   
13 28.7 2.95, (2H, m) 15, 14, 11, 12  12, 16, 15 
14 132.8     
15 129.8 7.03, (1H, dd, J = 8.7, 2.9) 13, 14, 18, 17 16 13, 16, 18 
16 117.1 6.78, (1H, d, J = 8.2) 1, 14, 17 15 15 
17 152.7     
18 133.8 6.67, (1H, d, J = 2.3) 13, 1, 2, 17  9, 12, 7, 15 
19 129.7 6.58, (1H, s) 7, 1, 6, 3, 4, 5  9, 8, 18 
20 61.8 3.93, (3H, s) 3   
21 61.6 3.81, (3H, s) 4   
Sug.      
1’ 104.9 4.97, (1H, d, J = 7.2) 17 2‘ 2‘ 
2’ 75.3 3.44, (1H, m) 4‘, 3‘, 1‘ 1‘, 4‘  
3’ 77.5 3.43, (1H, m)    
4’ 75.3 3.44, (1H, m) 4‘, 3‘, 1‘   
5’ 76.6 3.38, (1H, m) 3‘  6‘ 
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Pos. δC (ppm) δH (ppm), m, J (Hz) HMBC COSY NOESY 
6’ 68.0 3.96, (1H, dd, J = 11.0, 2.1) 
3.56, (1H, m) 
 5’, 6’ 5’, 4’ 
1’’ 109.6 4.83, (1H, brs) 6‘, 4“ 2“ 6‘ 
2’’ 82.8 3.91, (1H, m) 3“ 1“, 3“ 3“, 4“ 
3’’ 78.6 3.78, (1H, m) 2“ 2“ 5“ 
4’’ 85.6 3.83, (1H, m)  5“ 5”, 3” 
5’’ 62.7 3.67, (1H, dd, J = 11.7, 3.2) 
3.58, (1H, m) 
4” 5”, 4” 4” 
 
 
 
Figure 3.76: 1H NMR spectrum of compound 24. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
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Compounds 25 and 26 
 
Figure 3.77: Structures of myricanol 5-O-α-L-arabinofuranosyl-(1-6)-β-D-glucopyranoside (25) and myricanol 5-O-β-
D-glucopranosyl-(1-6)-β-D-glucopyranoside or myricanol gentiobioside (26). 
 
Compounds 25 (myricanol 5-O-α-L-arabinofuranosyl-(1-6)-β-D-glucopyranoside) and 26 
(myricanol 5-O-β-D-glucopranosyl-(1-6)-β-D-glucopyranoside or myricanol gentiobioside) 
(Figure 3.77) were isolated from S2 subfractions F5.C5 and F5.C7 (Figure 3.34). The structure 
elucidation of the two compounds were achieved based on obtained spectroscopic data in 
comparison to literature data by Sakurai et al.129(25) and Yaguchi et al.128 (26). The 13C NMR 
data of the two compounds were similar, their differences were observed in carbon shifts of 
their sugar moieties. The 1H and 13C NMR data are summarized in Table 3.23 and other 
characteristics are listed below. 
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Compound 25 (myricanol 5-O-α-L-arabinofuranosyl-(1-6)-β-D-glucopyranoside): White 
amorphous powder, purple- blue spot on TLC (mobile phase MP_1, Rf value ~ 0.40) when 
visualized under VIS and fluorescent blue under UV 366 nm (Figure 3.49). ESI-MS exhibited ions 
at m/z 651.26 [M-H]- and 1303.5 [2M–H]- in the negative mode, calculated for molecular 
formula C32H44O14. Optical rotation was [α]D
25= -56 (c 0.1, MeOH). UV absorption maxima 
(MeOH) at the wavelengths 212, 255 and 298 nm. 
Compound 26 (myricanol 5-O-β-D-glucopranosyl-(1-6)-β-D-glucopyranoside), a myricanol 
gentiobioside has the following characteristics: white amorphous powder, purple-blue spot on 
TLC (Rf value ~ 0.31), ESI-MS, m/z 681.27 [M-H]- in the negative mode, calculated mass = 682 Da 
and molecular formula of C
33
H
46
O
15
, optical rotation value  [α]D
25= -73 (c 0.1, MeOH), UV 
absorption maxima (MeOH) at 212, 255 and 298 nm. 
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Table 3.23: NMR data for compounds 25 and 26. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. 25 26 
δC (ppm) δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
1 126.5  129.7  
2 129.6  126.6  
3 146.5  146.5  
4 149.3  149.4  
5 149.9  149.7  
6 131.3  131.2  
7 27.6 2.97-2.93, (1H, m) 
2.68-2.63, (1H, m) 
27.5 2.93-2.81, (1H, m) 
2.68-2.63, (1H, m) 
8 27.1 1.84-1.79, (2H, m) 27.1 1.94-1.87, (1H, m) 
1.84 – 1.78, (1H, m) 
9 24.1  1.59-1.50, (1H, m) 
1.46-1.40,(1H, m) 
24.0 1.59-1.49, (1H, m) 
1.44-1.40, (1H, m) 
10 40.5 1.95-1.88, (1H, m) 
1.59-1.50, (1H, m ) 
40.4 1.84-1.78, (1H, m) 
1.59-1.49, (1H, m) 
11 69.4 3.92, (1H, m) 69.2 3.90, (1H, m) 
12 35.8 2.27-2.21, (1H, m) 
1.67-1.61, (1H, m) 
35.7 2.26-2.21, (1H, m) 
1.66-1.62, (1H, m) 
13 28.2 2.90-2.82, (2H, m) 28.1 2.93-2.81, (2H, m) 
14 132.0  132.0  
15 131.0 7.03, (1H, dd, J = 2.1, 8.2) 131.0 7.03, (1H, dd, J = 8.2, 1.9) 
16 117.3 6.77, (1H, d, J = 8.1) 117.3 6.78, (1H, d, J = 8.2) 
17 153.0  152.8  
18 135.1 7.10, (1H, d, J = 1.8) 135.1 7.08, (1H, brs) 
19 130.5 6.83, (1H, s) 130.5 6.83, (1H, s) 
20 62.1 3.97,(3H, s) 62.1 3.97, (3H, s) 
21 61.6 3.89, (3H, s) 61.6 3.88, (3H, s) 
Glyc.     
1’ 105.4 4.94, (1H, d, J = 7.3) 105.1 5.01, (1H, d, J = 7.10) 
2’ 75.7 3.46-3.39, (1H, m) 75.7 3.48-3.43, (1H, m) 
3’ 76.9 3.46-3.39, (1H, m) 77.8 3.48-3.43, (1H, m) 
4’ 72.0 3.36-3.33, (1H, m) 71.5 3.48-3.43, (1H, m) 
5’ 78.0 3.46-3.39, (1H, m) 77.6  3.48-3.43, (1H, m) 
6’ 68.1 3.94, (1H, m) 
3.58-3.55, (1H, m) 
69.7 4.07, (1H, brd, J = 11.5) 
3.77-3.759, (1H, m) 
1’’ 109.8 4.82, (1H, brs) 104.5 4.23, (1H, d, J = 7.7) 
2’’ 83.1 3.88, (1H, m) 75.0 3.15-3.09, (1H, m) 
3’’ 78.8 3.75, (1H, m) 77.9 3.21-3.19, (1H, m) 
4’’ 85.7 3.84-3.81, (1H, m) 71.5 3.21-3.19, (1H, m) 
5’’ 62.9 3.65, (1H, m) 
3.58-3.55, (1H, m) 
77.9 3.15-3.09, (1H, m) 
6’’   62.7 3.79, (1H, dd, J = 11.8, 2.2) 
3.59, (1H, dd, J = 5.8, 11.8) 
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3.3.5.3 Methylated ellagic acid glycosides (MEAG) 
Methylated ellagic acid glycosides (MEAG) are derivatives of ellagic acid. They were also 
isolated from S2 subfractions. The TLC overview of the isolated MEAG is shown in Figure 3.78. 
All isolated MEAG were detected as fluorescent blue spots when visualized under UV 366 nm 
after spraying with anisaldehyde-sulphuric acid. No detection was observed prior spraying with 
anisaldehyde-sulphuric acid reagent on the plate and after spraying when visualized under 
visible light (VIS). 
Three MEAG were successfully isolated and their detailed structure elucidation is described in 
the succeeding subsections. The assignment of 1H and 13C NMR spectra was based on reported 
literature data of ellagic acid as reference compound. Further to this, the most important tool 
used for assignment of quaternary carbon signals on the ellagic acid of isolated MEAG was the 
long range C-H correlation from HMBC experiment. Assignment of position of the methoxy 
groups and glycoside was deduced from long range HMBC and a NOESY experiment of the 
particular compound. 
 
 
Figure 3.78: NP-TLC overview of the isolated MEAG, compounds 27, 28 and 29. Mobile phase MP_1. Detection: UV 
366 nm. Spraying reagent: anisaldehyde-sulphuric acid. 
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Compound 27  
 
Figure 3.79: Structure of myriside: 3,4 di-O-methyl ellagic acid 4’-O-β-D-xylopyranoside (27). 
 
Compound 27 (Figure 3.79) was identified as 3,4 di-O-methyl ellagic acid 4’-O-β-D-
xylopyranoside, a new MEAG and was given a name myriside. 27 was isolated as yellowish 
amorphous powder with [α]D
25= -38.3 (c 0.1, MeOH) and it displayed a fluorescent blue spot on 
TLC with Rf value ~ 0.60 (mobile phase MP_1) after derivatization with anisaldehyde-sulphuric 
acid reagent (Figure 3.78). The UV spectrum (MeOH) showed absorption maximum at 255.1 
nm. The molecular formula of C21H17O12 for myriside was achieved based on the HREIS-MS 
exhibited ions at m/z 461.0735 [M-H]- and 923.1510 [2M–H]- in the negative mode.  
The 1H NMR spectrum of 27 showed two methoxy group protons signals at δH 4.10 and 4.01 
ppm directly correlated to δC 62.0 and 57.1 ppm in the HSQC experiment, and were assigned to 
position C-3 and C-4. The assignment of methoxy groups to position C-3 and C-4 was 
determined by the long range HMBC correlation between δH 4.10 ppm and δC-3 142.6 ppm, δH 
4.01 ppm and δC-4 155.6 ppm as well as between δH 7.68 ppm and δc-3 and δc-4. Further hint for 
the methoxy groups assignment was based on the observed cross peak between δH-5 7.68 ppm 
and δH-4 4.01 ppm in the NOESY experiment.  
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Two singlets signals were further observed in the aromatic region at δH 7.68 and 7.69 ppm each 
integrated for one proton. These protons were found to have direct correlation in the HSQC 
with δC-5 108.0 ppm and δC-5’ 113.4 ppm. From the long range correlation HMBC experiment 
between these two protons and quaternary carbons signals resulted to the assignment of 
carbon values at position C-1, C-2, C-3, C-4, C-6 and C-6a and their respective primed numbers 
were achieved. 
Anomeric proton signal was observed at δH-1” 4.76 ppm, d, J =7.5 Hz and other four sugar 
protons signals between δH 3.99 - 3.41 ppm, their respective carbon values were obtained in 
the direct correlation HSQC experiment. Assignment of their positions at C-2’’, C-3’’, C-4’’and C-
5’’ were based on homonuclear H-H COSY experiment through their proton couplings network. 
The position of the glycosidic linkage at C-4’ was determined by long range correlation HMBC 
between anomeric proton δH-1” 4.76 ppm and C-4’ carbon at δC 152.9 ppm. This was further 
confirmed in the NOESY following observation of cross peak between δH-5’ 7.69 ppm and δH-1” 
4.76 ppm  
Confirmation of sugar type and its absolute configuration was performed as described in 
3.3.6.2.1. The 1D and 2D NMR data of 27 are summarized in Table 3.24. Determination of the 
sugar configuration was achieved as explained in section 3.3.5.2.1. 
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Table 3.24: 1D and 2D NMR data for compound 27. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
Pos. δC 
(ppm) 
δH (ppm), m, J (Hz) HMBC COSY NOESY/ROESY 
1 98.6     
2 139.5     
3 142.6     
4 155.6     
5 108.0 7.68, (1H, s) 1, 6, 3, 4, 6a  4- OMe 
6 115.1     
6a 162.2     
1’ 98.6     
2’ 139.5     
3’ 142.6     
4’ 152.9     
5’ 113.4 7.69, (1H, s) 
 
1’, 6’, 2’, 4’, 6a’  1” 
6’ 115.6     
6a’ 162.5     
3-OCH3 62.0 4.10, (3H, s) 3   
4- OCH3 57.1 4.01, (3H, s) 4  5 
Sug.      
1’’ 104.7 4.76, (1H, d, J = 7.5) 5”, 2", 3”, 4’ 2’ 3”, 2”, 5’ 
2’’ 74.6 3.57-3.53, (1H, m) 3”, 1”, 5” 1’, 3’  
3’’ 77.2 3.46-3.40, (1H, m) 3”, 1”, 5”,2” 2’  
4’’ 71.1 3.61-3.58, (1H, m) 3”, 5” 3’/5’  
5’’ 67.1 3.99, (1H, m) 
3.46-3.41, (1H, m) 
3”, 1”, 4” 5’, 4’  
 
 
 
Figure 3.80: 1H NMR spectrum of compound 27. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
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Figure 3.81: NOESY correlation between methoxy protons at position 4 and proton H-5, a proof that they are in 
neighbouring position. Likewise for the anomeric proton (H-1”) and H-5’. The later enabled the assignement of 
glycosidic linkage at position 4’. 
 
 
Compounds 28 and 29 
 
Figure 3.82: Structures of largertannin (28) and ducheside A (29). 
 
Compound 28 and 29 (Figure 3.82) were identified as largertannin (3,4 di-O- methyl ellagic acid 
4’-O- β-D-glucopyranoside) and ducheside A (3-O-methyl-ellagic acid 4’-O-β-D-xylopyranoside). 
The isolation and structure elucidation of 29 was reported for the first time by Ye and Yang175. 
The existence of compound 28 was found through searching in SciFinder, unfortunately no 
reference corresponding to this compound was available. NMR data of 29 was not found for 
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comparison purposes, though its isolation is reported from few plant species but none of these 
literature contained the full assignment NMR data of 29. Therefore, structure confirmation of 28 
and 29 was achieved from the following obtained spectroscopic and HRESI-MS data. 
NMR data for compounds 28 and 29 were similar to a large extent with those of compound 27 
and they both had sugar substitution at C-4’. The difference between 27 and 28 was the 
attached sugar moiety i.e. D-xylose for 27 and D-glucose for 28. Moreover, the difference 
between 27 and 29 was the number of attached methoxy groups i.e. 2 methoxy groups at 
position C-3 and C-4 for 27 and 1 methoxy group at position C-3 for 29. Regardless of the above 
mentioned differences for the three compound, all other obtained 1D and 2D-NMR spectra data 
were quite similar for the three compounds. The proton and carbon NMR for compounds 28 
and 29 is given in Table 3.25. 
Further characteristics of 28 were: yellowish amorphous powder with optical rotation  [α]D
25= -
24.6 (c 0.1, MeOH) and Rf value of ~ 0.40 (Figure 3.78). Molecular formula of C22H20O13 
following HREIS-MS exhibited ions at m/z 491.0821 [M-H]- and 983.1733 [2M–H]- in the negative 
mode. The UV spectrum (pyridine) showed absorption maximum at 354.9 nm.  
Compound 29 was obtained as yellow amorphous powder, [α]D
25= -60 (c 0.1, MeOH), Rf value ~ 
0.50 (Figure 3.78). HREIS-MS exhibited ions at m/z 449.0716 [M-H]- in the negative mode 
corresponding to molecular formula of C
20
H
16
O
12..The UV spectrum (MeOH) showed absorption 
maximum at 265.0 nm. The sugar configuration was achieved as described in section 3.3.5.2.1.
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Table 3.25: NMR data for compounds 28 and 29. 1H NMR (600 MHz), 13C NMR (150 MHz), pyridine-d5, 298 K. 
Pos. 28 29 
δC (ppm) δH (ppm), m, J (Hz) δC (ppm) δH (ppm), m, J (Hz) 
1 114.0  112.2  
2 142.3  142.8  
3 141.8  141.2  
4 154.9  154.2  
5 107.8 7.79, (1H, s) 112.7 8.02, (1H, s) 
6 114.8  114.4  
6a 159.7  159.6  
1’ 107.6  106.9  
2’ 137.7  137.6  
3’ 149.4  145.2  
4’ 149.4  149.0  
5’ 113.7 8.47, (1H, s) 114.2 8.44, (1H, ) 
6’ 114.0  115.7  
6a’ 159.2  159.9  
3-OCH3 61.5 4.12, (3H, s) 61.2 4.17, (3H, s) 
4-OCH3 56.5 3.83, (3H, s)   
Sug.     
1’’ 103. 6 5.94, (1H, d, J = 7.7) 104.5 5.78, (1H, d, J = 6.6) 
2’’ 74.8 4.28, (1H, t, J = 8.1) 74.5 4.30-4.26, (1H, m) 
3’’ 71.0 4.35, (1H, m) 78.1 4.30-4.26, (1H, m) 
4’’ 78.4 4.39, (1H, m) 70.8 4.30-4.26, (1H, m) 
5’’ 79.1 4.14, (1H, m) 67.5 4.41-4.38, (1H, m) 
3.88-3.82, (1H, m) 
6” 62.1 4.42, (1H, dd, J = 12.0, 4.7) 
4.54, (1H, dd, J = 12.0, 2.2) 
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3.3.5.4 Further compounds 
Apart from tannins, diarylheptanoids and MEAG, further two compounds (30 and 31) were 
isolated (Figure 3.83). The structure elucidation of 30 and 31 was accomplished as described in 
the following sections.  
 
Figure 3.83: NP-TLC overview of the other compounds (30 and 31) isolated from fraction S2 of methanolic extract 
of M. salicifolia. Mobile phase MP_1. Detection: VIS (left) and UV 366 nm (right). Spray reagent: anisaldehyde-
sulphuric acid. 
 
Compound 30 
 
Figure 3.84: Structure of 2,9-dimethyl-8-O-(6’-O-galloyl)-β-D-glucopyranoside-2,4-dienedioic acid (30). 
 
Compound 30 (Figure 3.84) was isolated as off-white amorphous powder with optical rotational 
value [α]D
25= -19 (c 0.1, MeOH). HREIS-MS exhibited ions at m/z 555.1720 [M-H]- in the negative 
mode and m/z 557.1862 [M+H]+ in the positive mode , corresponding to molecular formula of 
C25H32O14. The UV absorption maximum (MeOH) was exhibited at 265 nm. On the TLC, 30 
displays dark brown spot (Rf value ~ 0.68) following spraying with anisaldehyde-sulphuric acid 
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reagent and visualized under day light (Figure 3.83 left, mobile phase MP_1). The structure 
elucidation of 30 was achieved with the aid of NMR data summarized in Table 3.26 and 
confirmed by the mass and molecular formula obtained from HRESI-MS. From the obtained 
data it was concluded that 30 contains two double bonds, one sugar and one galloyl moiety. 
The sugar moiety was deduced to be β-D-glucose as described in section 3.3.5.2.1. It is the first 
time the isolation of this compound is reported and its chemical name was deduced to be 2,9-
dimethyl-8-O-(6’-O-galloyl)-β-D-glucopyranoside-2,4-dienedioic acid. 
 
Table 3.26: 1 and 2D NMR data for compound 30. 1H NMR (600 MHz), 13C NMR (150 MHz), methanol-d4, 298 K. 
Pos. δC 
(ppm) 
δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 172.6     
2 126.0     
3 140.2 7.03, (1H, d, J = 11.0) 12, 2, 4, 5, 1 12, 4 5, 4 
4 128.3 6.25, (1H, dd, J = 11.4, 14.9) 6, 2, 3 5, 3 5, 7 
5 143.3 5.99-5.94,(1H, m) 6, 9, 3 6, 4 3, 4, 7, 6  
6 37.5 2.46-2.40, (1H, m) 
1.9-1.93, (1H, m) 
11, 9, 8, 4, 5 5 11, 9, 6/7, 5, 
4 
7 39.1 2.54-2.51, (1H, m) 
2.46-2.40, (1H, m) 
6, 8, 1’, 5, 10 8 8, 6/7, 5, 4 
8 81.6 4.10, (1H, brs) 6, 1’ 7, 9 11, 9, 2.42, 
6/7 
9 38.5 1.86, (1H, brs)   11, 7 
10 178.0     
11 14.6 0.83, (3H, d, J = 6.9). 6, 9, 8 9  
12 12.8 1.79, (3H, s) 1, 4, 3, 5,   
Gluc.      
1’ 103.9 4.43, (1H, d, J = 7.7) 2’, 3’, 8 2’ 2’, 4’,3’, 
2’ 75.4 3.19, (1H, m) 5’, 1’ 1’, 3’  
3’ 75.4 3.58-3.55, (1H, m) 4’, 5’ 1’ 4’  
4‘ 72.0 3.38, (1H, m) 6’, 4’, 2’, 3’, 5’   
5‘ 78.1 3.38, (1H, m) 6’, 4’, 3’, 5’   
6’ 64.9 4.50, (1H, dd, J = 11.7, 2.0) 
4.38, (1H, dd, J = 11.7, 6.6) 
3’, 4’, C=O   
Gal.      
1” 121.6     
2”/6” 110.3 7.09, (2H, s) 2”/6”, 1”, 4”, 3”/5”,2, C=O   
3”/5” 146.5     
4” 139.8     
C=O 168.3     
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Figure 3.85: 1H NMR spectrum of compound 30. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K. 
 
Compound 31 
 
Figure 3.86: Structure of 4,11-dimethyl-10-O-β-D-glucopyranoside-2,4,6-trienedioic acid (31). 
 
Compound 31 (Figure 3.86) was isolated as off-white amorphous powder with optical rotation 
value of [α]D
25= -22 (c 0.1, MeOH). On the TLC 31 shows a deep dark brown spot (Rf value ~ 
0.58) following spraying with anisaldehyde-sulphuric acid reagent and visualization under 
visible light (VIS) and a florescent reddish spot under UV 366 nm. In the UV spectrum (MeOH) of 
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31, absorption maximum was observed at wavelength 295 nm. HREIS-MS exhibited ions at m/z 
429.1766 [M-H]- in the negative mode and m/z 448.2175 [M+NH4]+ in the positive mode , 
corresponding to molecular formula of C20H30O10. 
The 1D and 2D NMR data of 31 are summarized in Table 27. From the obtained spectroscopic 
data, 31 was concluded to be 4,11-dimethyl-10-O-β-D-glucopyranoside-2,4,6-trienedioic acid. In 
comparison to compound 30, compound 31 was found to contain no galloyl moiety and 
possessing longer chain (C-14). Compound 31 is a new compound and is not yet reported in the 
literature. 
 
Table 3.27: 1 and 2D NMR data for compound 31. 1H NMR (600 MHz), 13C NMR (150 MHz), methanol-d4, 298 K. 
Pos. δC 
(ppm) 
δH (ppm), m, J (Hz) HMBC COSY NOESY 
1 172.2      
2 118.8 5.83, (1H, d, J = 15.5) 4, 1, 3 11, 3 
3 149.9 7.26, (1H, d, J = 15.5) 14, 2, 4, 5, 1 2 11, 2, 5 
4 132.5     
5 139.8 6.38, (1H, d, J = 11.6) 14, 6, 7, 3 11, 6 11, 7, 3 
6 128.9 6.49, (1H, dd, J = 14.8, 11.3) 8, 4 7, 5 13, 11, 8 
7 140.8 6.02, (1H, d, J = 7.4) 8, 11, 6, 4, 5 8, 6 13, 8, 5 
8 37.1 2.57-2.54, (1H, m) 
2.04-1.98, (1H, m) 
13, 9, 10, 6, 7 9, 7 13, 7 
9 39.2 2.51, (1H, dd, J = 15.2, 7.5) 
2.43, (1H, dd, J = 15.2, 5.4) 
10, 12, 11 10 10, 1’, 13 
10 81.3 4.10, (1H, m) 8, 11, 1’, 12 9, 11 13, 11, 9, 1’ 
11 38.6 1.91-1.89, (1H, m)  10 13, 8, 10 
12 178.2     
13 15.0 0.92, (3H, d, J = 6.8) 8, 11, 10  11, 8, 9, 10 
14 12.5 1.87, (3H, s) 4, 5, 3  2, 6 
Gluc.      
1’ 103.8 4.39, (1H, d, J = 7.7) 5’, 10 2’ 11, 9, 2’, 5’, 10 
2’ 75.4 3.16, (1H, dd, J = 8.8, 7.9) 3’, 1’ 1’  
3’ 78.1 3.36, (1H, t, J = 8.8) 4’, 2’ 2’ 1’ 
4‘ 71.6 3.31, (1H, m) 6’, 3’  1’ 
5‘ 77.9 3.27-3.25, (1H, m)  6’  
6’ 62.8 3.84, (1H, dd, J = 11.7, 2.3) 
3.68, (1H, dd, J = 11.7, 5.2) 
4’, 3’ 5’ 5’ 
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Figure 3.87: 1H NMR spectrum of compound 31. 1H NMR (600 MHz), 13C NMR (150 MHz), MeOH-d4, 298 K.
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3.4 Summary and discussion of the isolated compounds from M. salicifolia 
bark 
3.4.1 Summary on the isolated compounds 
Phytochemical characterization of M. salicifolia bark methanolic extract resulted in isolation 
and structure elucidation of 31 compounds. The identified compounds belongs to various 
groups such as: condensed tannins (1 - 8), hydrolysable tannins (9), cyclic diarylheptanoids (10 
– 26), ellagic acid derivatives (27 – 29) and others (30 – 31). 10 out of 31 elucidated compounds 
were identified to be completely new and not to be reported in literature yet. 1 dimeric A-type 
prodelphinidin (7), 6 cyclic diarylheptanoid glycosides (16 – 18 and 22 - 24), 1 methylated 
ellagic acid glycoside (27) and 2 other compounds (30 and 31). A list of isolated compounds is 
shown in Table 3.28. 
 
Table 3.28: Summary of the isolated compounds obtained from the methanolic extract of M. salicifolia bark. 
 Compound, amount and status. Colour of 
the 
amorphous 
powder 
Molecular 
formula 
Mass 
(Da) 
UV. 
Max. 
(nm) 
Optical 
rotation  
(c 0.1, MeOH) 
Tannins 
1 gallocatechin (49.0 mg). 
KNOWN 
Light orange C15H14O7 306 
 
270 
(MeOH) 
+25.06 
2 epigallocatechin-3-O-gallate  
(1.1 mg). KNOWN 
Light orange C22H18O11 
 
458  
 
275 
(MeOH) 
-96.8 
3 prodelphinidin B1: (-)-
epigallocatechin-(4β→8)-
gallocatechin (2.3 mg). KNOWN 
Light orange C30H26O14 
 
610 270 
(MeOH) 
-15.33 
4 epigallocatechin-3-O-gallate-
(4β→8)-gallocatechin  
(12.5 mg). KNOWN 
Orange C37H30O18 762 275 
(MeOH) 
+168 
5 epigallocatechin-(4β→8)-
gallocatechin 3-O-gallate  
(9.1 mg). NEW 
(further proof needed) 
Orange C37H30O18 762 275 
(MeOH) 
+ 220 
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 Compound, amount and status. Colour of 
the 
amorphous 
powder 
Molecular 
formula 
Mass 
(Da) 
UV. Max. 
(nm) 
Optical 
rotation  
(c 0.1, MeOH) 
6 ephedrannin D5: (-)-
epigallocatechin-
(2β→O→7,4β→8)–gallocatechin 
(6.0 mg).  
NEW to the genus 
Orange C30H24O14 
 
608 270 
(MeOH) 
-82.4 
7 myricedin: (+)-gallocatechin-
(2β→O→7,4β→8)-gallocatechin 
(0.7 mg). NEW 
Orange C30H24O14 
 
608 279 
(MeOH) 
-22.6 
8 adenodimerin C: (+)-
gallocatechin-3-O-gallate 
(2β→O→7,4β→8)–gallocatechin 
(3.0 mg). KNOWN 
Orange C37H28O18 760 275 
(MeOH) 
+20.5 
9 castalagin (1.6 mg). KNOWN Off-white C41H26O26 934 - +15.6  
Cyclic diarylheptanoids 
10 juglanin B-sulphate (1.0 mg). 
KNOWN 
Off-white C20H24O7S 408 254,  
300 
(MeOH) 
-12.5 
11 myricanol (30.5 mg). KNOWN White C21H26O5 358 259.9, 
298 
(MeOH) 
-76.5  
12 myricanone (6.6 mg). KNOWN Off-white C21H24O5 
 
356 259.9, 
300 
(MeOH) 
-26 
13 myricanol 5-O-β-D-glucose 
(77.0 mg). KNOWN 
White  C27H36O10 520 216, 
255.1, 
299 
((MeOH)) 
-52.4 
14 myricanone 5-O-β-D-glucose 
(10.2 mg). KNOWN 
Off-white C27H34O10 518 254,  
280 
((MeOH) 
-44 
15 myricanol 11-O-β-D-
xylopyranoside (0.7 mg). 
KNOWN 
White C26H34O9 490 214,  
260,  
298. 
(MeOH) 
-80.8 
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 Compound, amount and status. Colour of 
the 
amorphous 
powder 
Molecular 
formula 
Mass 
(Da) 
UV. Max. 
(nm) 
Optical 
rotation  
(c 0.1, MeOH) 
16 salicimeckol: 7-hydroxymyricanol 
5-O-β-D-glucose (2.5 mg). NEW 
White C27H36O11 536 213,  
250,  
295 
(MeOH) 
-56 
17 salicireneol A: Juglanin B 3-O-β-
D-glucoside (0.5 mg). NEW 
White C26H34O9  
 
490 214, 254 
285 
(MeOH) 
-49 
18 salicireneol B: 16-
hydroxyjuglanin B 17-O-β-D-
glucoside. (0.7 mg). NEW 
White  506 216,  
253,  
298 
(MeOH) 
-33.6 
19 myricanol 5-O-β-D-(6'-O-galloyl) 
glucoside (13.3 mg). KNOWN 
Deep green C34H40O14 
 
672 213,  
255,  
298 
(MeOH) 
-52.7 
20 myricanol 5-O-β-D-(6'-O-galloyl) 
glucoside (5.8 mg). KNOWN 
Yellow C34H40O14 
 
672 213,  
255,  
298 
(MeOH) 
-33.6 
21 myricanone 5-O-β-D-(6'-O-
galloyl) glucoside (3.1 mg). 
KNOWN 
Off-white C34H38O14 
 
670 213,  
255,  
280 
(MeOH) 
-44 
22 saliciclaireone A: myricanone 5-
O-β-D-glucopranosyl-(1-6)-β-D-
glucopyranoside (4.2 mg). NEW 
Off-white C33H44O15 
 
680  
 
214,  
250,  
300 
(MeOH) 
-51.6 
23 saliciclaireone B: neomyricanone 
5-O-β-D-glucopranosyl-(1-6)-β-D-
glucopyranoside (0.9 mg). NEW 
Off-white C33H44O15 680 214,  
250,  
298 
(MeOH) 
-43.1 
24 saliciclaireone C: myricanone 17-
O-α-L-arabinofuranosyl-(1-6)-β-
D-glucopyranoside (0.9 mg). 
NEW 
Off-white C32H42O14 650 215,  
252,  
295 
(MeOH) 
-36 
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 Compound, amount and status. Colour of 
the 
amorphous 
powder 
Molecular 
formula 
Mass 
(Da) 
UV. Max. 
(nm) 
Optical 
rotation  
(c 0.1, MeOH) 
25 myricanol 5-O-α-L-
arabinofuranosyl-(1-6)-β-D-
glucopyranoside (2.2 mg). 
KNOWN 
White C32H44O14 652 212,  
255,  
298 
(MeOH) 
-56 
26 myricanol gentiobioside: 
myricanol 5-O-β-D-
glucopranosyl-(1-6)-β-D-
glucopyranoside (2.6 mg). 
KNOWN 
White C33H46O15 682 212,  
255,  
298 
(MeOH) 
-73 
Methylated ellagic acid glycosides (MEAG) 
27 myriside: 3,4 di-O-methyl ellagic 
4’-O-β-D-xylopyranoside (1.9 
mg). NEW 
Yellowish C21H18O12 462 255.1 
(MeOH) 
-38.3 
28 largertannin: 3,4 di-O-methyl 
ellagic acid 4’-O-β-D-
glucopyranoside (6.0 mg). 
NEW to the genus 
Yellowish C22H20O13 492 354.9 
(Pyridine) 
-24.6 
29 ducheside A: 3-O-methyl-ellagic 
acid 4’-O-β-D-xylopyranoside 
(18.6 mg). NEW to the genus 
Yellowish C20H16O12 448 265 
(MeOH) 
-60 
Other compounds 
30 2,9-dimethyl-8-O-(6’-O-galloyl)-β-
D-glucopyranoside-2,4-
dienedioic acid (1.4 mg). NEW 
Off-white C
25
H
32
O
14
 556 265 
(MeOH) 
-19 
31 4,11-dimethyl-10-O-β-D-
glucopyranoside-2,4,6-
trienedioic acid (0.6 mg) NEW 
Off-white C
20
H
30
O
10
 430 295 
(MeOH) 
-22 
 
 
3.4.2 Determination of absolute configuration of isolated diarylheptanoids 
The isolated cyclic diarylheptanoids in this study contained either sugar, hydroxyl, carbonyl or 
sulphate group at their position 11. Some of these compounds possessed further hydroxyl or 
sugar (mono or diglycoside) attached to either position 3, 5, or 17. Therefore, determination of 
absolute configuration for these compounds to provide their full stereochemistry was 
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inevitable. The absolute configuration of the sugars was achieved through an already 
established method140. Determination of absolute configuration of the aglycone was achieved 
by CD spectra calculations (performed by Prof. Dr. Thomas Schmidt, Institute of Pharmaceutical 
Biology and Phytochemistry, University of Münster).  
Previously, absolute configuration of diarylheptanoids has been achieved through X-ray 
crystallography, comparison of optical rotations signs with the already established X-ray 
structure or by using Mosher’s reagent method123. 
Determination of absolute configuration of myricanol isolated from M. nagi was achieved via X-
ray crystallography of a brominated derivative of myricanol141. The said myricanol has optical 
rotation [α]D
27.5= -65.6 (c 3% in CHCl3). From the resulting X-ray crystal structure it was 
concluded that myricanol was 11R-configured. Furthermore, the group recorded CD spectra of 
myricanol as negative cotton effects at 240, 257 and 290 nm. In another study, Joshi et al.169 
determined the absolute configuration of a racemate myricanol ([∝]𝐷= 0) isolated from M. 
cerifera also by using X-ray crystallography method. They found that the crystal structure of 
racemate myricanol contained two independent molecules (+)-aR,11S-myricanol and (-)-aS,11R-
myricanol whereby the second was similar to that of 11R-myricanol obtained by Begley et al.141. 
Following X-ray crystallography performed by the group of Begley141, several groups afterwards 
concluded the absolute configuration of myricanol based on the optical rotation sign (negative 
sign (11R) and positive sign (11S)). Inoue et al.186 isolated myricanol from M. rubra with [∝]𝐷 = -
62.9. Takaeda et al.131 isolated myricanol from M. rubra with [∝]𝐷 = -27.6 (c 0.65 in CHCl3). Sun 
et al.87 isolated myricanol from M. esculenta with[∝]𝐷 = -64 (c 0.05 in CHCl3). The negative 
optical rotation of the myricanol from different groups were correlated to 11R-configuration 
obtained by X-ray crystallography of brominated derivative of myricanol141.  
Confirmation of the absolute configuration by comparing the optical rotation signs to that of 
brominated derivative of myricanol141 was further used for isolated cyclic diarylheptanoids 
containing attached glycosides117,126,128,129, galloylglucoside110,128 or sulphate110,112 group. The 
cyclic diarylheptanoid glycosides were cleaved prior measurement of their optical rotations for 
comparison. They were concluded to have 11R- or 11S-configuration due to their negative or 
positive optical rotations respectively. 
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In this study, a CD simulation method to determine absolute configuration of cyclic 
diarylheptanoids (meta,meta-bridged biphenyls) containing a chiral centre at position 11 was 
used. The method is described in the material and methods section 3.2.8.8 and in the results 
section 3.3.5.2.1. The optical rotation signs of the isolated cyclic diarylheptanoids in this study 
were negative with different values (Table 3.28). In addition to that, the recorded experimental 
CD spectra in Figure 3.54 (1 – 12) showed the negative cotton effect at the region of 231, 255 
and 296 nm. Based on the similarities of recorded CD spectra (aglycone and the diarylheptanoid 
glycosides) it was concluded that there was no effect of an attached glycoside or sulphate group 
to the aglycone. Additionally, matching of the recorded CD spectra to the calculated CD spectra 
as shown in Figure 3.56 C showed very good match between the two spectra. Hence, based on 
these calculations the absolute configuration of these compounds was confirmed to be 11R- 
and very predominantly Sa-configured. The presence of a smaller amount of the Ra atropisomer 
in the conformational equilibrium of these compounds was also concluded due to the observed 
perfect match of recorded CD spectra to the calculated CD spectra of the equilibrium mixture of 
R,Sa (97%) and  R,Ra (3%) (Figure 3.56 D). 
The obtained absolute configuration of natural myricanol in this study matches very well to the 
one achieved by X-ray in the group of Begley141. However, in this study the established CD 
calculation of myricanol was further used as a reference and a non-destructive method to 
determine the absolute configuration of isolated diarylheptanoids containing glycosides or 
sufate groups. The method used is reliable as the obtained results were in agreement to the 
published crystal structure. It should also be noted that this method was used to determine the 
absolute configuration of the meta,meta-bridged biphenyls with chiral centre at position 11. 
There was no sample to prove if the same method can also be applied for the cyclic 
diarylheptanoids of the meta,para- diphenyl ether type as well as for the ones without chiral 
centre at position 11. 
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3.4.3 Comparison of isolated compounds from M. salicifolia and other plant species 
3.4.3.1 Tannins  
Isolation of tannins from Myrica species has been limitedly reported. However, reisolation of 
some of these reported tannins was achieved also in M. salicifolia. The reisolated compounds 
are gallocatechin (1), epigallocatechin-3-O-gallate (2), adenodimerin C (8) and castalagin (9). 
The existing literature data on previously reported tannins (Table 3.29) provide evidence of the 
taxonomic relationship between M. salicifolia and other Myrica species.  
In addition to that, five prodelphinidins (compounds 3 – 7) which have not been previously 
reported in the genus Myrica were isolated in this study (Table 3.29). This is the first time that, 
prodelphinidin B1 (epigallocatechin-(4β→8)-gallocatechin) (3), epigallocatechin 3-O-gallate-
(4β→8)-gallocatechin (4), epigallocatechin–(4β→8)–gallocatechin 3-O-gallate (5), ephedrannin 
D5 (epigallocatechin (2β→O→7,4β→8)–gallocatechin) (6) and myricedin ((+)-gallocatechin-
(2β→O→7,4β→8)-gallocatechin) (7) are reported to the genus Myrica. 
The isolation of proanthocyanidins from M. salicifolia was preceded by a tedious period of 
searching for the right chromatographic separation method. The same challenge of complex 
chromatographic separation of proanthocyanidins due to their vast occurrence as similar 
isomeric oligomers in plant sources is often reported in literature. This could be an answer as to 
why there are limited literature reports on isolation of individual proanthocyanidins from the 
genus Myrica despite the reported high contents of tannins in the bark of Myrica species87,106. 
Such a high content of tannins was also observed in the bark of M. salicifolia already after 
Sephadex® LH-20 fractionation, where 162.46 g of crude methanolic extract yielded a 
proanthocyanidin polymer fraction of 96.45 g (59.4%) and three further fractions (S4-S7) 
containing tannins (Figure 3.25). 
 
3.4.3.2 Cyclic diarylheptanoids 
The isolation and identification of cyclic diarylheptanoids (10 - 26) from the crude methanolic 
extract of M. salicifolia bark further showed its relation to other Myrica species. Several cyclic 
diarylheptanoids have been reported from other Myrica species and some of these compounds 
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were also isolated in this study (Table 3.29). Myricanol (11) and myricanone (12) are the two 
cyclic diarylheptanoids which are frequently reported in almost all Myrica species that have 
been phytochemically investigated. Some authors are suggesting that both compounds can be 
used as chemotaxonomic markers of the genus Myrica71,135. Table 3.29 contains a summary of 
the isolated cyclic diarylheptanoids from M. salicifolia which have been also isolated from other 
Myrica species.  
Additionally, six cyclic diarylheptanoids glycosides (16-18, 21-23) are reported for the first time 
in the genus Myrica. The new isolated diarylheptanoids have slight variations from already 
described ones in term of position of the glycosidic linkage, number and position of hydroxyl 
groups, position of keto group as well as number and type of attached sugar moieties. 
Salicimeckol (7-hydroxymyricanol 5-O-β-D-glucoside, 16), a new cyclic diarylheptanoid, was 
found to be similar to myricanol 5-O-β-D-glucoside (13), a known compound117,126,128. However, 
the observed difference between the two was the attachment of an extra hydroxyl group to 
position 7 of salicimeckol. Salicireneol A (juglanin B 3-O-β-D-glucoside, 17) was observed to be 
similar to juglanin B172,173 with exception of attachment of a glucose moiety at position 3 of the 
juglanin B. Moreover, NMR data of saliciclaireone A (myricanone 5-O-β-D-glucopranosyl-(1-6)-β-
D-glucopyranoside, 22) and saliciclaireone B (neomyricanone 5-O-β-D-glucopranosyl-(1-6)-β-D-
glucopyranoside, 23) were resembling the known structures of myricanone 5-O-β-D-
glucopyranoside117,126 and neo myricanone 5-O-β-D-glucopyranoside117 except that the two 
compounds were found to contain an extra glucose moiety in each. Saliciclaireone C 
(myricanone 17-O-α-L-arabinofuranosyl-(1-6)-β-D-glucopyranoside, 24) were similar to known 
compound (25) myricanol 5-O-α-L-arabinofuranosyl-(1-6)-β-D-glucopyranoside129, but 24 was 
found to contain a glycosidic linkage at position 17 and a keto group instead of hydroxyl group at 
position C-11 of the aglycone. 
 
3.4.3.3 Methylated ellagic acid glycosides (MEAG) 
Three methylated ellagic acid glycosides (27 – 29) were isolated from M. salicifolia. However, to 
date, there is no literature data describing the existence of these compounds in the genus 
Myrica. There is also limited literature data describing their isolation from other plants. 
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Therefore, this is the first time myriside (3,4 di-O-methyl ellagic 4’-O-β-D-xylopyranoside 27), 
largertannin  (3,4 di-O-methyl ellagic acid 4’-O-β-D-glucopyranoside 28) and ducheside A (3-O-
methyl-ellagic acid 4’-O-β-D-xylopyranoside 29) are reported in Myrica.  
The identification of these three compounds was challenging as they tend to change solubility 
over time. Some of the isolated compounds which are believed to be MEAG could not be 
dissolved in any of the solvent just as little in the NMR solvents. This made their identification 
and structure elucidation impossible, hence they are not reported in this thesis. The solubility 
of myriside (27) was achieved in deuterated methanol, thereafter its identification and 
structure elucidation was successfully done. Compounds 28 and 29 were totally dissolved in the 
deuterated methanol in the first place, but within a few minutes they precipitated. Their 
identification and structure elucidation by 1D and 2D NMR measurement was achieved after 
dissolving them in deuterated pyridine and shaking the mixture in the water bath at 40 οC until 
a clear solution was achieved. The cause of the solubility change of the MEAGs was not 
investigated in this study. However, the solubility change of these compounds causes the 
difficulty in their isolation, purification and identification. This could also be a reason to the 
scarcity of literature data not only from Myrica but also from other plant species. The solubility 
change problems for methyl ellagic acid glycosides were also reported by Hillis and Yazaki176. 
However, they also did not investigate the underlying mechanism. 
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Table 3.29: Reported literature on the isolation of the known compounds isolated from M. salicifolia. 
Isolated compound Other Myrica species  Other plant species 
Tannins 
1 gallocatechin  M. gale107, M. rubra106 Green tea143, Salix purpurea162, 
Trifolium repens144, Catha 
edulis177 to mention a few. 
2 epigallocatechin -3-O-gallate M. nagi87, M. rubra117,178 Green tea143, etc. 
3 prodelphinidin B1 
(epigallocatechin-(4β→8)-
gallocatechin 
NONE Cistus incanus154, Lotus 
pedunculatus155, Catha edulis177, 
Stryphnodendron adstringens153 
4 epigallocatechin 3-O-gallate-
(4β→8)-gallocatechin  
NONE Cistus incanus154, Hamamelis 
virginiana157 
5 epigallocatechin–(4β→8)–
gallocatechin 3-O-gallate 
NONE NONE 
6 ephedrannin D5 
(epigallocatechin (2β→O→7, 
4β→8)–gallocatechin 
NONE Ephedra sinica160 
8 adenodimerin C (gallocatechin-
3-O-gallate (2β→O→7,4β→8)–
gallocatechin) 
M. adenophora109 NONE 
9 castalagin  M. esculenta87 Quercus robur166,167, Quercus 
petraea179,180, Castanea 
sativa181,182, Anogeissus 
leiocarpus91, Eugenia grandis183 
Cyclic diarylheptanoids 
10 juglanin B-sulphate  M. rubra110,112 NONE 
11 myricanol  M. rubra117,128, M. 
cerifera119, M. nagi141,184, M. 
arborea126, M. esculenta87, 
M. nana185, M. 
adenophora109 
NONE 
12 myricanone  M. rubra117,128, M. nagi141,184, 
M. esculenta87, M. nana185, 
M. gale125, M. 
adenophora109 
NONE 
13 myricanol 5-O-β-D-glucose  M. rubra117,128, M. arborea126 NONE 
14 myricanone 5-O-β-D-glucose  M. rubra117 NONE 
15 myricanol 11-O-β-D-
xylopyranoside  
M. rubra128, M. arborea126, 
M. adenophora109 
NONE 
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Isolated compound Other Myrica species  Other plant species 
19 myricanol 5-O-β-D-(6'-O-
galloyl) glucoside  
M. rubra128 NONE 
20 myricanol 5-O-β-D-(6'-O-
galloyl) glucoside  
M. rubra128 NONE 
21 myricanone 5-O-β-D-(6'-O-
galloyl) glucoside 
M. rubra128 NONE 
25 myricanol 5-O-α-L-
arabinofuranosyl-(1-6)-β-D-
glucopyranoside  
M. rubra129 NONE 
26 myricanol 5-O-β-D-
glucopranosyl-(1-6)-β-D-
glucopyranoside or myricanol 
gentiobioside  
M. rubra128 NONE 
Methylated ellagic acid glycosides (MEAG) 
28 largertannin (3,4 di-O-methyl 
ellagic acid 4’-O-β-D-
glucopyranoside)  
NONE SciFinder could not provide a 
reference from which 
largertannin was isolated 
29 ducheside A (3-O-methyl-
ellagic acid 4’-O-β-D-
xylopyranoside) 
NONE Duchesnea indica175 
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3.5 Conclusion 
M. salicifolia bark is a common potent medicinal plant part used as a drug in Maasai community 
of north-eastern Tanzania. However, phytochemical characterization up to a point of individual 
isolated compounds as well as pharmacological studies to scientifically prove its medicinal 
effectiveness are scarce. For this reason, crude methanolic extract of M. salicifolia bark was 
subjected to phytochemical investigation. This resulted in isolation of 31 compounds belonging 
to different compound classes such as proanthocyanidins, ellagitannins, cyclic diarylheptanoids, 
methylated ellagic acid glycosides and others (section 3.4.1). The isolation of compounds was 
not focused to a specific group of compounds but on every possible compound for 
documentation and also for scientific back up of the plant phytochemical composition. Besides, 
it was observed that the methanolic extract of M. salicifolia contained mainly 
proanthocyanidins and cyclic diarylheptanoids in large quantity compared to other compound 
classes. 
Moreover, a method to determine absolute configuration of the isolated cyclic diarylheptanoids 
of meta,meta-bridged biphenyls type having chiral centre at position 11 by using CD calculation 
was established. The method was established by help of Prof. Dr. Thomas Schmidt from 
Institute of Pharmaceutical Biology and Phytochemistry, University of Münster. 
In addition, the phytochemical composition of M. salicifolia, demonstrated the taxonomic 
relationship of the plant with other reported Myrica species. The taxonomic relationship was 
deduced from comparison of isolated M. salicifolia compounds to the same compounds 
reported from other Myrica species (section 3.4.2). Furthermore, the existence of a new class 
of compounds, methylated ellagic acid glycosides (MEAG), to the genus Myrica was discovered. 
Finally, there is still a great number of compound to discover and elucidate from M. salicifolia 
bark that were not achieved in this study. Among the encountered challenges were, the 
presence of too many compounds with low amount in the non-tannin fractions S1-S3 (Figure 
3.18). Therefore, for further thorough analysis and isolation of non-tannins compounds from 
the M. salicifolia bark in the future, a higher amount of the starting bark material for the 
extraction is absolutely recommended. 
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4 Summary and future recommendation 
In this study, an ethnopharmacological survey was conducted in Arusha and Manyara regions of 
north-eastern Tanzania. The objective of the survey was a detailed investigation and 
documentation of commonly used Maasai medicinal plants in the area. A total of 65 consented 
traditional medicinal practitioners (TMPs) were interviewed. Information was collected by using 
a semi structured questionnaire interview. Four commonly used medicinal plants were 
investigated, namely Myrica salicifolia (Myricaceae), Pappea capensis (Sapindaceae), Flacourtia 
indica (Salicaceae) and Vangueria apiculata (Rubiaceae). Documentation on plant parts used, 
drug preparation, traditional medicinal uses, drug administration and overdose management 
was achieved. A number of diseases were reported to be cured by the four plants. The most 
mentioned diseases to be treated by M. salicifolia were gonorrhoea (81%) and running nose 
(73%). P. capensis was mainly used for the enhancement of libido (89%) and to treat blood loss 
(72%). F. indica was applied to treat fever (92%), malaria (90%) and jaundice (87%). The most 
mentioned applications for V. apiculata were eye infection (73%) and diarrhoea (66%). 
Moreover, all four plants were reported to cure further disorders and diseases like joints pain, 
back pain, gouts, diarrhoea, stomach upset, etc. Furthermore, the survey revealed that barks 
and roots were the most utilized plant parts. Drug administration was observed not to be 
uniform, in terms of concentration, time and dose. 
Phytochemical investigation of a crude methanolic extract of M. salicifolia bark was performed 
following its documented ethnopharmacological survey data. The phytochemical investigation 
resulted in isolation of 34 compounds belonging to different compounds classes: 8 
proanthocyanidins, 1 ellagitannin, 17 cyclic diarylheptanoids, 3 methylated ellagic acid 
glycosides and 5 further compounds.  10 of the isolated compounds from M. salicifolia were 
identified to be completely new, not described in the literature yet. Additionally, the existence 
of a new class of compounds to the genus Myrica was also discovered, the so called methylated 
ellagic acid glycosides (MEAG). It was further noticed that the methanolic extract of M. 
salicifolia contained mainly proanthocyanidins and cyclic diarylheptanoids in large quantity 
compared to other compound classes. Moreover, taxonomic relationship of M. salifolia to other 
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reported Myrica species was demonstrated by the compounds isolated from M. salicifolia. 
Some of the compounds were also reported from other Myrica species, for example myricanol 
(11) and myricanone (12). These two compounds are found in almost every Myrica species 
which has been phytochemically investigated. 
Finally, the objective of the work was accomplished to a great extent, however further 
investigations are recommended for the future. 
Due to time constraints, the isolated compounds were not investigated for their 
pharmacological activities. However, existing literature data on in-vitro and/or in-vivo biological 
activity of the mentioned classes of compounds isolated from other plants species and also 
from Myrica provide a preliminary indication of a healing potential of this plant. 
To provide scientific confirmation of the healing potential of M. salicifolia bark, prospective in-
vitro and/or in-vivo pharmacological investigations of the isolated compounds should be 
conducted by using assays which adhere to the diseases claimed to be treated by M. salicifolia 
bark.  
Also further phytochemical investigation of M. salicifolia bark should be conducted to achieve 
the complete phytochemical composition of the bark. The future phytochemical investigation 
should focus on the non-polar extracts (dichloromethane and ethylacetate extracts) which 
could not be investigated in this research work. But also the polar extracts (methanol 100% and 
methanol 50% extract) should be further processed.  In the methanolic fraction are still a great 
number of compounds not isolated as they were found in very small amounts. In addition, 
there are further compounds that would have a good yield, but due to time limitations they 
were not isolated yet. 
Moreover, phytochemical and pharmacological investigations of the remaining three medicinal 
plants F. indica, P. capensis and V. apiculata should be performed in the same way as for M. 
salicifolia. 
Lastly, dissemination of the results is essential and should be done to increase awareness of the 
four medicinal plants. This should be done in Arusha and Manyara regions, where the 
ethnopharmacological survey was conducted, but also in all other parts of Tanzania. Moreover, 
Summary and future recommendation 
188 
 
results dissemination should be done in different languages in such a way that every Tanzanian 
would understand and be in position to utilize the knowledge whenever in need.
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6 Appendix 
6.1 Plant samples and voucher specimen collection sites 
Plant name Region Area of collection Parts collected Elev. 
(m) 
Southings Eastings 
M. salicifolia Arusha Ngorongoro 
Conservation 
Area (Mokilali 
village), Repeater 
area 
Stems, roots, leaves 2958 3.26998 35.43458 
Arusha Arusha National 
Park, Miriakamba 
area 
Roots, stems 2600 3.23539 36.78986 
Arusha Monduli 
mountains area 
Roots, bark, leaves 2188 3.2338 36.48629 
Kilimanjaro Kilimanjaro 
National Park, 
Londorosi area 
Stems, roots, leaves 2925 2.97628 37.1943 
P. capensis Arusha Ngorongoro 
Conservation 
Area, Mishili 
village, Londolo 
area. 
Roots, bark, leaves 1728 3.00993 35.53213 
Kilimanjaro Uparo village, 
Kawawa road 
area 
Roots, stems 888 3.37588 37.45669 
Arusha Monduli Juu, 
Amairete village. 
Bark, roots, leaves 1783 3.1418 36.2303 
Arusha Lake Duluti 
Catchment forest 
reserve 
Stems 1287 3.3911 36.78811 
F. indica Arusha Nkoanenkole 
Catchment forest 
reserve 
Roots, bark, leaves, stems 1383 3.32902 36.8601 
Kilimanjaro Kikavu area near 
Weruweru village 
Roots, bark, leaves, stems 926 3.32359 37.21609 
V. apiculata Arusha Ngorongoro 
Conservation 
Area, Kitete wild 
life corridor 
Stems, roots, leaves, bark 1778 3.20849 35.88888 
Arusha Monduli Juu, 
Amairete village 
Stems, roots, leaves 1772 3.25198 36.3912 
Arusha Ngongongare 
village 
Leaves, stems, roots 1385 3.31336 36.87664 
Kilimanjaro Kikavu area near 
Weruweru village 
Roots, bark, stems, leaves 926 3.32359 37.21609 
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6.2 Location of the interviewed TMPs 
TMP Gender Age (Yrs) Ethnical group Region District Village Elev. (m) Southings Eastings 
1 M 59 Maasai Arusha Monduli Emairete 1773 3.23862 36.38392 
2 M Elder Maasai Arusha Monduli Emairete 1816 3.25839 36.40024 
3 M Elder Maasai Arusha Monduli Emairete 1767 3.1536 36.24017 
4 F Elder Maasai Arusha Monduli Mti Mmoja 1387 3.41442 36.34145 
5 F Elder Maasai Arusha Monduli Mti Mmoja 1393 3.41611 36.27681 
6 F Elder Maasai Arusha Monduli Mti Mmoja 1411 3.40319 36.3166 
7 M 68 Maasai Arusha Monduli Mswakini juu 1055 3.62871 36.04805 
8 M 71 Maasai Arusha Monduli Mswakini juu 1087 3.66769 36.05683 
9 M Elder Maasai Arusha Monduli Esilalei 1076 3.48274 36.00033 
10 F 89 Maasai Arusha Monduli Lemiyoni 1099 3.56462 36.11232 
11 M 74 Maasai Arusha Monduli Makuyuni 1071 3.55265 36.09772 
12 M 57 Maasai Arusha Monduli Lokisale 1487 3.76241 36.42029 
13 F 55 Maasai Arusha Monduli Bwawani 1234 3.55982 36.59927 
14 M 65 Maasai Arusha Monduli Engaruka chini 805 2.99626 35.99886 
15 M 85 Maasai Arusha Monduli Engaruka Juu 886 2.99432 35.9734 
16 F Elder Maasai Arusha Monduli Selela 1051 3.21441 35.95958 
17 M Elder Maasai Arusha Ngorongoro Osinoni 1774 3.36267 35.09418 
18 F 50 Maasai Arusha Ngorongoro Enduleni 1687 3.22101 35.26678 
19 F 50 Maasai Arusha Ngorongoro Olerobi 2402 3.24484 35.48767 
20 M 57 Maasai Arusha Ngorongoro Olerobi 2487 3.20961 35.45918 
21 F 52 Maasai Arusha Ngorongoro Nainokanoka 2603 3.02535 35.69004 
22 M 63 Maasai Arusha Ngorongoro Nainokanoka 2603 3.02831 35.69046 
23 M Elder Maasai Arusha Ngorongoro Erkepus 1813 3.11943 35.68994 
24 F 58 Maasai Arusha Ngorongoro Erkepus 2368 3.11195 35.68204 
25 F Elder Maasai Arusha Ngorongoro Nakurro 2461 2.95734 35.70001 
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TMP Gender Age (Yrs) Ethnical group Region District Village Elev. (m) Southings Eastings 
26 F Elder Maasai Arusha Ngorongoro Aleilalei 2421 2.9437 35.69836 
27 F Elder Maasai Arusha Ngorongoro Ngoile 1319 3.36626 35.48332 
28 M Elder Maasai Arusha Ngorongoro Oloipiri 2002 2.04288 35.43497 
29 M Elder Maasai Arusha Ngorongoro Sakala 2032 2.07235 35.60486 
30 M Elder Maasai Arusha Ngorongoro Masurumunyi 1212 2.5051 35.60578 
31 M 65 Sonjo Arusha Ngorongoro Samunge 1362 2.15496 35.70259 
32 M Elder Sonjo Arusha Ngorongoro Digodigo 1295 2.14626 35.73663 
33 M Elder Maasai Arusha Ngorongoro Engarasero 658 2.61299 35.8793 
34 M 78 Maasai Arusha Ngorongoro Engarasero 673 2.61638 35.87821 
35 F 56 Maasai Arusha Ngorongoro Engarasero 658 2.61299 35.8793 
36 F Elder Maasai Manyara Simanjiro Narakauo 1487 4.17542 36.50721 
37 F Elder Maasai Manyara Simanjiro Narakauo 1428 4.23035 36.49099 
38 F Elder Maasai Manyara Simanjiro Njiro 1361 4.46151 37.205 
39 F Elder Maasai Manyara Simanjiro Njiro 1339 4.45857 37.19987 
40 F Elder Maasai Manyara Simanjiro Laangai 1321 4.26816 37.2086 
41 F Elder Maasai Manyara Simanjiro Narosoito 1332 4.44078 37.20198 
42 M 55 Muarusha Manyara Simanjiro Namalulu 1407 4.34789 36.95582 
43 F 50 Maasai Manyara Simanjiro Sukuro 1456 4.03829 36.54712 
44 F Elder Maasai Manyara Simanjiro Sukuro 1473 4.01962 36.53444 
45 M Elder Muarusha Manyara Simanjiro Terrat 1406 3.88659 36.59645 
46 F 80 Maasai Manyara Simanjiro Terrat 1427 3.88068 36.58871 
47 F Elder Maasai Manyara Simanjiro Loswaki 1398 3.86568 36.61665 
48 M Elder Maasai Manyara Simanjiro Ngage 647 4.16888 37.4818 
49 M Elder Maasai Manyara Simanjiro Loiborsoit B 644 4.33889 37.46945 
50 F Elder Maasai Manyara Simanjiro Landanai 1174 4.0781 37.13743 
51 M Elder Maasai Manyara Simanjiro Naberera  1447 4.20551 36.93122 
52 F Elder Maasai Manyara Simanjiro Rotiana 1450 4.15155 36.82554 
53 M Elder Maasai Manyara Simanjiro Kitwai A 1120 4.70308 37.05108 
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TMP Gender Age (Yrs) Ethnical group Region District Village Elev. (m) Southings Eastings 
54 M Elder Maasai Manyara Simanjiro Loibosiret 1358 4.2174 36.37105 
55 M 77 Maasai Manyara Simanjiro Emboreet 1518 3.97654 36.43325 
56 F 60 Maasai Manyara Simanjiro Loibosoit A 1576 3.88093 36.43081 
57 M Elder Maasai Manyara Kiteto Ndedo 1021 4.87433 36.78964 
58 M Elder Maasai Manyara Kiteto Ndaleta 1618 5.22357 36.49631 
59 F Elder Maasai Manyara Kiteto Mbigiri 1269 5.32589 37.02747 
60 M Elder Maasai Manyara Kiteto Kibaya 1469 5.31535 36.56672 
61 F Elder Maasai Manyara Kiteto Loolera 1257 5.36553 37.24114 
62 M Elder Maasai Manyara Kiteto Loolera 1287 5.39836 37.22775 
63 M Elder Maasai Manyara Kiteto Lembapuli 1241 5.38875 37.26522 
64 M Elder Maasai Manyara Kiteto Namelok 1646 5.39669 36.51591 
65 M Elder Maasai Manyara Kiteto Irkiushibor 1114 4.78977 36.38186 
 
Note:  
Elder = older TMP, looks older than 50 years but did not know his/her age 
F = female TMP 
M = male TMP 
Elev. = elevation 
Yrs = years 
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6.3 Reported medicinal uses of the four plants 
Plant name Diseases treated 
Number of TMPs responding 
on particular disease 
Total number of 
responding TMPs % 
M. salicifolia 
Gonorrhoea 53 65 81.54 
Running nose/Flue 48 65 73.85 
Back pains 43 65 66.15 
Sinus headache 40 65 61.54 
Severe cough 36 65 55.38 
Joint pains 31 65 47.69 
Immunity boosting 30 65 46.15 
Abdominal pains  13 65 20 
Pneumonia 11 65 16.92 
Gouts 10 65 15.38 
Urination problems 10 65 15.38 
Fever 8 65 12.31 
Tonsillitis 5 65 7.69 
Colic 4 65 6.15 
Liver problems 2 65 3.08 
Diarrhoea 2 65 3.08 
Tuberculosis 2 65 3.08 
Malaria 2 65 3.08 
P. capensis 
Libido 58 65 89.23 
Blood loss  47 65 72.30 
Joint pains 45 65 69.23 
Back pains 38 65 58.46 
General body strength 33 65 50.77 
Abdominal pains 21 65 32.31 
Malaria 20 65 30.77 
Bile oversecretion 16 65 24.61 
Stomach upset  15 65 23.08 
Diarrhoea 15 65 23.08 
Gouts 12 65 18.46 
STDs 9 65 13.85 
Appetizer 8 65 12.31 
Urination problems 7 65 10.77 
Fever 4 65 6.154 
Colic 4 65 6.154 
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Reported medicinal uses of the four plants continued 
Plant name Diseases treated 
Number of TMPs responding 
on particular disease 
Total number of 
responding TMPs % 
F. indica 
Fever 60 65 92.31 
Malaria 59 65 90.77 
Jaundice 57 65 87.69 
Enlarged spleen 56 65 86.15 
Joint pains 49 65 75.38 
Pneumonia 48 65 73.84 
Stomach upset 45 65 69.23 
Difficulty in breathing 45 65 69.23 
Back pains 43 65 66.15 
Gouts 33 65 50.77 
Mastitic breasts 32 65 49.23 
Asthma 27 65 41.54 
Dizziness 24 65 36.92 
Body strength 23 65 35.38 
Urination problems 22 65 33.85 
Diarrhoea 14 65 21.54 
STDs 13 65 20.00 
Bile oversecretion 4 65 6.15 
Phlegmon 2 65 3.08 
Burn wounds 2 65 3.08 
V. apiculata 
Eye infection/Sticky eyes 48 65 73.85 
Diarrhoea 43 65 66.15 
Stomach upset 42 65 64.62 
Reduced milk secretion  33 65 50.77 
General body strength 30 65 46.15 
Joint pains 24 65 36.92 
Back pains 17 65 26.15 
Gouts 12 65 18.46 
Malaria 12 65 18.46 
Lungs pain 6 65 9.23 
6.4 Plant parts used 
Plant part 
M. salicifolia P. capensis F. indica V. apiculata 
Number of 
responding 
TMPs % 
Number of 
responding 
TMPs 
% Number of 
responding 
TMPs 
% Number of 
responding 
TMPs 
% 
Roots 53 81.5 48 73.8 60 92.3 58 89.2 
Bark  60 92.3 52 80 44 67.7 14 21.5 
Stems 18 27.7 19 29.2 23 35.4 30 46.1 
Leaves 0 0 0 0 0 0 48 73.8 
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6.5 Plants collection and storage, remedies preparations, dosage, application form and application time 
Plant Plant parts collection 
and storage 
Remedies preparation  Dosage Application 
form 
Application time 
M. salicifolia 
Roots, stems and bark:  
are collected from the 
wild, the outer dirty part 
is removed,  the 
remaining part is sun 
dried, crushed and 
stored  in a plastic bag 
or tightened  glass or 
plastic containers.   
 
 
 Leaves:  The V. 
apiculata leaves are 
collected, dried, crushed 
and then stored in 
tightened containers. 
For all four plants: 
 1.  Crushed (fresh/dried) plant parts 
are infused in warm water, thoroughly 
stirred and left to stand for a few hours 
before utilization. 
2.  Crushed plants parts, drug 
decoctions and drug infusions, are 
mixed with boiling soup of either 
beef/goat/ lamb fatty meat, left to boil 
for several minutes, thoroughly stirred 
and consumed while warm.  
3. One teaspoon of crushed plant part 
roots/bark/stem is mixed in a boiling 
tea with milk, left to boil for a few 
minutes, then filtered and consumed.  
4. Powdered plant material is mixed 
with water, boiled, followed by 
addition of 2 spoons of ghee and 
filtered. 
Depends on body weight. 
250 – 1000 mL of remedy is 
taken in the morning and in 
the evening. Less is taken by 
children and pregnant 
women (about 250 mL). 
Oral, inhalation. Morning, afternoon and 
evening. Taken after 
meal. 
P. capensis 
No specific dose, but dose 
adapted to specific patients 
e. g. 250 mL for children, 
500 mL for women and 1 L 
for men. Remedy is, taken 2 
to 3 times a day until 
recovery. 
Oral. Preferably morning and 
in the evening, few 
minutes before meal. 
Can also be taken at any 
time. 
F. indica 
No specific dosage.  Oral. Morning and/or 
evening. After or before 
meal time. 
V. apiculata 
V. apiculata leaves are placed in warm 
water, stirred, left for several hours, 
filtered then used to wash sticky eyes/ 
infected eyes.   
Another way of preparation is 
decoction, where by fresh or dried 
leaves are boiled with water, cooled, 
filtered and then utilized.  
Note:  preparation for the bark, roots 
and stems, is described above. 
No specific dosage.  Oral, bathing / 
washing 
infected eyes. 
Morning and/or 
evening. After or before 
meal time. 
